PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
"35343622","Geometric approaches to assessing the numerical feasibility for conducting matching-adjusted indirect comparisons","Glimm E, Yau L.","Pharm Stat. 2022 Mar 28. doi: 10.1002/pst.2210. Online ahead of print.","Glimm E","Pharm Stat","2022","2022/03/28","","","10.1002/pst.2210"
"35337365","Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucel","Cartron G, Fox CP, Liu FF, Kostic A, Hasskarl J, Li D, Bonner A, Zhang Y, Maloney DG, Kuruvilla J.","Exp Hematol Oncol. 2022 Mar 25;11(1):17. doi: 10.1186/s40164-022-00268-z.","Cartron G","Exp Hematol Oncol","2022","2022/03/26","PMC8953336","","10.1186/s40164-022-00268-z"
"35289710","Carfilzomib 56 mg/m(2) twice-weekly in combination with dexamethasone and daratumumab (KdD) versus daratumumab in combination with bortezomib and dexamethasone (DVd): a matching-adjusted indirect treatment comparison","Weisel K, Nooka AK, Terpos E, Spencer A, Goldschmidt H, Dirnberger F, DeCosta L, Yusuf A, Kumar S.","Leuk Lymphoma. 2022 Mar 15:1-10. doi: 10.1080/10428194.2022.2047962. Online ahead of print.","Weisel K","Leuk Lymphoma","2022","2022/03/15","","","10.1080/10428194.2022.2047962"
"35281934","Eluxadoline Versus Antispasmodics in the Treatment of Irritable Bowel Syndrome: An Adjusted Indirect Treatment Comparison Meta-analysis","Qin D, Tao QF, Huang SL, Chen M, Zheng H.","Front Pharmacol. 2022 Feb 23;13:757969. doi: 10.3389/fphar.2022.757969. eCollection 2022.","Qin D","Front Pharmacol","2022","2022/03/14","PMC8906885","","10.3389/fphar.2022.757969"
"35280921","Thirty-day mortality with andexanet alfa compared with prothrombin complex concentrate therapy for life-threatening direct oral anticoagulant-related bleeding","Cohen AT, Lewis M, Connor A, Connolly SJ, Yue P, Curnutte J, Alikhan R, MacCallum P, Tan J, Green L.","J Am Coll Emerg Physicians Open. 2022 Mar 5;3(2):e12655. doi: 10.1002/emp2.12655. eCollection 2022 Apr.","Cohen AT","J Am Coll Emerg Physicians Open","2022","2022/03/14","PMC8898077","","10.1002/emp2.12655"
"35279814","Transarterial Radioembolization Versus Atezolizumab-Bevacizumab in Unresectable Hepatocellular Carcinoma: A Matching-Adjusted Indirect Comparison of Time to Deterioration in Quality of Life","Agirrezabal I, Brennan VK, Colaone F, Shergill S, Pereira H, Chatellier G, Vilgrain V.","Adv Ther. 2022 Mar 12. doi: 10.1007/s12325-022-02099-0. Online ahead of print.","Agirrezabal I","Adv Ther","2022","2022/03/13","","","10.1007/s12325-022-02099-0"
"35277411","Pharmacological and non-pharmacological interventions for adults with ADHD: protocol for a systematic review and network meta-analysis","Cortese S, Del Giovane C, Chamberlain S, Philipsen A, Young S, Bilbow A, Cipriani A.","BMJ Open. 2022 Mar 11;12(3):e058102. doi: 10.1136/bmjopen-2021-058102.","Cortese S","BMJ Open","2022","2022/03/12","PMC8919448","","10.1136/bmjopen-2021-058102"
"35272073","Comparison of Different Biologics for Treating Chronic Rhinosinusitis with Nasal Polyps: A Network Analysis","Cai S, Xu S, Lou H, Zhang L.","J Allergy Clin Immunol Pract. 2022 Mar 8:S2213-2198(22)00235-5. doi: 10.1016/j.jaip.2022.02.034. Online ahead of print.","Cai S","J Allergy Clin Immunol Pract","2022","2022/03/10","","","10.1016/j.jaip.2022.02.034"
"35267593","Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer","Lorusso D, Guy H, Samyshkin Y, Hawkes C, Estenson K, Coleman RL.","Cancers (Basel). 2022 Mar 2;14(5):1285. doi: 10.3390/cancers14051285.","Lorusso D","Cancers (Basel)","2022","2022/03/10","PMC8909094","","10.3390/cancers14051285"
"35237351","A population-based study in resected esophageal or gastroesophageal junction cancer aligned with CheckMate 577","Pape M, Vissers PAJ, Beerepoot LV, van Berge Henegouwen MI, Lagarde SM, Mook S, Moehler M, van Laarhoven HWM, Verhoeven RHA.","Ther Adv Med Oncol. 2022 Feb 26;14:17588359221075495. doi: 10.1177/17588359221075495. eCollection 2022.","Pape M","Ther Adv Med Oncol","2022","2022/03/03","PMC8883292","","10.1177/17588359221075495"
"35232230","Effectiveness of crizotinib versus entrectinib in ROS1-positive non-small-cell lung cancer using clinical and real-world data","Tremblay G, Groff M, Iadeluca L, Daniele P, Wilner K, Wiltshire R, Bartolome L, Usari T, Cappelleri JC, Camidge DR.","Future Oncol. 2022 Mar 2. doi: 10.2217/fon-2021-1102. Online ahead of print.","Tremblay G","Future Oncol","2022","2022/03/02","","","10.2217/fon-2021-1102"
"35179764","Systematic review and pooled analysis of survival outcomes in patients with relapsed or refractory B-cell acute lymphoblastic leukaemia who have undergone haematopoietic stem cell transplant","Russell-Smith TA, Chadda S, LeReun C, Bajko P, Doogan E.","Eur Rev Med Pharmacol Sci. 2022 Feb;26(3):975-995. doi: 10.26355/eurrev_202202_28007.","Russell-Smith TA","Eur Rev Med Pharmacol Sci","2022","2022/02/18","","","10.26355/eurrev_202202_28007"
"35175308","Proptosis and Diplopia Response With Teprotumumab and Placebo vs the Recommended Treatment Regimen With Intravenous Methylprednisolone in Moderate to Severe Thyroid Eye Disease: A Meta-analysis and Matching-Adjusted Indirect Comparison","Douglas RS, Dailey R, Subramanian PS, Barbesino G, Ugradar S, Batten R, Qadeer RA, Cameron C.","JAMA Ophthalmol. 2022 Feb 17:e216284. doi: 10.1001/jamaophthalmol.2021.6284. Online ahead of print.","Douglas RS","JAMA Ophthalmol","2022","2022/02/17","PMC8855315","","10.1001/jamaophthalmol.2021.6284"
"35158805","Cost-Effectiveness Analysis of Axicabtagene Ciloleucel vs. Tisagenlecleucel for the Management of Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Spain","Bastos-Oreiro M, de Las Heras A, Presa M, Casado MA, Pardo C, Martín-Escudero V, Sureda A.","Cancers (Basel). 2022 Jan 21;14(3):538. doi: 10.3390/cancers14030538.","Bastos-Oreiro M","Cancers (Basel)","2022","2022/02/15","PMC8833685","","10.3390/cancers14030538"
"35157216","A Matching-Adjusted Indirect Comparison of Single-Arm Trials in Patients with Relapsed or Refractory Follicular Lymphoma Who Received at Least Two Prior Systemic Treatments: Tazemetostat was Associated with a Lower Risk for Safety Outcomes Versus the PI3-Kinase Inhibitors Idelalisib, Duvelisib, Copanlisib, and Umbralisib","Proudman D, Nellesen D, Gupta D, Adib D, Yang J, Mamlouk K.","Adv Ther. 2022 Feb 14. doi: 10.1007/s12325-022-02054-z. Online ahead of print.","Proudman D","Adv Ther","2022","2022/02/14","","","10.1007/s12325-022-02054-z"
"35138877","Oral Antihypertensives for Nonsevere Pregnancy Hypertension: Systematic Review, Network Meta- and Trial Sequential Analyses","Bone JN, Sandhu A, Abalos ED, Khalil A, Singer J, Prasad S, Omar S, Vidler M, von Dadelszen P, Magee LA.","Hypertension. 2022 Mar;79(3):614-628. doi: 10.1161/HYPERTENSIONAHA.121.18415. Epub 2022 Jan 4.","Bone JN","Hypertension","2022","2022/02/09","PMC8823910","","10.1161/HYPERTENSIONAHA.121.18415"
"35129275","Indirect treatment comparisons: Choosing the right tool for the job","Pratley RE, Gorst-Rasmussen A.","Diabetes Obes Metab. 2022 Feb 7. doi: 10.1111/dom.14664. Online ahead of print.","Pratley RE","Diabetes Obes Metab","2022","2022/02/07","","","10.1111/dom.14664"
"35128059","A Method for Reconstructing Individual Patient Data From Kaplan-Meier Survival Curves That Incorporate Marked Censoring Times","Rogula B, Lozano-Ortega G, Johnston KM.","MDM Policy Pract. 2022 Jan 31;7(1):23814683221077643. doi: 10.1177/23814683221077643. eCollection 2022 Jan-Jun.","Rogula B","MDM Policy Pract","2022","2022/02/07","PMC8808036","","10.1177/23814683221077643"
"35114819","Indirect treatment comparisons of avapritinib versus midostaurin for patients with advanced systemic mastocytosis","Pilkington H, Smith S, Roskell N, Iannazzo S.","Future Oncol. 2022 Feb 4. doi: 10.2217/fon-2021-1509. Online ahead of print.","Pilkington H","Future Oncol","2022","2022/02/04","","","10.2217/fon-2021-1509"
"35106186","Effect of pretreatment with dexamethasone on the efficacy and immune-related adverse events of immunotherapy in first-line treatment for advanced non-small cell lung cancer: a network meta-analysis of randomized control trials","Li Y, He F, Liu S, Zhang Y, Li L, Wang B, Lan L, Pan Z.","Am J Clin Exp Immunol. 2021 Dec 15;10(4):93-102. eCollection 2021.","Li Y","Am J Clin Exp Immunol","2021","2022/02/02","PMC8784760","",""
"35090692","Non-optimal methodology questions indirect treatment comparison of dupilumab vs. other biologics in severe asthma","Bourdin A, Molinari N.","Respir Med. 2022 Jan;191:105999. doi: 10.1016/j.rmed.2020.105999. Epub 2020 May 15.","Bourdin A","Respir Med","2022","2022/01/29","","","10.1016/j.rmed.2020.105999"
"35090691","Response to the correspondence: ""Non-optimal methodology questions indirect treatment comparison of dupilumab vs other biologics in severe asthma""","Bateman ED, Khan AH, Xu Y, Guyot P, Chao J, Kamat S, Rowe P, Burnett H, Msihid J, Weinreich D, Pavord ID.","Respir Med. 2022 Jan;191:106088. doi: 10.1016/j.rmed.2020.106088. Epub 2020 Jul 9.","Bateman ED","Respir Med","2022","2022/01/29","","","10.1016/j.rmed.2020.106088"
"35090690","Comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma [Respir Med 2020]","Martin N, Papi A, Bratton DJ, Chan R, Howarth PH, Abbott CB, Keene ON, Bel EH.","Respir Med. 2022 Jan;191:106065. doi: 10.1016/j.rmed.2020.106065. Epub 2020 Jun 11.","Martin N","Respir Med","2022","2022/01/29","","","10.1016/j.rmed.2020.106065"
"35090688","Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma","Bateman ED, Khan AH, Xu Y, Guyot P, Chao J, Kamat S, Rowe P, Burnett H, Msihid J, Weinreich D, Pavord ID.","Respir Med. 2022 Jan;191:105991. doi: 10.1016/j.rmed.2020.105991. Epub 2020 Apr 29.","Bateman ED","Respir Med","2022","2022/01/29","","","10.1016/j.rmed.2020.105991"
"35073727","Indirect comparison of pembrolizumab monotherapy versus nivolumab + ipilimumab in first-line metastatic lung cancer","Halmos B, Burke T, Kalyvas C, Insinga R, Vandormael K, Frederickson A, Piperdi B.","Immunotherapy. 2022 Apr;14(5):295-307. doi: 10.2217/imt-2021-0273. Epub 2022 Jan 25.","Halmos B","Immunotherapy","2022","2022/01/25","","","10.2217/imt-2021-0273"
"35068168","Indirect comparison of apomorphine sublingual film and levodopa inhalation powder for Parkinson's disease 'OFF' episodes","Thach A, Zichlin ML, Kirson N, Yang K, Gaburo K, Pappert E, Mehta D, Williams GR.","J Comp Eff Res. 2022 Mar;11(4):285-295. doi: 10.2217/cer-2021-0178. Epub 2022 Jan 24.","Thach A","J Comp Eff Res","2022","2022/01/24","","","10.2217/cer-2021-0178"
"35058055","Importance of Time Point-Specific Indirect Treatment Comparisons of Osteoporosis Treatments: A Systematic Literature Review and Network Meta-Analyses","Willems D, Javaid MK, Pinedo-Villanueva R, Libanati C, Yehoshua A, Charokopou M.","Clin Ther. 2022 Jan;44(1):81-97. doi: 10.1016/j.clinthera.2021.11.015. Epub 2022 Jan 19.","Willems D","Clin Ther","2022","2022/01/21","","","10.1016/j.clinthera.2021.11.015"
"35044552","An indirect comparison meta-analysis of noninvasive intravesical instillation and intravesical injection of botulinum toxin-A in bladder disorders","Yunfeng G, Fei L, Junbo L, Dingyuan Y, Chaoyou H.","Int Urol Nephrol. 2022 Mar;54(3):479-491. doi: 10.1007/s11255-022-03107-6. Epub 2022 Jan 19.","Yunfeng G","Int Urol Nephrol","2022","2022/01/19","","","10.1007/s11255-022-03107-6"
"35042448","An anchored simulated treatment comparison of uptitration of amlodipine compared with a low-dose combination treatment with amlodipine 5 mg/bisoprolol 5 mg for patients with hypertension suboptimally controlled by amlodipine 5 mg monotherapy","Foch C, Feifel J, Gottwald-Hostalek U.","Curr Med Res Opin. 2022 Apr;38(4):587-593. doi: 10.1080/03007995.2022.2030112. Epub 2022 Feb 1.","Foch C","Curr Med Res Opin","2022","2022/01/19","","","10.1080/03007995.2022.2030112"
"35040693","How does risdiplam compare with other treatments for Types 1-3 spinal muscular atrophy: a systematic literature review and indirect treatment comparison","Ribero VA, Daigl M, Martí Y, Gorni K, Evans R, Scott DA, Mahajan A, Abrams KR, Hawkins N.","J Comp Eff Res. 2022 Apr;11(5):347-370. doi: 10.2217/cer-2021-0216. Epub 2022 Jan 18.","Ribero VA","J Comp Eff Res","2022","2022/01/18","","","10.2217/cer-2021-0216"
"35030634","Indirect Comparison of Tisagenlecleucel and Historical Treatments for Relapsed/Refractory Diffuse Large B-cell Lymphoma","Maziarz RT, Zhang J, Yang H, Chai X, Yuan C, Schwarz E, Jakovac M, Martinez-Prieto M, Agarwal A, Degtyarev E, Tam CS, Salles GA.","Blood Adv. 2022 Jan 14:bloodadvances.2021006280. doi: 10.1182/bloodadvances.2021006280. Online ahead of print.","Maziarz RT","Blood Adv","2022","2022/01/14","","","10.1182/bloodadvances.2021006280"
"35028245","The Degree of Programmed Death-Ligand 1 (PD-L1) Positivity as a Determinant of Outcomes in Metastatic Triple-Negative Breast Cancer Treated With First-Line Immune Checkpoint Inhibitors","Di Spazio L, Rivano M, Cancanelli L, Chiumente M, Mengato D, Messori A.","Cureus. 2022 Jan 9;14(1):e21065. doi: 10.7759/cureus.21065. eCollection 2022 Jan.","Di Spazio L","Cureus","2022","2022/01/14","PMC8743568","","10.7759/cureus.21065"
"34999620","Current Therapies in Patients With Posterior Semicircular Canal BPPV, a Systematic Review and Network Meta-analysis","Li D, Cheng D, Yang W, Chen T, Zhang D, Ren J, Zhao Y.","Otol Neurotol. 2022 Apr 1;43(4):421-428. doi: 10.1097/MAO.0000000000003464.","Li D","Otol Neurotol","2022","2022/01/09","","","10.1097/MAO.0000000000003464"
"34991104","A Cost-effectiveness Analysis Comparing Pembrolizumab-Axitinib, Nivolumab-Ipilimumab, and Sunitinib for Treatment of Advanced Renal Cell Carcinoma","Chan A, Dang C, Wisniewski J, Weng X, Hynson E, Zhong L, Wilson L.","Am J Clin Oncol. 2022 Feb 1;45(2):66-73. doi: 10.1097/COC.0000000000000884.","Chan A","Am J Clin Oncol","2022","2022/01/06","","","10.1097/COC.0000000000000884"
"34981073","COVID-19 vaccination effectiveness rates by week and sources of bias","Ostropolets A, Hripcsak G.","medRxiv. 2021 Dec 24:2021.12.22.21268253. doi: 10.1101/2021.12.22.21268253. Preprint.","Ostropolets A","medRxiv","2021","2022/01/04","PMC8722616","","10.1101/2021.12.22.21268253"
"34978255","Comparative efficacy of tisagenlecleucel and lisocabtagene maraleucel among adults with relapsed/refractory large B-cell lymphomas: an indirect treatment comparison","Schuster SJ, Zhang J, Yang H, Agarwal A, Tang W, Martinez-Prieto M, Bollu V, Kuzan D, Maziarz RT, Kersten MJ.","Leuk Lymphoma. 2022 Jan 2:1-10. doi: 10.1080/10428194.2021.2010069. Online ahead of print.","Schuster SJ","Leuk Lymphoma","2022","2022/01/03","","","10.1080/10428194.2021.2010069"
"34966607","Efficacy of Immune Checkpoint Inhibitors in Patients with Mismatch Repair-Deficient or Microsatellite Instability-High Metastatic Colorectal Cancer: Analysis of Three Phase-II Trials","Cancanelli L, Rivano M, Di Spazio L, Chiumente M, Mengato D, Messori A.","Cureus. 2021 Nov 25;13(11):e19893. doi: 10.7759/cureus.19893. eCollection 2021 Nov.","Cancanelli L","Cureus","2021","2021/12/30","PMC8710086","","10.7759/cureus.19893"
"34931610","Comparative efficacy of ravulizumab and eculizumab in the treatment of atypical hemolytic uremic syndrome: An indirect comparison using clinical trial data ","Tomazos I, Hatswell AJ, Cataland S, Chen P, Freemantle N, Lommele Å, Deighton K, Knowles E, Sheerin NS, Rondeau E.","Clin Nephrol. 2021 Dec 21. doi: 10.5414/CN110516. Online ahead of print.","Tomazos I","Clin Nephrol","2021","2021/12/21","","","10.5414/CN110516"
"34922383","An indirect treatment comparison of semaglutide 2.0 mg versus dulaglutide 3.0 mg and 4.5 mg using multilevel network meta-regression","Lingvay I, Bauer R, Baker-Knight J, Lawson J, Pratley R.","J Clin Endocrinol Metab. 2021 Dec 18:dgab905. doi: 10.1210/clinem/dgab905. Online ahead of print.","Lingvay I","J Clin Endocrinol Metab","2021","2021/12/18","","","10.1210/clinem/dgab905"
"34912479","Use of [(177)Lu]Lu-DOTA-TATE in the treatment of gastroenteropancreatic neuroendocrine tumours: Results of a UK cost-effectiveness modelling study","Glover M, Caplin M, Leeuwenkamp OR, Longworth L.","EJC Suppl. 2021 Nov 9;16:14-23. doi: 10.1016/j.ejcsup.2021.06.003. eCollection 2021 Nov.","Glover M","EJC Suppl","2021","2021/12/16","PMC8591195","","10.1016/j.ejcsup.2021.06.003"
"34912478","Matching-adjusted indirect treatment comparison of [(177)Lu]Lu-DOTA-TATE, everolimus and sunitinib in advanced, unresectable gastroenteropancreatic neuroendocrine tumours: Relative effectiveness of [(177)Lu]Lu-DOTA-TATE in gastroenteropancreatic neuroendocrine tumours","Khan MS, Stamp E, Sammon C, Brabander T, de Herder WW, Pavel ME.","EJC Suppl. 2021 Nov 9;16:5-13. doi: 10.1016/j.ejcsup.2021.06.002. eCollection 2021 Nov.","Khan MS","EJC Suppl","2021","2021/12/16","PMC8591206","","10.1016/j.ejcsup.2021.06.002"
"34885106","Adjusted Comparison of Outcomes between Patients from CARTITUDE-1 versus Multiple Myeloma Patients with Prior Exposure to PI, Imid and Anti-CD-38 from a German Registry","Merz M, Goldschmidt H, Hari P, Agha M, Diels J, Ghilotti F, Perualila NJ, Cabrieto J, Haefliger B, Sliwka H, Schecter JM, Jackson CC, Olyslager Y, Akram M, Nesheiwat T, Kellermann L, Jagannath S.","Cancers (Basel). 2021 Nov 29;13(23):5996. doi: 10.3390/cancers13235996.","Merz M","Cancers (Basel)","2021","2021/12/10","PMC8656798","","10.3390/cancers13235996"
"34877623","Matching-Adjusted Indirect Comparison of Crisaborole Ointment 2% vs. Topical Calcineurin Inhibitors in the Treatment of Patients with Mild-to-Moderate Atopic Dermatitis","Thom H, Cheng V, Keeney E, Neary MP, Eccleston A, Zang C, Cappelleri JC, Cha A, Thyssen JP.","Dermatol Ther (Heidelb). 2022 Jan;12(1):185-194. doi: 10.1007/s13555-021-00646-1. Epub 2021 Dec 8.","Thom H","Dermatol Ther (Heidelb)","2022","2021/12/08","PMC8776944","","10.1007/s13555-021-00646-1"
"34864380","Indirect treatment comparison of cenobamate to other ASMs for the treatment of uncontrolled focal seizures","Privitera M, Richy FF, Schabert VF.","Epilepsy Behav. 2022 Jan;126:108429. doi: 10.1016/j.yebeh.2021.108429. Epub 2021 Dec 1.","Privitera M","Epilepsy Behav","2022","2021/12/05","","","10.1016/j.yebeh.2021.108429"
"34841472","Conceptual Framework and Methodological Challenges for Modeling Effectiveness in Oncology Treatment Sequence Models","Huang M, Ramsey S, Xue W, Xie J, Pellissier J, Briggs A.","Pharmacoeconomics. 2022 Mar;40(3):257-268. doi: 10.1007/s40273-021-01113-7. Epub 2021 Nov 29.","Huang M","Pharmacoeconomics","2022","2021/11/29","","","10.1007/s40273-021-01113-7"
"34822128","Comparative Efficacy of Ciltacabtagene Autoleucel in CARTITUDE-1 vs Physician's Choice of Therapy in the Long-Term Follow-Up of POLLUX, CASTOR, and EQUULEUS Clinical Trials for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma","Weisel K, Martin T, Krishnan A, Jagannath S, Londhe A, Nair S, Diels J, Vogel M, Schecter JM, Banerjee A, Berdeja JG, Nesheiwat T, Garrett A, Qi K, Valluri S, Usmani SZ, Yong K.","Clin Drug Investig. 2022 Jan;42(1):29-41. doi: 10.1007/s40261-021-01100-y. Epub 2021 Nov 25.","Weisel K","Clin Drug Investig","2022","2021/11/25","PMC8755696","","10.1007/s40261-021-01100-y"
"34797506","Apalutamide Compared with Darolutamide for the Treatment of Non-metastatic Castration-Resistant Prostate Cancer: Efficacy and Tolerability in a Matching-Adjusted Indirect Comparison","Chowdhury S, Oudard S, Uemura H, Joniau S, Dearden L, Capone C, Van Sanden S, Diels J, Hadaschik BA.","Adv Ther. 2022 Jan;39(1):518-531. doi: 10.1007/s12325-021-01885-6. Epub 2021 Nov 19.","Chowdhury S","Adv Ther","2022","2021/11/19","PMC8799579","","10.1007/s12325-021-01885-6"
"34765537","Efficacy of Brodalumab and Guselkumab in Patients with Moderate-to-Severe Plaque Psoriasis Who are Inadequate Responders to Ustekinumab: A Matching Adjusted Indirect Comparison","Hampton P, Borg E, Hansen JB, Augustin M.","Psoriasis (Auckl). 2021 Nov 3;11:123-131. doi: 10.2147/PTT.S326121. eCollection 2021.","Hampton P","Psoriasis (Auckl)","2021","2021/11/12","PMC8575184","","10.2147/PTT.S326121"
"34756316","A cost-consequence analysis of the preferential use of secukinumab versus adalimumab for the treatment of psoriatic arthritis","Jiménez-Morales A, Cáliz R, Aceituno S, Prades M, Blanch C.","Reumatol Clin (Engl Ed). 2021 Nov;17(9):536-542. doi: 10.1016/j.reumae.2020.05.009.","Jiménez-Morales A","Reumatol Clin (Engl Ed)","2021","2021/11/10","","","10.1016/j.reumae.2020.05.009"
"34754257","Indirect Treatment Comparison of Damoctocog Alfa Pegol versus Turoctocog Alfa Pegol as Prophylactic Treatment in Patients with Hemophilia A","Vashi P, Batt K, Klamroth R, Mancuso ME, Majewska R, Tiede A, Mantovani LG.","J Blood Med. 2021 Nov 1;12:935-943. doi: 10.2147/JBM.S321288. eCollection 2021.","Vashi P","J Blood Med","2021","2021/11/10","PMC8570287","","10.2147/JBM.S321288"
"34754238","Matching-Adjusted Indirect Comparison of Ribociclib Plus Fulvestrant versus Palbociclib Plus Letrozole as First-Line Treatment of HR+/HER2- Advanced Breast Cancer","Fasching PA, Delea TE, Lu YS, De Boer R, Hurvitz SA, Moynahan A, Chandiwana D, Lanoue B, Hu H, Thuerigen A, O'Shaughnessy J.","Cancer Manag Res. 2021 Nov 1;13:8179-8189. doi: 10.2147/CMAR.S325043. eCollection 2021.","Fasching PA","Cancer Manag Res","2021","2021/11/10","PMC8570288","","10.2147/CMAR.S325043"
"34751591","Palbociclib versus abemaciclib in HR+/HER2- advanced breast cancer: an indirect comparison of patient-reported end points","Law E, Gavanji R, Walsh S, Haltner A, McTavish R, Cameron C.","J Comp Eff Res. 2022 Feb;11(2):109-120. doi: 10.2217/cer-2021-0221. Epub 2021 Nov 9.","Law E","J Comp Eff Res","2022","2021/11/09","","","10.2217/cer-2021-0221"
"34740549","[Recommendations to develop Care Models for patients with Heart Failure (MAIC Project) from macromanagement]","Comin-Colet J, Calero-Molina E, Corbella X, Muñiz J, San Saturnino M, Ibarrola C; Comité Asesor Proyecto MAIC (Apéndice); APÉNDICE Todos los miembros del Comité Asesor del Proyecto MAIC cuya relación en orden alfabético aparece en la siguiente lista han contribuido en la autoría de este artículo.","J Healthc Qual Res. 2021 Nov 2:S2603-6479(21)00090-7. doi: 10.1016/j.jhqr.2021.09.003. Online ahead of print.","Comin-Colet J","J Healthc Qual Res","2021","2021/11/06","","","10.1016/j.jhqr.2021.09.003"
"34733356","Is there a preferred first-line therapy for metastatic renal cell carcinoma? A network meta-analysis","Cattrini C, Messina C, Airoldi C, Buti S, Roviello G, Mennitto A, Caffo O, Gennari A, Bersanelli M.","Ther Adv Urol. 2021 Oct 29;13:17562872211053189. doi: 10.1177/17562872211053189. eCollection 2021 Jan-Dec.","Cattrini C","Ther Adv Urol","2021","2021/11/04","PMC8558789","","10.1177/17562872211053189"
"34714524","Cost-Effectiveness of iGlarLixi Versus iDegLira in Type 2 Diabetes Mellitus Inadequately Controlled by GLP-1 Receptor Agonists and Oral Antihyperglycemic Therapy","McCrimmon RJ, Lamotte M, Ramos M, Alsaleh AJO, Souhami E, Lew E.","Diabetes Ther. 2021 Dec;12(12):3231-3241. doi: 10.1007/s13300-021-01156-1. Epub 2021 Oct 29.","McCrimmon RJ","Diabetes Ther","2021","2021/10/29","PMC8586382","","10.1007/s13300-021-01156-1"
"34714523","Cost-Effectiveness of iGlarLixi in People with Type 2 Diabetes Mellitus Suboptimally Controlled on Basal Insulin Plus Metformin in the UK","McCrimmon RJ, Falla E, Sha JZ, Alsaleh AJO, Lew E, Hudson R, Baxter M, Palmer K.","Diabetes Ther. 2021 Dec;12(12):3217-3230. doi: 10.1007/s13300-021-01159-y. Epub 2021 Oct 29.","McCrimmon RJ","Diabetes Ther","2021","2021/10/29","PMC8586275","","10.1007/s13300-021-01159-y"
"34672224","Matching-adjusted indirect comparison of pneumococcal vaccines V114 and PCV20","Mt-Isa S, Abderhalden LA, Musey L, Weiss T.","Expert Rev Vaccines. 2022 Jan;21(1):115-123. doi: 10.1080/14760584.2021.1994858. Epub 2021 Oct 27.","Mt-Isa S","Expert Rev Vaccines","2022","2021/10/21","","","10.1080/14760584.2021.1994858"
"34664200","Mogamulizumab for Previously Treated Mycosis Fungoides and Sézary Syndrome: An Evidence Review Group Perspective of a NICE Single Technology Appraisal","Grimm SE, Witlox W, Wolff R, Chalker A, Hiligsmann M, Wijnen B, Ahmadu C, Ryder S, Armstrong N, Duffy S, Syndikus I, Kleijnen J, Joore MA.","Pharmacoeconomics. 2021 Oct 19. doi: 10.1007/s40273-021-01098-3. Online ahead of print.","Grimm SE","Pharmacoeconomics","2021","2021/10/19","","","10.1007/s40273-021-01098-3"
"34663559","Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for resected melanoma","Weber JS, Ascierto PA, Middleton MR, Hennicken D, Zoffoli R, Pieters A, Amadi A, Kupas K, Kotapati S, Moshyk A, Schadendorf D.","Eur J Cancer. 2021 Nov;158:225-233. doi: 10.1016/j.ejca.2021.08.028. Epub 2021 Oct 15.","Weber JS","Eur J Cancer","2021","2021/10/19","","","10.1016/j.ejca.2021.08.028"
"34649296","Oral Anticoagulation Timing in Patients with Acute Ischemic Stroke and Atrial Fibrillation","Chang PY, Wang WT, Wu WL, Chang HC, Chen CH, Tsai YW, Chiou SH, Lip GYH, Cheng HM, Chiang CE.","Thromb Haemost. 2021 Oct 14. doi: 10.1055/a-1669-4987. Online ahead of print.","Chang PY","Thromb Haemost","2021","2021/10/14","","","10.1055/a-1669-4987"
"34641745","Combination anticoagulant or P2Y12 inhibitor with low-dose aspirin versus low-dose aspirin alone in patients at risk or with documented coronary and/or peripheral artery disease","Coleman CI, Kharat AA, Bookhart B, Baker WL.","Curr Med Res Opin. 2022 Jan;38(1):27-34. doi: 10.1080/03007995.2021.1991294. Epub 2021 Oct 26.","Coleman CI","Curr Med Res Opin","2022","2021/10/13","","","10.1080/03007995.2021.1991294"
"34621996","Rectal indomethacin and diclofenac are equally efficient in preventing pancreatitis following endoscopic retrograde cholangiopancreatography in average-risk patients","Yu S, Shen X, Li L, Bi X, Chen P, Wu W.","JGH Open. 2021 Aug 31;5(10):1119-1126. doi: 10.1002/jgh3.12643. eCollection 2021 Oct.","Yu S","JGH Open","2021","2021/10/08","PMC8485396","","10.1002/jgh3.12643"
"34616492","Population-adjusted indirect treatment comparison of maintenance PARP inhibitor with or without bevacizumab versus bevacizumab alone in women with newly diagnosed advanced ovarian cancer","Hettle R, McCrea C, Lee CK, Davidson R.","Ther Adv Med Oncol. 2021 Sep 30;13:17588359211049639. doi: 10.1177/17588359211049639. eCollection 2021.","Hettle R","Ther Adv Med Oncol","2021","2021/10/07","PMC8488507","","10.1177/17588359211049639"
"34608814","Letter in reply","Samjoo IA, Worthington E, Drudge C, Zhao M, Cameron C, Häring DA, Stoneman D, Klotz L, Adlard N.","J Comp Eff Res. 2021 Dec;10(17):1267-1269. doi: 10.2217/cer-2021-0203. Epub 2021 Oct 5.","Samjoo IA","J Comp Eff Res","2021","2021/10/05","","","10.2217/cer-2021-0203"
"34597975","Population-adjusted indirect treatment comparison of the SOLO1 and PAOLA-1/ENGOT-ov25 trials evaluating maintenance olaparib or bevacizumab or the combination of both in newly diagnosed, advanced BRCA-mutated ovarian cancer","Vergote I, Ray-Coquard I, Anderson DM, Cantuaria G, Colombo N, Garnier-Tixidre C, Gilbert L, Harter P, Hettle R, Lorusso D, Mäenpää J, Marth C, Matsumoto K, Ouwens M, Poveda A, Raspagliesi F, Rhodes K, Rubio Pérez MJ, Shapira-Frommer R, Shikama A, Sikorska M, Moore K, DiSilvestro P.","Eur J Cancer. 2021 Nov;157:415-423. doi: 10.1016/j.ejca.2021.08.023. Epub 2021 Sep 28.","Vergote I","Eur J Cancer","2021","2021/10/01","","","10.1016/j.ejca.2021.08.023"
"34597381","Indirect comparison of tisagenlecleucel and blinatumomab in pediatric relapsed/refractory acute lymphoblastic leukemia","Verneris MR, Ma Q, Zhang J, Keating A, Tiwari R, Li J, Yang H, Agarwal A, Pacaud L.","Blood Adv. 2021 Dec 14;5(23):5387-5395. doi: 10.1182/bloodadvances.2020004045.","Verneris MR","Blood Adv","2021","2021/10/01","","","10.1182/bloodadvances.2020004045"
"34589422","An Indirect Comparison Between Nivolumab + Ipilimumab + Two Cycles of Chemotherapy vs. Pembrolizumab + Chemotherapy as First-Line Treatment for Metastatic Non-Small Cell Lung Cancer","Jiang P, Mao Z, Wang Q, Jia X, Geng L, Xu H, Jiang L, Yang C, Jiao M, Guo H.","Front Oncol. 2021 Sep 13;11:698199. doi: 10.3389/fonc.2021.698199. eCollection 2021.","Jiang P","Front Oncol","2021","2021/09/30","PMC8473819","","10.3389/fonc.2021.698199"
"34586007","The tools to choose: applying indirect treatment comparisons to the selection of frontline targeted therapy for CLL","Seymour JF.","Leuk Lymphoma. 2021 Oct;62(10):2299-2302. doi: 10.1080/10428194.2021.1984462. Epub 2021 Sep 29.","Seymour JF","Leuk Lymphoma","2021","2021/09/29","","","10.1080/10428194.2021.1984462"
"34561812","DREAMM-2: Indirect Comparisons of Belantamab Mafodotin vs. Selinexor + Dexamethasone and Standard of Care Treatments in Relapsed/Refractory Multiple Myeloma","Prawitz T, Popat R, Suvannasankha A, Sarri G, Hughes R, Wang F, Hogea C, Ferrante SA, Gorsh B, Willson J, Kapetanakis V.","Adv Ther. 2021 Nov;38(11):5501-5518. doi: 10.1007/s12325-021-01884-7. Epub 2021 Sep 24.","Prawitz T","Adv Ther","2021","2021/09/25","PMC8523001","","10.1007/s12325-021-01884-7"
"34550592","Network Meta-Analysis","Watt J, Del Giovane C.","Methods Mol Biol. 2022;2345:187-201. doi: 10.1007/978-1-0716-1566-9_12.","Watt J","Methods Mol Biol","2022","2021/09/22","","","10.1007/978-1-0716-1566-9_12"
"34543649","Comparative efficacy of different methods for difficult biliary cannulation in ERCP: systematic review and network meta-analysis","Facciorusso A, Ramai D, Gkolfakis P, Khan SR, Papanikolaou IS, Triantafyllou K, Tringali A, Chandan S, Mohan BP, Adler DG.","Gastrointest Endosc. 2022 Jan;95(1):60-71.e12. doi: 10.1016/j.gie.2021.09.010. Epub 2021 Sep 17.","Facciorusso A","Gastrointest Endosc","2022","2021/09/20","","","10.1016/j.gie.2021.09.010"
"34537953","Efficacy of Vibegron and Mirabegron for Overactive Bladder: A Systematic Literature Review and Indirect Treatment Comparison","Kennelly MJ, Rhodes T, Girman CJ, Thomas E, Shortino D, Mudd PN Jr.","Adv Ther. 2021 Nov;38(11):5452-5464. doi: 10.1007/s12325-021-01902-8. Epub 2021 Sep 18.","Kennelly MJ","Adv Ther","2021","2021/09/19","PMC8520873","","10.1007/s12325-021-01902-8"
"34493319","Matching-adjusted indirect treatment comparison of liso-cel versus axi-cel in relapsed or refractory large B cell lymphoma","Maloney DG, Kuruvilla J, Liu FF, Kostic A, Kim Y, Bonner A, Zhang Y, Fox CP, Cartron G.","J Hematol Oncol. 2021 Sep 8;14(1):140. doi: 10.1186/s13045-021-01144-9.","Maloney DG","J Hematol Oncol","2021","2021/09/08","PMC8425084","","10.1186/s13045-021-01144-9"
"34488679","Comparison of monoclonal antibodies targeting CD38, SLAMF7 and PD-1/PD-L1 in combination with Bortezomib/Immunomodulators plus dexamethasone/prednisone for the treatment of multiple myeloma: an indirect-comparison Meta-analysis of randomised controlled trials","Ye W, Wu X, Liu X, Zheng X, Deng J, Gong Y.","BMC Cancer. 2021 Sep 6;21(1):994. doi: 10.1186/s12885-021-08588-9.","Ye W","BMC Cancer","2021","2021/09/07","PMC8419924","","10.1186/s12885-021-08588-9"
"34484486","Enhanced Visualization Methods for First Transurethral Resection of Bladder Tumour in Suspected Non-muscle-invasive Bladder Cancer: A Health Technology Assessment","Ontario Health (Quality).","Ont Health Technol Assess Ser. 2021 Aug 12;21(12):1-123. eCollection 2021.","Ontario Health (Quality)","Ont Health Technol Assess Ser","2021","2021/09/06","PMC8382283","",""
"34465265","Belantamab mafodotin for the treatment of relapsed/refractory multiple myeloma in heavily pretreated patients: a US cost-effectiveness analysis","Nikolaou A, Ambavane A, Shah A, Ma W, Tosh J, Kapetanakis V, Willson J, Wang F, Hogea C, Gorsh B, Gutierrez B, Sapra S, Suvannasankha A, Samyshkin Y.","Expert Rev Hematol. 2021 Dec;14(12):1137-1145. doi: 10.1080/17474086.2021.1970522. Epub 2021 Sep 20.","Nikolaou A","Expert Rev Hematol","2021","2021/09/01","","","10.1080/17474086.2021.1970522"
"34445916","Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison","Bhak RH, Mody-Patel N, Baver SB, Kunzweiler C, Yee CW, Sundaresan S, Swartz N, Duh MS, Krishnan S, Sarda SP.","Curr Med Res Opin. 2021 Nov;37(11):1913-1923. doi: 10.1080/03007995.2021.1971182. Epub 2021 Sep 3.","Bhak RH","Curr Med Res Opin","2021","2021/08/27","","","10.1080/03007995.2021.1971182"
"34402784","Indirect treatment comparison of solriamfetol, modafinil, and armodafinil for excessive daytime sleepiness in obstructive sleep apnea","Ronnebaum S, Bron M, Patel D, Menno D, Bujanover S, Kratochvil D, Lucas E, Stepnowsky C.","J Clin Sleep Med. 2021 Dec 1;17(12):2543-2555. doi: 10.5664/jcsm.9610.","Ronnebaum S","J Clin Sleep Med","2021","2021/08/17","PMC8726370","","10.5664/jcsm.9610"
"34402153","Efficacy and safety of iGlarLixi versus IDegAsp: Results of a systematic literature review and indirect treatment comparison","Home PD, Mehta R, Hafidh KAS, Gurova OY, Alvarez A, Serafini P, Pourrahmat MM.","Diabetes Obes Metab. 2021 Dec;23(12):2660-2669. doi: 10.1111/dom.14518. Epub 2021 Aug 31.","Home PD","Diabetes Obes Metab","2021","2021/08/17","","","10.1111/dom.14518"
"34384311","Indirect comparisons of siponimod with fingolimod and ofatumumab in multiple sclerosis: assessing the feasibility of propensity score matching analyses","Samjoo IA, Worthington E, Haltner A, Spin P, Drudge C, Cameron C, Brennan R, Dahlke F, Adlard N.","Curr Med Res Opin. 2021 Nov;37(11):1933-1944. doi: 10.1080/03007995.2021.1968362. Epub 2021 Aug 26.","Samjoo IA","Curr Med Res Opin","2021","2021/08/13","","","10.1080/03007995.2021.1968362"
"34383273","Nail Psoriasis and Quality-of-Life Measurement in Clinical Trials: Call for the Use of Nail-Specific Instruments","Blome C, Augustin M, Klein TM.","Am J Clin Dermatol. 2021 Nov;22(6):747-755. doi: 10.1007/s40257-021-00622-7. Epub 2021 Aug 12.","Blome C","Am J Clin Dermatol","2021","2021/08/12","PMC8566428","","10.1007/s40257-021-00622-7"
"34372979","How Assessment-Schedule Matching Limits Bias When Comparing Progression-Free Survival in Single-Arm Studies: An Application in Second-Line Urothelial Carcinoma Treatments","Kapetanakis V, Prawitz T, Schlichting M, Ishak KJ, Phatak H, Yu T, Bharmal M.","Value Health. 2021 Aug;24(8):1137-1144. doi: 10.1016/j.jval.2021.03.004. Epub 2021 May 8.","Kapetanakis V","Value Health","2021","2021/08/10","","","10.1016/j.jval.2021.03.004"
"34372977","Use of External Comparators for Health Technology Assessment Submissions Based on Single-Arm Trials","Patel D, Grimson F, Mihaylova E, Wagner P, Warren J, van Engen A, Kim J.","Value Health. 2021 Aug;24(8):1118-1125. doi: 10.1016/j.jval.2021.01.015. Epub 2021 Jun 8.","Patel D","Value Health","2021","2021/08/10","","","10.1016/j.jval.2021.01.015"
"34369674","[Changes of histology and ultrastructure of otopoint ""Stomach"" area in rabbits with chronic gastritis]","Liu HL, You LM, Liu JH, Long XY, Xu GZ.","Zhen Ci Yan Jiu. 2021 Jul 25;46(7):555-61. doi: 10.13702/j.1000-0607.200544.","Liu HL","Zhen Ci Yan Jiu","2021","2021/08/09","","","10.13702/j.1000-0607.200544"
"34368918","Matching-Adjusted Indirect Comparison of Efficacy and Consumption of rVIII-SingleChain Versus Two Recombinant FVIII Products Used for Prophylactic Treatment of Adults/Adolescents with Severe Haemophilia A","Bonanad S, Núñez R, Poveda JL, Kurnik K, Goldmann G, Andreozzi V, Vandewalle B, Santos S.","Adv Ther. 2021 Sep;38(9):4872-4884. doi: 10.1007/s12325-021-01853-0. Epub 2021 Aug 8.","Bonanad S","Adv Ther","2021","2021/08/09","PMC8408075","","10.1007/s12325-021-01853-0"
"34348729","Cost-effectiveness of empagliflozin in patients with type 2 diabetes and established cardiovascular disease in China","Ramos M, Men P, Wang X, Ustyugova A, Lamotte M.","Cost Eff Resour Alloc. 2021 Aug 4;19(1):46. doi: 10.1186/s12962-021-00299-z.","Ramos M","Cost Eff Resour Alloc","2021","2021/08/05","PMC8336098","","10.1186/s12962-021-00299-z"
"34340647","Comparative efficacy, safety, and cost-effectiveness of abobotulinumtoxinA and onabotulinumtoxinA in children with upper limb spasticity: a systematic literature review, indirect treatment comparison, and economic evaluation","Danchenko N, Johnston KM, Haeussler K, Whalen J.","J Med Econ. 2021 Jan-Dec;24(1):949-961. doi: 10.1080/13696998.2021.1957582.","Danchenko N","J Med Econ","2021","2021/08/03","","","10.1080/13696998.2021.1957582"
"34324742","Method's corner: Allergist's guide to network meta-analysis","Chu DK, Brignardello-Petersen R, Guyatt GH, Ricci C, Genuneit J.","Pediatr Allergy Immunol. 2022 Jan;33(1):e13609. doi: 10.1111/pai.13609. Epub 2021 Aug 16.","Chu DK","Pediatr Allergy Immunol","2022","2021/07/29","","","10.1111/pai.13609"
"34301232","Meta-analysis and indirect treatment comparison of modified FOLFIRINOX and gemcitabine plus nab-paclitaxel as first-line chemotherapy in advanced pancreatic cancer","Chen J, Hua Q, Wang H, Zhang D, Zhao L, Yu D, Pi G, Zhang T, Lin Z.","BMC Cancer. 2021 Jul 23;21(1):853. doi: 10.1186/s12885-021-08605-x.","Chen J","BMC Cancer","2021","2021/07/24","PMC8306351","","10.1186/s12885-021-08605-x"
"34292540","Cost-Minimization Analysis of Pembrolizumab Monotherapy Versus Nivolumab in Combination with Ipilimumab as First-Line Treatment for Metastatic PD-L1-Positive Non-small Cell Lung Cancer: A US Payer Perspective","Qiao N, Insinga R, Burke T, Lopes G.","Pharmacoecon Open. 2021 Dec;5(4):765-778. doi: 10.1007/s41669-021-00288-1. Epub 2021 Jul 22.","Qiao N","Pharmacoecon Open","2021","2021/07/22","PMC8611160","","10.1007/s41669-021-00288-1"
"34286894","An indirect treatment comparison of the efficacy of semaglutide 1.0 mg versus dulaglutide 3.0 and 4.5 mg","Pratley RE, Catarig AM, Lingvay I, Viljoen A, Paine A, Lawson J, Chubb B, Gorst-Rasmussen A, Miresashvili N.","Diabetes Obes Metab. 2021 Nov;23(11):2513-2520. doi: 10.1111/dom.14497. Epub 2021 Aug 9.","Pratley RE","Diabetes Obes Metab","2021","2021/07/21","","","10.1111/dom.14497"
"34285621","Efficacy of rFIXFc versus rIX-FP for the Treatment of Patients with Hemophilia B: Matching-Adjusted Indirect Comparison of B-LONG and PROLONG-9FP Trials","Astermark J, Wojciechowski P, Aballéa S, Hakimi Z, Nazir J, Klamroth R.","J Blood Med. 2021 Jul 14;12:613-621. doi: 10.2147/JBM.S312885. eCollection 2021.","Astermark J","J Blood Med","2021","2021/07/21","PMC8286734","","10.2147/JBM.S312885"
"34280545","Generalizability of heterogeneous treatment effects based on causal forests applied to two randomized clinical trials of intensive glycemic control","Raghavan S, Josey K, Bahn G, Reda D, Basu S, Berkowitz SA, Emanuele N, Reaven P, Ghosh D.","Ann Epidemiol. 2022 Jan;65:101-108. doi: 10.1016/j.annepidem.2021.07.003. Epub 2021 Jul 17.","Raghavan S","Ann Epidemiol","2022","2021/07/19","PMC8748294","NIHMS1725473","10.1016/j.annepidem.2021.07.003"
"34278835","Cost-minimization analysis comparing eltrombopag vs romiplostim for adults with chronic immune thrombocytopenia","Patwardhan P, Proudman D, Allen J, Lucas S, Nellesen D.","J Manag Care Spec Pharm. 2021 Oct;27(10):1447-1456. doi: 10.18553/jmcp.2021.21080. Epub 2021 Jul 19.","Patwardhan P","J Manag Care Spec Pharm","2021","2021/07/19","","","10.18553/jmcp.2021.21080"
"34277983","A population-adjusted indirect comparison of cardiovascular benefits of once-weekly subcutaneous semaglutide and dulaglutide in the treatment of patients with type 2 diabetes, with or without established cardiovascular disease","Evans LM, Mellbin L, Johansen P, Lawson J, Paine A, Sandberg A.","Endocrinol Diabetes Metab. 2021 May 15;4(3):e00259. doi: 10.1002/edm2.259. eCollection 2021 Jul.","Evans LM","Endocrinol Diabetes Metab","2021","2021/07/19","PMC8279621","","10.1002/edm2.259"
"34277438","Platinum-Based Chemotherapy and Immunotherapy in Early Triple-Negative Breast Cancer: A Meta-Analysis and Indirect Treatment Comparison","He Q, Peng Y, Sun J, Liu J.","Front Oncol. 2021 Jul 1;11:693542. doi: 10.3389/fonc.2021.693542. eCollection 2021.","He Q","Front Oncol","2021","2021/07/19","PMC8281677","","10.3389/fonc.2021.693542"
"34274891","Comparative short-term efficacy and safety of add-on anti-seizure medications in Dravet syndrome: An indirect treatment comparison","Devi N, Madaan P, Asrar MM, Sahu JK, Bansal D.","Seizure. 2021 Oct;91:316-324. doi: 10.1016/j.seizure.2021.06.020. Epub 2021 Jun 29.","Devi N","Seizure","2021","2021/07/18","","","10.1016/j.seizure.2021.06.020"
"34256668","Matching-adjusted indirect comparison of efficacy outcomes for ciltacabtagene autoleucel in CARTITUDE-1 versus idecabtagene vicleucel in KarMMa for the treatment of patients with relapsed or refractory multiple myeloma","Martin T, Usmani SZ, Schecter JM, Vogel M, Jackson CC, Deraedt W, Tian H, Yeh TM, Banerjee A, Pacaud L, Garrett A, Haltner A, Cameron C, Van Sanden S, Diels J, Valluri S, Samjoo IA.","Curr Med Res Opin. 2021 Oct;37(10):1779-1788. doi: 10.1080/03007995.2021.1953456. Epub 2021 Jul 23.","Martin T","Curr Med Res Opin","2021","2021/07/14","","","10.1080/03007995.2021.1953456"
"34250585","Cost-Effectiveness of Bosutinib for the Treatment of Adult Patients with Chronic Phase Chronic Myeloid Leukemia in the Second-Line Setting","Muresan B, Mamolo C, Cappelleri JC, Postma MJ, Heeg B.","Appl Health Econ Health Policy. 2021 Nov;19(6):929-940. doi: 10.1007/s40258-021-00666-0. Epub 2021 Jul 12.","Muresan B","Appl Health Econ Health Policy","2021","2021/07/12","PMC8545733","","10.1007/s40258-021-00666-0"
"34250584","Effectiveness of Radiofrequency Catheter Ablation Using Ablation Index Versus Second Generation Cryoballoon in the Treatment of Persistent Atrial Fibrillation: A Matching-Adjusted Indirect Comparison","Hussein A, Stabile G, Dawkins K, Spin P, Goldstein L, Wei T, Velleca M, Patel L, Gupta D.","Adv Ther. 2021 Aug;38(8):4388-4402. doi: 10.1007/s12325-021-01846-z. Epub 2021 Jul 12.","Hussein A","Adv Ther","2021","2021/07/12","PMC8342373","","10.1007/s12325-021-01846-z"
"34236007","Matching-adjusted indirect treatment comparison of onasemnogene abeparvovec and nusinersen for the treatment of symptomatic patients with spinal muscular atrophy type 1","Bischof M, Lorenzi M, Lee J, Druyts E, Balijepalli C, Dabbous O.","Curr Med Res Opin. 2021 Oct;37(10):1719-1730. doi: 10.1080/03007995.2021.1947216. Epub 2021 Jul 20.","Bischof M","Curr Med Res Opin","2021","2021/07/08","","","10.1080/03007995.2021.1947216"
"34231369","Indirect treatment comparison of olaparib and talazoparib in germline BRCA-mutated HER2-negative metastatic breast cancer","McCrea C, Hettle R, Gulati P, Taneja A, Rajora P.","J Comp Eff Res. 2021 Sep;10(13):1021-1030. doi: 10.2217/cer-2021-0097. Epub 2021 Jul 7.","McCrea C","J Comp Eff Res","2021","2021/07/07","","","10.2217/cer-2021-0097"
"34196111","Methods for population adjustment with limited access to individual patient data: A review and simulation study","Remiro-Azócar A, Heath A, Baio G.","Res Synth Methods. 2021 Nov;12(6):750-775. doi: 10.1002/jrsm.1511. Epub 2021 Sep 5.","Remiro-Azócar A","Res Synth Methods","2021","2021/07/01","","","10.1002/jrsm.1511"
"34168470","Economic Analysis of Leak Complications in Anastomoses Performed with Powered versus Manual Circular Staplers in Left-Sided Colorectal Resections: A US-Based Cost Analysis","Pollack E, Johnston S, Petraiuolo WJ, Roy S, Galvain T.","Clinicoecon Outcomes Res. 2021 Jun 17;13:531-540. doi: 10.2147/CEOR.S305296. eCollection 2021.","Pollack E","Clinicoecon Outcomes Res","2021","2021/06/25","PMC8217739","","10.2147/CEOR.S305296"
"34114935","Cost-effectiveness analysis of anti-IL-5 therapies of severe eosinophilic asthma in Spain","González-Barcala FJ, Muñoz-Gall X, Mariscal E, García A, Yang S, van de Wetering G, Izquierdo-Alonso JL.","J Med Econ. 2021 Jan-Dec;24(1):874-882. doi: 10.1080/13696998.2021.1941065.","González-Barcala FJ","J Med Econ","2021","2021/06/11","","","10.1080/13696998.2021.1941065"
"34098842","Cost-effectiveness of pembrolizumab + chemotherapy versus chemotherapy and pembrolizumab monotherapy in first line treatment of NSCLC in the US - updated analyses with additional trial follow-up","Insinga RP, Feliciano JL, Qiao N, Vandormael K, Zhang Y.","J Med Econ. 2021 Jan-Dec;24(1):792-805. doi: 10.1080/13696998.2021.1937188.","Insinga RP","J Med Econ","2021","2021/06/08","","","10.1080/13696998.2021.1937188"
"34093199","Calcitonin Gene-Related Peptide Monoclonal Antibodies Versus Botulinum Neurotoxin a in the Preventive Treatment of Chronic Migraine: An Adjusted Indirect Treatment Comparison Meta-Analysis","Chen YY, Ye XQ, Tang TC, She TW, Chen M, Zheng H.","Front Pharmacol. 2021 May 19;12:671845. doi: 10.3389/fphar.2021.671845. eCollection 2021.","Chen YY","Front Pharmacol","2021","2021/06/07","PMC8170150","","10.3389/fphar.2021.671845"
"34080140","The Cost-Effectiveness of Lorlatinib Versus Chemotherapy as a Second- or Third-Line Treatment in Anaplastic Lymphoma Kinase (ALK)-Positive Non-small-cell Lung Cancer in Sweden","Nilsson FOL, Asanin ST, Masters ET, Iadeluca L, Almond C, Cooper M, Smith S.","Pharmacoeconomics. 2021 Aug;39(8):941-952. doi: 10.1007/s40273-021-01015-8. Epub 2021 Jun 3.","Nilsson FOL","Pharmacoeconomics","2021","2021/06/03","PMC8298221","","10.1007/s40273-021-01015-8"
"34074239","A method for assessing robustness of the results of a star-shaped network meta-analysis under the unidentifiable consistency assumption","Yoon JH, Dias S, Hahn S.","BMC Med Res Methodol. 2021 Jun 1;21(1):113. doi: 10.1186/s12874-021-01290-1.","Yoon JH","BMC Med Res Methodol","2021","2021/06/02","PMC8171049","","10.1186/s12874-021-01290-1"
"34067521","Sustained Complete Response after Biological Downstaging in Patients with Hepatocellular Carcinoma: XXL-Like Prioritization for Liver Transplantation or ""Wait and See"" Strategy?","Vitale A, Scolari F, Bertacco A, Gringeri E, D'Amico F, Bassi D, D'Amico FE, Angeli P, Burra P, Lai Q, Cillo U.","Cancers (Basel). 2021 May 17;13(10):2406. doi: 10.3390/cancers13102406.","Vitale A","Cancers (Basel)","2021","2021/06/02","PMC8156031","","10.3390/cancers13102406"
"34067288","Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer","Rapposelli IG, Casadei-Gardini A, Vivaldi C, Bartolini G, Bernardini L, Passardi A, Frassineti GL, Massa V, Cucchetti A.","Biomolecules. 2021 May 22;11(6):780. doi: 10.3390/biom11060780.","Rapposelli IG","Biomolecules","2021","2021/06/02","PMC8224606","","10.3390/biom11060780"
"34031743","Outcomes associated with the use of a new powered circular stapler for left-sided colorectal reconstructions: a propensity score matching-adjusted indirect comparison with manual circular staplers","Sylla P, Sagar P, Johnston SS, Dwarakanathan HR, Waggoner JR, Schwiers M, Roy S.","Surg Endosc. 2022 Apr;36(4):2541-2553. doi: 10.1007/s00464-021-08542-7. Epub 2021 May 24.","Sylla P","Surg Endosc","2022","2021/05/25","PMC8921098","","10.1007/s00464-021-08542-7"
"34021886","Cost-Effectiveness of Tisagenlecleucel in Paediatric Acute Lymphoblastic Leukaemia (pALL) and Adult Diffuse Large B-Cell Lymphoma (DLBCL) in Switzerland","Moradi-Lakeh M, Yaghoubi M, Seitz P, Javanbakht M, Brock E.","Adv Ther. 2021 Jun;38(6):3427-3443. doi: 10.1007/s12325-021-01767-x. Epub 2021 May 22.","Moradi-Lakeh M","Adv Ther","2021","2021/05/22","","","10.1007/s12325-021-01767-x"
"34021585","Matching-adjusted indirect comparisons of oral rimegepant versus placebo, erenumab, and galcanezumab examining monthly migraine days and health-related quality of life in the treatment of migraine","Popoff E, Johnston K, Croop R, Thiry A, Harris L, Powell L, Coric V, L'Italien G, Moren J.","Headache. 2021 Jun;61(6):906-915. doi: 10.1111/head.14128. Epub 2021 May 22.","Popoff E","Headache","2021","2021/05/22","PMC8361942","","10.1111/head.14128"
"34018204","Transporting experimental results with entropy balancing","Josey KP, Berkowitz SA, Ghosh D, Raghavan S.","Stat Med. 2021 Aug 30;40(19):4310-4326. doi: 10.1002/sim.9031. Epub 2021 May 20.","Josey KP","Stat Med","2021","2021/05/21","PMC8487904","NIHMS1702607","10.1002/sim.9031"
"34012392","Calcitonin Gene-Related Peptide Monoclonal Antibody Versus Botulinum Toxin for the Preventive Treatment of Chronic Migraine: Evidence From Indirect Treatment Comparison","Lu J, Zhang Q, Guo X, Liu W, Xu C, Hu X, Ni J, Lu H, Zhao H.","Front Pharmacol. 2021 May 3;12:631204. doi: 10.3389/fphar.2021.631204. eCollection 2021.","Lu J","Front Pharmacol","2021","2021/05/20","PMC8126691","","10.3389/fphar.2021.631204"
"33992428","Primary and Secondary Prevention Strategies for Gastrointestinal Bleeding in Patients with Left Ventricular Assist Device: A Systematic Review and Network Meta-analysis","Rai D, Tariq R, Tahir MW, Chowdhury M, Wahab A, Kharsa A, Bandyopadhyay D, Feitell SC, Parikh V, Aronow WS, Lanier GM, Levine E, Fonarow GC, Kaul V.","Curr Probl Cardiol. 2021 Nov;46(11):100835. doi: 10.1016/j.cpcardiol.2021.100835. Epub 2021 Mar 26.","Rai D","Curr Probl Cardiol","2021","2021/05/16","","","10.1016/j.cpcardiol.2021.100835"
"33979770","Matching-adjusted indirect treatment comparison of ozanimod versus teriflunomide for relapsing multiple sclerosis","Cohan S, Tencer T, Arndorfer S, Zhu X, Zivkovic M, Kumar J.","Mult Scler Relat Disord. 2021 Jul;52:102972. doi: 10.1016/j.msard.2021.102972. Epub 2021 Apr 25.","Cohan S","Mult Scler Relat Disord","2021","2021/05/12","","","10.1016/j.msard.2021.102972"
"33970454","Indirect Treatment Comparison of Liso-Cel vs. Salvage Chemotherapy in Diffuse Large B-Cell Lymphoma: TRANSCEND vs. SCHOLAR-1","Salles G, Spin P, Liu FF, Garcia J, Kim Y, Hasskarl J.","Adv Ther. 2021 Jun;38(6):3266-3280. doi: 10.1007/s12325-021-01756-0. Epub 2021 May 10.","Salles G","Adv Ther","2021","2021/05/10","PMC8189990","","10.1007/s12325-021-01756-0"
"33970192","Association of Rotavirus Vaccines With Reduction in Rotavirus Gastroenteritis in Children Younger Than 5 Years: A Systematic Review and Meta-analysis of Randomized Clinical Trials and Observational Studies","Sun ZW, Fu Y, Lu HL, Yang RX, Goyal H, Jiang Y, Xu HG.","JAMA Pediatr. 2021 Jul 1;175(7):e210347. doi: 10.1001/jamapediatrics.2021.0347. Epub 2021 Jul 6.","Sun ZW","JAMA Pediatr","2021","2021/05/10","PMC8111566","","10.1001/jamapediatrics.2021.0347"
"33963582","Conflating marginal and conditional treatment effects: Comments on ""Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study""","Remiro-Azócar A, Heath A, Baio G.","Stat Med. 2021 May 20;40(11):2753-2758. doi: 10.1002/sim.8857.","Remiro-Azócar A","Stat Med","2021","2021/05/08","","","10.1002/sim.8857"
"33955326","Matching-adjusted indirect comparisons of safety and efficacy of acalabrutinib versus other targeted therapies in patients with treatment-naïve chronic lymphocytic leukemia","Davids MS, Telford C, Abhyankar S, Waweru C, Ringshausen I.","Leuk Lymphoma. 2021 Oct;62(10):2342-2351. doi: 10.1080/10428194.2021.1913144. Epub 2021 May 6.","Davids MS","Leuk Lymphoma","2021","2021/05/06","","","10.1080/10428194.2021.1913144"
"33941549","Cost-effectiveness of empagliflozin versus canagliflozin, dapagliflozin, or standard of care in patients with type 2 diabetes and established cardiovascular disease","Reifsnider OS, Kansal AR, Gandhi PK, Cragin L, Brand SB, Pfarr E, Fahrbach K, Ustyugova A.","BMJ Open Diabetes Res Care. 2021 May;9(1):e001313. doi: 10.1136/bmjdrc-2020-001313.","Reifsnider OS","BMJ Open Diabetes Res Care","2021","2021/05/04","PMC8098979","","10.1136/bmjdrc-2020-001313"
"33929726","Subcutaneous Versus Sublingual Immunotherapy for Adults with Allergic Rhinitis: A Systematic Review with Meta-Analyses","Tie K, Miller C, Zanation AM, Ebert CS Jr.","Laryngoscope. 2022 Mar;132(3):499-508. doi: 10.1002/lary.29586. Epub 2021 Apr 30.","Tie K","Laryngoscope","2022","2021/04/30","","","10.1002/lary.29586"
"33896344","Matching adjusted indirect comparisons of efficacy outcomes for idecabtagene vicleucel (ide-cel, bb2121) versus selinexor + dexamethasone and belantamab mafodotin in relapsed and refractory multiple myeloma","Rodriguez-Otero P, Ayers D, Cope S, Davies FE, Delforge M, Mojebi A, Jansen JP, Weisel K, Hege K, Dhanasiri S.","Leuk Lymphoma. 2021 Oct;62(10):2482-2491. doi: 10.1080/10428194.2021.1913143. Epub 2021 Apr 24.","Rodriguez-Otero P","Leuk Lymphoma","2021","2021/04/26","","","10.1080/10428194.2021.1913143"
"33888418","Comparison Between Sirolimus- and Paclitaxel-Coated Balloon for Revascularization of Coronary Arteries: The SIRPAC (SIRolimus-PAClitaxel) Study","Cortese B, Caiazzo G, Di Palma G, De Rosa S.","Cardiovasc Revasc Med. 2021 Jul;28:1-6. doi: 10.1016/j.carrev.2021.04.013. Epub 2021 Apr 17.","Cortese B","Cardiovasc Revasc Med","2021","2021/04/23","PMC8373518","","10.1016/j.carrev.2021.04.013"
"33871055","Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis","Sbidian E, Chaimani A, Garcia-Doval I, Doney L, Dressler C, Hua C, Hughes C, Naldi L, Afach S, Le Cleach L.","Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.","Sbidian E","Cochrane Database Syst Rev","2021","2021/04/19","PMC8408312","","10.1002/14651858.CD011535.pub4"
"33863352","Comparative efficacy of subcutaneous (CT-P13) and intravenous infliximab in adult patients with rheumatoid arthritis: a network meta-regression of individual patient data from two randomised trials","Combe B, Allanore Y, Alten R, Caporali R, Durez P, Iannone F, Nurmohamed MT, Toumi M, Lee SJ, Kwon TS, Noh J, Park G, Yoo DH.","Arthritis Res Ther. 2021 Apr 16;23(1):119. doi: 10.1186/s13075-021-02487-x.","Combe B","Arthritis Res Ther","2021","2021/04/17","PMC8051052","","10.1186/s13075-021-02487-x"
"33847901","Comparative Efficacy and Safety of Ozanimod and Dimethyl Fumarate for Relapsing-Remitting Multiple Sclerosis Using Matching-Adjusted Indirect Comparison","Cohan S, Kumar J, Arndorfer S, Zhu X, Zivkovic M, Tencer T.","CNS Drugs. 2021 Jul;35(7):795-804. doi: 10.1007/s40263-021-00805-0. Epub 2021 Apr 13.","Cohan S","CNS Drugs","2021","2021/04/13","PMC8310468","","10.1007/s40263-021-00805-0"
"33839603","Pembrolizumab+chemotherapy versus atezolizumab+chemotherapy+/-bevacizumab for the first-line treatment of non-squamous NSCLC: A matching-adjusted indirect comparison","Halmos B, Burke T, Kalyvas C, Vandormael K, Frederickson A, Piperdi B.","Lung Cancer. 2021 May;155:175-182. doi: 10.1016/j.lungcan.2021.03.020. Epub 2021 Mar 30.","Halmos B","Lung Cancer","2021","2021/04/11","","","10.1016/j.lungcan.2021.03.020"
"33830214","Comparison of Treatments for Nonmetastatic Castration-Resistant Prostate Cancer: Matching-Adjusted Indirect Comparison and Network Meta-Analysis","Wang L, Paller C, Hong H, Rosman L, De Felice A, Brawley O, Alexander GC.","J Natl Cancer Inst. 2022 Feb 7;114(2):191-202. doi: 10.1093/jnci/djab071.","Wang L","J Natl Cancer Inst","2022","2021/04/08","PMC8826526","","10.1093/jnci/djab071"
"33822328","Comparative Efficacy of Cabozantinib and Ramucirumab After Sorafenib for Patients with Hepatocellular Carcinoma and Alpha-fetoprotein ≥ 400 ng/mL: A Matching-Adjusted Indirect Comparison","Trojan J, Mollon P, Daniele B, Marteau F, Martín L, Li Y, Xu Q, Piscaglia F, Zaucha R, Sarker D, Lim HY, Venerito M.","Adv Ther. 2021 May;38(5):2472-2490. doi: 10.1007/s12325-021-01700-2. Epub 2021 Apr 6.","Trojan J","Adv Ther","2021","2021/04/06","PMC8107171","","10.1007/s12325-021-01700-2"
"33818140","Indirect Comparison of Darolutamide versus Apalutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer","Halabi S, Jiang S, Terasawa E, Garcia-Horton V, Ayyagari R, Waldeck AR, Shore N.","J Urol. 2021 Aug;206(2):298-307. doi: 10.1097/JU.0000000000001767. Epub 2021 Apr 5.","Halabi S","J Urol","2021","2021/04/05","","","10.1097/JU.0000000000001767"
"33791945","Cost Effectiveness and Budget Impact of Siponimod Compared to Interferon Beta-1a in the Treatment of Adult Patients with Secondary Progressive Multiple Sclerosis with Active Disease in Switzerland","Schur N, Gudala K, Vudumula U, Vadapalle S, Bhadhuri A, Casanova A, Adlard N, Schwenkglenks M.","Pharmacoeconomics. 2021 May;39(5):563-577. doi: 10.1007/s40273-021-01023-8. Epub 2021 Apr 1.","Schur N","Pharmacoeconomics","2021","2021/04/01","PMC8079303","","10.1007/s40273-021-01023-8"
"33781519","Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia in Japan","Wakase S, Teshima T, Zhang J, Ma Q, Watanabe Y, Yang H, Qi CZ, Chai X, Xie Y, Wu EQ, Igarashi A.","Transplant Cell Ther. 2021 Mar;27(3):241.e1-241.e11. doi: 10.1016/j.jtct.2020.12.023. Epub 2020 Dec 26.","Wakase S","Transplant Cell Ther","2021","2021/03/30","","","10.1016/j.jtct.2020.12.023"
"33768123","Comparative Effectiveness of Remestemcel-L-rknd versus Ruxolitinib in Pediatric Patients with Steroid-Refractory Acute Graft-Versus-Host Disease using Simulated Treatment Comparisons","Tremblay G, Tomaras D, Strati E, Forsythe A.","J Health Econ Outcomes Res. 2021 Feb 23;8(1):10-17. doi: 10.36469/jheor.2021.19008.","Tremblay G","J Health Econ Outcomes Res","2021","2021/03/26","PMC7983491","","10.36469/jheor.2021.19008"
"33749159","SGLT2i versus ARNI in heart failure with reduced ejection fraction: a systematic review and meta-analysis","Yan Y, Liu B, Du J, Wang J, Jing X, Liu Y, Deng S, Du J, She Q.","ESC Heart Fail. 2021 Jun;8(3):2210-2219. doi: 10.1002/ehf2.13313. Epub 2021 Mar 21.","Yan Y","ESC Heart Fail","2021","2021/03/22","PMC8120387","","10.1002/ehf2.13313"
"33745079","Regorafenib versus cabozantinb as second-line treatment after sorafenib for unresectable hepatocellular carcinoma: matching-adjusted indirect comparison analysis","Casadei-Gardini A, Rimassa L, Rimini M, Yoo C, Ryoo BY, Lonardi S, Masi G, Kim HD, Vivaldi C, Ryu MH, Rizzato MD, Salani F, Bang Y, Pellino A, Catanese S, Burgio V, Cascinu S, Cucchetti A.","J Cancer Res Clin Oncol. 2021 Dec;147(12):3665-3671. doi: 10.1007/s00432-021-03602-w. Epub 2021 Mar 20.","Casadei-Gardini A","J Cancer Res Clin Oncol","2021","2021/03/21","","","10.1007/s00432-021-03602-w"
"33733983","An indirect comparison between bosutinib, nilotinib and dasatinib in first-line chronic phase chronic myeloid leukemia","Muresan B, Mamolo C, Cappelleri JC, Leip E, Viqueira A, Heeg B.","Curr Med Res Opin. 2021 May;37(5):801-809. doi: 10.1080/03007995.2021.1896489. Epub 2021 Apr 2.","Muresan B","Curr Med Res Opin","2021","2021/03/18","","","10.1080/03007995.2021.1896489"
"33733815","Comparative effectiveness of glasdegib versus venetoclax combined with low-dose cytarabine in acute myeloid leukemia","Tremblay G, Daniele P, Bell T, Chan G, Brown A, Cappelleri JC.","J Comp Eff Res. 2021 May;10(7):603-612. doi: 10.2217/cer-2020-0280. Epub 2021 Mar 18.","Tremblay G","J Comp Eff Res","2021","2021/03/18","","","10.2217/cer-2020-0280"
"33709889","Matching-Adjusted Indirect Comparisons in the assessment of hemato-oncological drugs","Martínez-Sesmero JM, De Castro-Carpeño J, López-de Las Heras A, Fernández-Nistal A, Parrondo-García FJ.","Farm Hosp. 2021 Feb 10;45(2):55-60. doi: 10.7399/fh.11443.","Martínez-Sesmero JM","Farm Hosp","2021","2021/03/12","","","10.7399/fh.11443"
"33691581","Cost effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the United States","Liu R, Oluwole OO, Diakite I, Botteman MF, Snider JT, Locke FL.","J Med Econ. 2021 Jan-Dec;24(1):458-468. doi: 10.1080/13696998.2021.1901721.","Liu R","J Med Econ","2021","2021/03/11","","","10.1080/13696998.2021.1901721"
"33687695","Cost-effectiveness of Empagliflozin Compared with Dapagliflozin for the Treatment of Patients with Type 2 Diabetes Mellitus and Established Cardiovascular Disease in Greece","Gourzoulidis G, Tzanetakos C, Ioannidis I, Tsimihodimos V, Diogo V, Karpouzos G, Papageorgiou G, Kourlaba G.","Clin Drug Investig. 2021 Apr;41(4):371-380. doi: 10.1007/s40261-021-01013-w. Epub 2021 Mar 9.","Gourzoulidis G","Clin Drug Investig","2021","2021/03/09","","","10.1007/s40261-021-01013-w"
"33675139","A comparison of reweighting estimators of average treatment effects in real world populations","Lin CY, Kaizar E, Faries D, Johnston J.","Pharm Stat. 2021 Jul;20(4):765-782. doi: 10.1002/pst.2106. Epub 2021 Mar 6.","Lin CY","Pharm Stat","2021","2021/03/06","PMC8359356","","10.1002/pst.2106"
"33674928","Characterization of a Real-World Response Variable and Comparison with RECIST-Based Response Rates from Clinical Trials in Advanced NSCLC","Ma X, Bellomo L, Magee K, Bennette CS, Tymejczyk O, Samant M, Tucker M, Nussbaum N, Bowser BE, Kraut JS, Bourla AB.","Adv Ther. 2021 Apr;38(4):1843-1859. doi: 10.1007/s12325-021-01659-0. Epub 2021 Mar 5.","Ma X","Adv Ther","2021","2021/03/06","PMC8004504","","10.1007/s12325-021-01659-0"
"33664606","Efficacy of rFVIIIFc versus Emicizumab for the Treatment of Patients with Hemophilia A without Inhibitors: Matching-Adjusted Indirect Comparison of A-LONG and HAVEN Trials","Klamroth R, Wojciechowski P, Aballéa S, Diamand F, Hakimi Z, Nazir J, Abad-Franch L, Lethagen S, Santagostino E, Tarantino MD.","J Blood Med. 2021 Feb 25;12:115-122. doi: 10.2147/JBM.S288283. eCollection 2021.","Klamroth R","J Blood Med","2021","2021/03/05","PMC7921628","","10.2147/JBM.S288283"
"33646565","Indirect Comparison of Lanadelumab and Intravenous C1-INH Using Data from the HELP and CHANGE Studies: Bayesian and Frequentist Analyses","Mendivil J, Malmenäs M, Haeussler K, Hunger M, Jain G, Devercelli G.","Drugs R D. 2021 Mar;21(1):113-121. doi: 10.1007/s40268-021-00337-4. Epub 2021 Mar 1.","Mendivil J","Drugs R D","2021","2021/03/01","PMC7937585","","10.1007/s40268-021-00337-4"
"33641593","Network meta-analysis comparing the efficacy of biologic treatments for achieving complete resolution of nail psoriasis","Reich K, Conrad C, Kristensen LE, Smith SD, Puig L, Rich P, Sapin C, Holzkaemper T, Koppelhus U, Schuster C.","J Dermatolog Treat. 2021 Mar 1:1-9. doi: 10.1080/09546634.2021.1892024. Online ahead of print.","Reich K","J Dermatolog Treat","2021","2021/03/01","","","10.1080/09546634.2021.1892024"
"33640861","Number Needed to Treat and Number Needed to Harm analysis of the zuranolone phase 2 clinical trial results in major depressive disorder","Arnaud A, Suthoff E, Stenson K, Werneburg B, Hodgkins P, Bonthapally V, Jonas J, Meyer K, O'Day K.","J Affect Disord. 2021 Apr 15;285:112-119. doi: 10.1016/j.jad.2021.02.027. Epub 2021 Feb 10.","Arnaud A","J Affect Disord","2021","2021/02/28","","","10.1016/j.jad.2021.02.027"
"33638735","Is Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma Superior Even to Lenvatinib? A Matching-Adjusted Indirect Comparison","Casadei-Gardini A, Tada T, Shimose S, Kumada T, Niizeki T, Cascinu S, Cucchetti A.","Target Oncol. 2021 Mar;16(2):249-254. doi: 10.1007/s11523-021-00803-8. Epub 2021 Feb 27.","Casadei-Gardini A","Target Oncol","2021","2021/02/27","","","10.1007/s11523-021-00803-8"
"33626934","Matching-adjusted indirect comparison of palbociclib versus ribociclib and abemaciclib in hormone receptor-positive/HER2-negative advanced breast cancer","Rugo HS, Haltner A, Zhan L, Tran A, Bananis E, Hooper B, Mitra D, Cameron C.","J Comp Eff Res. 2021 Apr;10(6):457-467. doi: 10.2217/cer-2020-0272. Epub 2021 Feb 25.","Rugo HS","J Comp Eff Res","2021","2021/02/25","","","10.2217/cer-2020-0272"
"33603419","Preliminary Cost-Effectiveness and Cost-Utility Analysis of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma in Italy","Ghetti G, D'Avella MC, Pradelli L.","Clinicoecon Outcomes Res. 2021 Feb 10;13:121-133. doi: 10.2147/CEOR.S295605. eCollection 2021.","Ghetti G","Clinicoecon Outcomes Res","2021","2021/02/19","PMC7882423","","10.2147/CEOR.S295605"
"33599181","Integrating efficacy and safety of vedolizumab compared with other advanced therapies to assess net clinical benefit of ulcerative colitis treatments: a network meta-analysis","Jairath V, Chan K, Lasch K, Keeping S, Agboton C, Blake A, Patel H.","Expert Rev Gastroenterol Hepatol. 2021 Jun;15(6):711-722. doi: 10.1080/17474124.2021.1880319. Epub 2021 Mar 4.","Jairath V","Expert Rev Gastroenterol Hepatol","2021","2021/02/18","","","10.1080/17474124.2021.1880319"
"33598857","Comparative Effectiveness Research for CAR-T Therapies in Multiple Myeloma: Appropriate Comparisons Require Careful Considerations of Data Sources and Patient Populations","Shah N, Sussman M, Crivera C, Valluri S, Benner J, Jagannath S.","Clin Drug Investig. 2021 Mar;41(3):201-210. doi: 10.1007/s40261-021-01012-x. Epub 2021 Feb 18.","Shah N","Clin Drug Investig","2021","2021/02/18","","","10.1007/s40261-021-01012-x"
"33556898","A matching-adjusted indirect comparison of combination nivolumab plus ipilimumab with BRAF plus MEK inhibitors for the treatment of BRAF-mutant advanced melanoma(☆)","Tarhini AA, Toor K, Chan K, McDermott DF, Mohr P, Larkin J, Hodi FS, Lee CH, Rizzo JI, Johnson H, Moshyk A, Rao S, Kotapati S, Atkins MB.","ESMO Open. 2021 Apr;6(2):100050. doi: 10.1016/j.esmoop.2021.100050. Epub 2021 Feb 6.","Tarhini AA","ESMO Open","2021","2021/02/08","PMC7872980","","10.1016/j.esmoop.2021.100050"
"33548517","Indirect Treatment Comparison of Biologics in Chronic Rhinosinusitis with Nasal Polyps","Peters AT, Han JK, Hellings P, Heffler E, Gevaert P, Bachert C, Xu Y, Chuang CC, Neupane B, Msihid J, Mannent LP, Guyot P, Kamat S.","J Allergy Clin Immunol Pract. 2021 Jun;9(6):2461-2471.e5. doi: 10.1016/j.jaip.2021.01.031. Epub 2021 Feb 4.","Peters AT","J Allergy Clin Immunol Pract","2021","2021/02/06","","","10.1016/j.jaip.2021.01.031"
"33521161","A Systematic Literature Review and Indirect Treatment Comparison of Efficacy of Repository Corticotropin Injection versus Synthetic Adrenocorticotropic Hormone for Infantile Spasms","Duchowny MS, Chopra I, Niewoehner J, Wan GJ, Devine B.","J Health Econ Outcomes Res. 2021 Jan 27;8(1):1-9. doi: 10.36469/jheor.2021.18727.","Duchowny MS","J Health Econ Outcomes Res","2021","2021/02/01","PMC7839629","","10.36469/jheor.2021.18727"
"33515055","Effectiveness of convective water vapor energy therapy versus prostatic urethral lift for symptomatic benign prostatic hyperplasia: a systematic review and indirect comparison","Tallman CT, Zantek PF, Hernandez N, Morton RA Jr, Qi D, Gonzalez RR.","World J Urol. 2021 Sep;39(9):3207-3215. doi: 10.1007/s00345-021-03595-8. Epub 2021 Jan 30.","Tallman CT","World J Urol","2021","2021/01/30","","","10.1007/s00345-021-03595-8"
"33488773","Matching comparisons of therapeutic efficacy suggest better clinical outcomes for patients treated with peginterferon beta-1a than with glatiramer acetate","Scott TF, Su R, Xiong K, Altincatal A, Castrillo-Viguera C, Naylor ML.","Ther Adv Neurol Disord. 2021 Jan 12;14:1756286420975916. doi: 10.1177/1756286420975916. eCollection 2021.","Scott TF","Ther Adv Neurol Disord","2021","2021/01/25","PMC7809527","","10.1177/1756286420975916"
"33472427","Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society","Diener HC, Ashina M, Durand-Zaleski I, Kurth T, Lantéri-Minet M, Lipton RB, Ollendorf DA, Pozo-Rosich P, Tassorelli C, Terwindt G.","Cephalalgia. 2021 Mar;41(3):279-293. doi: 10.1177/0333102421989247. Epub 2021 Jan 20.","Diener HC","Cephalalgia","2021","2021/01/21","PMC7961634","","10.1177/0333102421989247"
"33469994","Meta-analysis of efficacy and safety of inhaled ciprofloxacin in non-cystic fibrosis bronchiectasis patients","Wang S, Zhang A, Yao X.","Intern Med J. 2021 Sep;51(9):1505-1512. doi: 10.1111/imj.15210.","Wang S","Intern Med J","2021","2021/01/20","","","10.1111/imj.15210"
"33461352","The cost-effectiveness of glasdegib in combination with low-dose cytarabine, for the treatment of newly diagnosed acute myeloid leukemia in adult patients who are not eligible to receive intensive induction chemotherapy in Canada","Hu Y, Charaan M, van Oostrum I, Heeg B, Bell T.","J Med Econ. 2021 Jan-Dec;24(1):150-161. doi: 10.1080/13696998.2021.1875743.","Hu Y","J Med Econ","2021","2021/01/19","","","10.1080/13696998.2021.1875743"
"33448252","Joining the Dots: Linking Disconnected Networks of Evidence Using Dose-Response Model-Based Network Meta-Analysis","Pedder H, Dias S, Bennetts M, Boucher M, Welton NJ.","Med Decis Making. 2021 Feb;41(2):194-208. doi: 10.1177/0272989X20983315. Epub 2021 Jan 15.","Pedder H","Med Decis Making","2021","2021/01/15","PMC7879230","","10.1177/0272989X20983315"
"33442996","Network meta-analysis of nivolumab plus ipilimumab in the second-line setting for advanced hepatocellular carcinoma","Parikh ND, Marshall A, Betts KA, Song J, Zhao J, Yuan M, Wu A, Huff KD, Kim R.","J Comp Eff Res. 2021 Apr;10(5):343-352. doi: 10.2217/cer-2020-0236. Epub 2021 Jan 14.","Parikh ND","J Comp Eff Res","2021","2021/01/14","","","10.2217/cer-2020-0236"
"33376418","Comparability of European League Against Rheumatology-Recommended Pharmacological Treatments of Oral Ulcers Associated with Behçet's Disease: A Systematic Literature Review of Randomized Controlled Trials","Nazareth T, Hart EM, Ronnebaum SM, Mehta S, Patel DA, Kötter I.","Open Access Rheumatol. 2020 Dec 21;12:323-335. doi: 10.2147/OARRR.S277036. eCollection 2020.","Nazareth T","Open Access Rheumatol","2020","2020/12/30","PMC7762439","","10.2147/OARRR.S277036"
"33435879","When does the use of individual patient data in network meta-analysis make a difference? A simulation study","Kanters S, Karim ME, Thorlund K, Anis A, Bansback N.","BMC Med Res Methodol. 2021 Jan 13;21(1):21. doi: 10.1186/s12874-020-01198-2.","Kanters S","BMC Med Res Methodol","2021","2021/01/13","PMC7805229","","10.1186/s12874-020-01198-2"
"33423240","Evaluating the Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Empagliflozin 25 mg for Treatment of Patients with Type 2 Diabetes in the UK Setting","Capehorn M, Hallén N, Baker-Knight J, Glah D, Hunt B.","Diabetes Ther. 2021 Feb;12(2):537-555. doi: 10.1007/s13300-020-00989-6. Epub 2021 Jan 9.","Capehorn M","Diabetes Ther","2021","2021/01/10","PMC7846640","","10.1007/s13300-020-00989-6"
"33393412","Cost-effectiveness of valbenazine compared with deutetrabenazine for the treatment of tardive dyskinesia","Ganz ML, Chavan A, Dhanda R, Serbin M, Yonan C.","J Med Econ. 2021 Jan-Dec;24(1):103-113. doi: 10.1080/13696998.2020.1867443.","Ganz ML","J Med Econ","2021","2021/01/04","","","10.1080/13696998.2020.1867443"
"33377987","Recombinant FVIIIFc Versus BAY 94-9027 for Treatment of Patients with Haemophilia A: Comparative Efficacy Using a Matching Adjusted Indirect Comparison","Hakimi Z, Santagostino E, Postma MJ, Nazir J.","Adv Ther. 2021 Feb;38(2):1263-1274. doi: 10.1007/s12325-020-01599-1. Epub 2020 Dec 30.","Hakimi Z","Adv Ther","2021","2020/12/30","PMC7889532","","10.1007/s12325-020-01599-1"
"33339864","Dynamic data-driven meta-analysis for prioritisation of host genes implicated in COVID-19","Parkinson N, Rodgers N, Head Fourman M, Wang B, Zechner M, Swets MC, Millar JE, Law A, Russell CD, Baillie JK, Clohisey S.","Sci Rep. 2020 Dec 18;10(1):22303. doi: 10.1038/s41598-020-79033-3.","Parkinson N","Sci Rep","2020","2020/12/19","PMC7749145","","10.1038/s41598-020-79033-3"
"33292314","Cost-effectiveness analysis of ceritinib vs. crizotinib in previously untreated anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) in Hong Kong","Loong HH, Wong CKH, Leung LKS, Chan CPK, Chang A, Zhou ZY, Xie J, Gibbs M.","Cost Eff Resour Alloc. 2020 Nov 7;18(1):50. doi: 10.1186/s12962-020-00244-6.","Loong HH","Cost Eff Resour Alloc","2020","2020/12/09","PMC7648263","","10.1186/s12962-020-00244-6"
"33291810","A Matching-Adjusted Indirect Comparison of Pembrolizumab + Chemotherapy vs. Nivolumab + Ipilimumab as First-Line Therapies in Patients with PD-L1 TPS ≥1% Metastatic NSCLC","Halmos B, Burke T, Kalyvas C, Insinga R, Vandormael K, Frederickson A, Piperdi B.","Cancers (Basel). 2020 Dec 4;12(12):3648. doi: 10.3390/cancers12123648.","Halmos B","Cancers (Basel)","2020","2020/12/09","PMC7762014","","10.3390/cancers12123648"
"33267884","Choice across 10 pharmacologic combination strategies for type 2 diabetes: a cost-effectiveness analysis","Gu S, Shi L, Shao H, Wang X, Hu X, Gu Y, Dong H.","BMC Med. 2020 Dec 3;18(1):378. doi: 10.1186/s12916-020-01837-x.","Gu S","BMC Med","2020","2020/12/03","PMC7713153","","10.1186/s12916-020-01837-x"
"33570887","Pharmacoeconomic Report: Halobetasol Propionate and Tazarotene (Duobrii): (Bausch Health, Canada Inc.): Indication: Psoriasis, moderate-to-severe plaque","","Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Dec.","","Pharmacoeconomic Report: Halobetasol Propionate and Tazarotene (Duobrii): (Bausch Health, Canada Inc.): Indication: Psoriasis, moderate-to-severe plaque","2020","2020/12/01","","",""
"33555772","Brivaracetam versus Levetiracetam for Epilepsy: A Review of Comparative Clinical Safety","Subramonian A, Farrah K.","Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Dec 1.","Subramonian A","Brivaracetam versus Levetiracetam for Epilepsy: A Review of Comparative Clinical Safety","2020","2020/12/01","","",""
"33244703","A Matching-Adjusted Indirect Comparison of Upadacitinib Versus Tofacitinib in Adults with Moderate-to-Severe Rheumatoid Arthritis","Edwards CJ, Sawant R, Garg V, Du EX, Friedman A, Betts KA.","Rheumatol Ther. 2021 Mar;8(1):167-181. doi: 10.1007/s40744-020-00257-w. Epub 2020 Nov 26.","Edwards CJ","Rheumatol Ther","2021","2020/11/27","PMC7991064","","10.1007/s40744-020-00257-w"
"33228440","Front-line daratumumab-VTd versus standard-of-care in ASCT-eligible multiple myeloma: matching-adjusted indirect comparison","Moreau P, Hebraud B, Facon T, Leleu X, Hulin C, Hashim M, Hu Y, Caillot D, Benboubker L, Zweegman S, Merz M, Weisel K, Salwender H, Mai EK, Goldschmidt H, Bertsch U, Vanquickelberghe V, Kampfenkel T, Boer C, Krotneva S, Proskorovsky I, He J, Lam A, Lee C, Cote S, Sonneveld P.","Immunotherapy. 2021 Feb;13(2):143-154. doi: 10.2217/imt-2020-0266. Epub 2020 Nov 24.","Moreau P","Immunotherapy","2021","2020/11/24","","","10.2217/imt-2020-0266"
"33215981","Dual influenza and pneumococcal vaccination was associated with lower short-term risks of all-cause and acute respiratory hospitalizations among the elderly in Shenzhen, China: a retrospective cohort study","Jiang Y, Ye Z, Chen D, Shu Y.","Emerg Microbes Infect. 2020 Dec;9(1):2578-2587. doi: 10.1080/22221751.2020.1854624.","Jiang Y","Emerg Microbes Infect","2020","2020/11/20","PMC7734018","","10.1080/22221751.2020.1854624"
"33213193","Cardiovascular safety of Glimepiride: An indirect comparison from CAROLINA and CARMELINA","Ghosh S, Mukhopadhyay P, Pandey P, Chatterjee P, Pandit K.","Diab Vasc Dis Res. 2020 Nov-Dec;17(6):1479164120973653. doi: 10.1177/1479164120973653.","Ghosh S","Diab Vasc Dis Res","2020","2020/11/20","PMC7919221","","10.1177/1479164120973653"
"33193875","Comparative Overall Survival of CDK4/6 Inhibitors Plus Endocrine Therapy vs. Endocrine Therapy Alone for Hormone receptor-positive, HER2-negative metastatic breast cancer","Lin M, Chen Y, Jin Y, Hu X, Zhang J.","J Cancer. 2020 Oct 18;11(24):7127-7136. doi: 10.7150/jca.48944. eCollection 2020.","Lin M","J Cancer","2020","2020/11/16","PMC7646186","","10.7150/jca.48944"
"33155118","Evaluating cost-effectiveness in the management of neuroendocrine neoplasms","White BE, Mujica-Mota R, Snowsill T, Gamper EM, Srirajaskanthan R, Ramage JK.","Rev Endocr Metab Disord. 2021 Sep;22(3):647-663. doi: 10.1007/s11154-020-09608-y. Epub 2020 Nov 6.","White BE","Rev Endocr Metab Disord","2021","2020/11/06","PMC8346405","","10.1007/s11154-020-09608-y"
"33145711","Lenalidomide with Rituximab for Previously Treated Follicular Lymphoma and Marginal Zone Lymphoma: An Evidence Review Group Perspective of a NICE Single Technology Appraisal","Witlox WJA, Grimm SE, Riemsma R, Armstrong N, Ryder S, Duffy S, Carrera VH, Posadzki P, Worthy G, Pouwels XGLV, Ramaekers BLT, Kleijnen J, Joore MA, van Asselt ADI.","Pharmacoeconomics. 2021 Feb;39(2):171-180. doi: 10.1007/s40273-020-00971-x. Epub 2020 Nov 4.","Witlox WJA","Pharmacoeconomics","2021","2020/11/04","PMC7867510","","10.1007/s40273-020-00971-x"
"33131206","Alternative weighting schemes when performing matching-adjusted indirect comparisons","Jackson D, Rhodes K, Ouwens M.","Res Synth Methods. 2021 May;12(3):333-346. doi: 10.1002/jrsm.1466. Epub 2020 Dec 22.","Jackson D","Res Synth Methods","2021","2020/11/01","","","10.1002/jrsm.1466"
"33119182","Immune-related adverse events of a PD-L1 inhibitor plus chemotherapy versus a PD-L1 inhibitor alone in first-line treatment for advanced non-small cell lung cancer: A meta-analysis of randomized control trials","Wang M, Liang H, Wang W, Zhao S, Cai X, Zhao Y, Li C, Cheng B, Xiong S, Li J, He J, Liang W.","Cancer. 2021 Mar 1;127(5):777-786. doi: 10.1002/cncr.33270. Epub 2020 Oct 29.","Wang M","Cancer","2021","2020/10/29","","","10.1002/cncr.33270"
"33111986","Matching-adjusted indirect comparisons: Application to time-to-event data","Aouni J, Gaudel-Dedieu N, Sebastien B.","Stat Med. 2021 Feb 10;40(3):566-577. doi: 10.1002/sim.8789. Epub 2020 Oct 27.","Aouni J","Stat Med","2021","2020/10/28","","","10.1002/sim.8789"
"33090003","Comparison of ofatumumab and other disease-modifying therapies for relapsing multiple sclerosis: a network meta-analysis","Samjoo IA, Worthington E, Drudge C, Zhao M, Cameron C, Häring DA, Stoneman D, Klotz L, Adlard N.","J Comp Eff Res. 2020 Dec;9(18):1255-1274. doi: 10.2217/cer-2020-0122. Epub 2020 Oct 22.","Samjoo IA","J Comp Eff Res","2020","2020/10/22","","","10.2217/cer-2020-0122"
"33069083","Patterns of Mycobacterium avium-intracellulare complex infection in duodenal endoscopic biopsies in HIV/AIDS patients","AbdullGaffar B, Bashir M.","Ann Diagn Pathol. 2020 Dec;49:151638. doi: 10.1016/j.anndiagpath.2020.151638. Epub 2020 Oct 8.","AbdullGaffar B","Ann Diagn Pathol","2020","2020/10/17","","","10.1016/j.anndiagpath.2020.151638"
"33067698","Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Standard of Care in Latin America for Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Propensity Score Matching Analysis","Hungria V, Martínez-Baños DM, Mateos MV, Dimopoulos MA, Cavo M, Heeg B, Garcia A, Lam A, Machnicki G, He J, Fernandez M.","Adv Ther. 2020 Dec;37(12):4996-5009. doi: 10.1007/s12325-020-01521-9. Epub 2020 Oct 16.","Hungria V","Adv Ther","2020","2020/10/17","PMC7595972","","10.1007/s12325-020-01521-9"
"33062927","Impact of Patient Characteristics on Treatment Outcomes in Symptomatic Venous Thromboembolism: Results of HOKUSAI-VTE Randomized Trial Analysis","van Hout B, Hawe E, Cohen AT.","TH Open. 2020 Sep 23;4(3):e245-e254. doi: 10.1055/s-0040-1716496. eCollection 2020 Jul.","van Hout B","TH Open","2020","2020/10/16","PMC7553796","","10.1055/s-0040-1716496"
"33052055","Comparative efficacy of cemiplimab versus other systemic treatments for advanced cutaneous squamous cell carcinoma","Keeping S, Xu Y, Chen CI, Cope S, Mojebi A, Kuznik A, Konidaris G, Ayers D, Sasane M, Allen R, Huynh TM, Popoff E, Freeman M, Andria ML, Fury MG, Singh K, Stockfleth E, Challapalli A, Schmults CD.","Future Oncol. 2021 Feb;17(5):611-627. doi: 10.2217/fon-2020-0823. Epub 2020 Oct 14.","Keeping S","Future Oncol","2021","2020/10/14","","","10.2217/fon-2020-0823"
"33051255","Efficacy and Safety of Different Doses of Systemic Corticosteroids in COPD Exacerbation","Pu X, Liu L, Feng B, Wang M, Dong L, Zhang Z, Fan Q, Li Y, Wang G.","Respir Care. 2021 Feb;66(2):316-326. doi: 10.4187/respcare.07925. Epub 2020 Oct 13.","Pu X","Respir Care","2021","2020/10/14","","","10.4187/respcare.07925"
"33036834","The future of Cochrane Neonatal","Soll RF, Ovelman C, McGuire W.","Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.","Soll RF","Early Hum Dev","2020","2020/10/10","","","10.1016/j.earlhumdev.2020.105191"
"33015906","Assessing the performance of population adjustment methods for anchored indirect comparisons: A simulation study","Phillippo DM, Dias S, Ades AE, Welton NJ.","Stat Med. 2020 Dec 30;39(30):4885-4911. doi: 10.1002/sim.8759. Epub 2020 Oct 4.","Phillippo DM","Stat Med","2020","2020/10/05","PMC8690023","","10.1002/sim.8759"
"33001384","A Systematic Review of the Clinical Efficacy of Treatments in Relapsed or Refractory Diffuse Large B Cell Lymphoma","Thuresson PO, Vander Velde N, Gupta P, Talbot J.","Adv Ther. 2020 Dec;37(12):4877-4893. doi: 10.1007/s12325-020-01507-7. Epub 2020 Oct 1.","Thuresson PO","Adv Ther","2020","2020/10/01","PMC7595978","","10.1007/s12325-020-01507-7"
"33570892","Pharmacoeconomic Report: Eculizumab (Soliris): Alexion Pharma Canada Corp: Indication: Neuromyelitis optica spectrum disorder","","Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2020 Oct.","","Pharmacoeconomic Report: Eculizumab (Soliris): Alexion Pharma Canada Corp: Indication: Neuromyelitis optica spectrum disorder","2020","2020/10/01","","",""
"32993519","Performance of unanchored matching-adjusted indirect comparison (MAIC) for the evidence synthesis of single-arm trials with time-to-event outcomes","Jiang Y, Ni W.","BMC Med Res Methodol. 2020 Sep 29;20(1):241. doi: 10.1186/s12874-020-01124-6.","Jiang Y","BMC Med Res Methodol","2020","2020/09/30","PMC7526361","","10.1186/s12874-020-01124-6"
"32969597","Efficacy of bendamustine and rituximab in unfit patients with previously untreated chronic lymphocytic leukemia. Indirect comparison with ibrutinib in a real-world setting. A GIMEMA-ERIC and US study","Cuneo A, Mato AR, Rigolin GM, Piciocchi A, Gentile M, Laurenti L, Allan JN, Pagel JM, Brander DM, Hill BT, Winter A, Lamanna N, Tam CS, Jacobs R, Lansigan F, Barr PM, Shadman M, Skarbnik AP, Pu JJ, Sehgal AR, Schuster SJ, Shah NN, Ujjani CS, Roeker L, Orlandi EM, Billio A, Trentin L, Spacek M, Marchetti M, Tedeschi A, Ilariucci F, Gaidano G, Doubek M, Farina L, Molica S, Di Raimondo F, Coscia M, Mauro FR, de la Serna J, Medina Perez A, Ferrarini I, Cimino G, Cavallari M, Cucci R, Vignetti M, Foà R, Ghia P; GIMEMA, European Research Initiative (ERIC) on CLL, US study group.","Cancer Med. 2020 Nov;9(22):8468-8479. doi: 10.1002/cam4.3470. Epub 2020 Sep 24.","Cuneo A","Cancer Med","2020","2020/09/24","PMC7666748","","10.1002/cam4.3470"
"32957804","Summarising salient information on historical controls: A structured assessment of validity and comparability across studies","Hatswell A, Freemantle N, Baio G, Lesaffre E, van Rosmalen J.","Clin Trials. 2020 Dec;17(6):607-616. doi: 10.1177/1740774520944855. Epub 2020 Sep 21.","Hatswell A","Clin Trials","2020","2020/09/22","PMC7649932","","10.1177/1740774520944855"
"32914703","Systematic Review and Meta-Analysis of Multitargeted Tyrosine Kinase Inhibitors in Patients With Intractable Metastatic Colorectal Cancer","Gao Z, Cao C, Bao Y, Fan Y, Chen G, Fu P.","Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820943241. doi: 10.1177/1533033820943241.","Gao Z","Technol Cancer Res Treat","2020","2020/09/11","PMC7488883","","10.1177/1533033820943241"
"32892660","Indirect treatment comparison of the efficacy of patisiran and inotersen for hereditary transthyretin-mediated amyloidosis with polyneuropathy","Gorevic P, Franklin J, Chen J, Sajeev G, Wang JCH, Lin H.","Expert Opin Pharmacother. 2021 Jan;22(1):121-129. doi: 10.1080/14656566.2020.1811850. Epub 2020 Sep 7.","Gorevic P","Expert Opin Pharmacother","2021","2020/09/07","","","10.1080/14656566.2020.1811850"
"32856150","Comparative efficacy of first-line therapeutic interventions for achalasia: a systematic review and network meta-analysis","Facciorusso A, Singh S, Abbas Fehmi SM, Annese V, Lipham J, Yadlapati R.","Surg Endosc. 2021 Aug;35(8):4305-4314. doi: 10.1007/s00464-020-07920-x. Epub 2020 Aug 27.","Facciorusso A","Surg Endosc","2021","2020/08/29","PMC8011535","NIHMS1680894","10.1007/s00464-020-07920-x"
"32853779","Practical considerations of utilizing propensity score methods in clinical development using real-world and historical data","Li Q, Lin J, Chi A, Davies S.","Contemp Clin Trials. 2020 Oct;97:106123. doi: 10.1016/j.cct.2020.106123. Epub 2020 Aug 24.","Li Q","Contemp Clin Trials","2020","2020/08/28","","","10.1016/j.cct.2020.106123"
"32853126","Monoclonal antibodies against calcitonin gene-related peptide in chronic migraine: an adjusted indirect treatment comparison","Briceño-Casado MDP, Gil-Sierra MD, Fénix-Caballero S.","Farm Hosp. 2020 Aug 21;44(5):212-217. doi: 10.7399/fh.11419.","Briceño-Casado MDP","Farm Hosp","2020","2020/08/28","","","10.7399/fh.11419"
"32839071","Response to comment on: Pairwise indirect treatment comparison of dupilumab versus other biologics in patients with uncontrolled persistent asthma (Respir. Med. 2020)","Bateman ED, Khan AH, Xu Y, Guyot P, Chao J, Kamat S, Rowe P, Burnett H, Msihid J, Weinreich DM, Pavord ID.","Respir Med. 2022 Jan;191:106106. doi: 10.1016/j.rmed.2020.106106. Epub 2020 Aug 5.","Bateman ED","Respir Med","2022","2020/08/26","","","10.1016/j.rmed.2020.106106"
"32827435","Efficacy of Once-Weekly Semaglutide vs Empagliflozin Added to Metformin in Type 2 Diabetes: Patient-Level Meta-analysis","Lingvay I, Capehorn MS, Catarig AM, Johansen P, Lawson J, Sandberg A, Shaw R, Paine A.","J Clin Endocrinol Metab. 2020 Dec 1;105(12):e4593-604. doi: 10.1210/clinem/dgaa577.","Lingvay I","J Clin Endocrinol Metab","2020","2020/08/23","PMC7549924","","10.1210/clinem/dgaa577"
"32826180","Cost-effectiveness of Pembrolizumab versus Carboplatin-based Chemotherapy as First-line Treatment of PD-L1-positive Locally Advanced or Metastatic Urothelial Carcinoma Ineligible for Cisplatin-based Therapy in the United States","Hale O, Patterson K, Lai Y, Meng Y, Li H, Godwin JL, Homet Moreno B, Mamtani R.","Clin Genitourin Cancer. 2021 Feb;19(1):e17-e30. doi: 10.1016/j.clgc.2020.07.006. Epub 2020 Jul 16.","Hale O","Clin Genitourin Cancer","2021","2020/08/23","","","10.1016/j.clgc.2020.07.006"
"32804408","Daratumumab-lenalidomide-dexamethasone vs standard-of-care regimens: Efficacy in transplant-ineligible untreated myeloma","Durie BGM, Kumar SK, Usmani SZ, Nonyane BAS, Ammann EM, Lam A, Kobos R, Maiese EM, Facon T.","Am J Hematol. 2020 Dec;95(12):1486-1494. doi: 10.1002/ajh.25963. Epub 2020 Sep 5.","Durie BGM","Am J Hematol","2020","2020/08/18","PMC7754114","","10.1002/ajh.25963"
"32801167","Cladribine vs other drugs in MS: Merging randomized trial with real-life data","Signori A, Saccà F, Lanzillo R, Maniscalco GT, Signoriello E, Repice AM, Annovazzi P, Baroncini D, Clerico M, Binello E, Cerqua R, Mataluni G, Perini P, Bonavita S, Lavorgna L, Zarbo IR, Laroni A, Pareja-Gutierrez L, La Gioia S, Frigeni B, Barcella V, Frau J, Cocco E, Fenu G, Clerici VT, Sartori A, Rasia S, Cordioli C, Stromillo ML, Di Sapio A, Pontecorvo S, Grasso R, Barone S, Barrilà C, Russo CV, Esposito S, Ippolito D, Landi D, Visconti A, Sormani MP.","Neurol Neuroimmunol Neuroinflamm. 2020 Aug 14;7(6):e878. doi: 10.1212/NXI.0000000000000878. Print 2020 Nov.","Signori A","Neurol Neuroimmunol Neuroinflamm","2020","2020/08/18","PMC7641098","","10.1212/NXI.0000000000000878"
"32798057","Efficacy and Safety of Commonly Used Insulin Analogues in the Treatment of Diabetic Ketoacidosis: A Bayesian Indirect Treatment Comparison","Vidyasagar K, Chandrasekar B, Chhabra M, Bhansali A, Bansal D.","Clin Ther. 2020 Aug;42(8):e115-e139. doi: 10.1016/j.clinthera.2020.06.017. Epub 2020 Aug 11.","Vidyasagar K","Clin Ther","2020","2020/08/17","","","10.1016/j.clinthera.2020.06.017"
"32761259","The Efficacy of Neoadjuvant Versus Adjuvant Therapy for Resectable Esophageal Cancer Patients: A Systematic Review and Meta-Analysis","Xiao X, Hong HG, Zeng X, Yang YS, Luan SY, Li Y, Chen LQ, Yuan Y.","World J Surg. 2020 Dec;44(12):4161-4174. doi: 10.1007/s00268-020-05721-w. Epub 2020 Aug 5.","Xiao X","World J Surg","2020","2020/08/08","","","10.1007/s00268-020-05721-w"
"32749937","Efficacy and safety of front-line treatments for advanced Hodgkin lymphoma: a systematic literature review","Dalal M, Gupta J, Price K, Zomas A, Miao H, Ashaye A.","Expert Rev Hematol. 2020 Aug;13(8):907-922. doi: 10.1080/17474086.2020.1793666. Epub 2020 Aug 4.","Dalal M","Expert Rev Hematol","2020","2020/08/05","","","10.1080/17474086.2020.1793666"
"32736593","Indirect comparison of efficacy between different antibiotic prophylaxis against the intracranial infection after craniotomy","Cao Y, Wang B, Shan J, Gong Z, Kuang J, Gao Y.","Antimicrob Resist Infect Control. 2020 Jul 31;9(1):122. doi: 10.1186/s13756-020-00784-9.","Cao Y","Antimicrob Resist Infect Control","2020","2020/08/02","PMC7393706","","10.1186/s13756-020-00784-9"
"32727171","Perspective of the comparative effectiveness of non-pharmacologic managements on postpartum hemorrhage using a network meta-analysis","Lee KJ, Hong K, Hwang H, Choi H, Sohn S.","Obstet Gynecol Sci. 2020 Sep;63(5):605-614. doi: 10.5468/ogs.20080. Epub 2020 Jul 30.","Lee KJ","Obstet Gynecol Sci","2020","2020/07/31","PMC7494765","","10.5468/ogs.20080"
"32693948","A Cost-Consequence Analysis of the Preferential Use of Secukinumab Versus Adalimumab for the Treatment of Psoriatic Arthritis","Jiménez-Morales A, Cáliz R, Aceituno S, Prades M, Blanch C.","Reumatol Clin (Engl Ed). 2020 Jul 18:S1699-258X(20)30132-7. doi: 10.1016/j.reuma.2020.05.004. Online ahead of print.","Jiménez-Morales A","Reumatol Clin (Engl Ed)","2020","2020/07/23","","","10.1016/j.reuma.2020.05.004"
"32684669","Multilevel network meta-regression for population-adjusted treatment comparisons","Phillippo DM, Dias S, Ades AE, Belger M, Brnabic A, Schacht A, Saure D, Kadziola Z, Welton NJ.","J R Stat Soc Ser A Stat Soc. 2020 Jun;183(3):1189-1210. doi: 10.1111/rssa.12579. Epub 2020 Jun 7.","Phillippo DM","J R Stat Soc Ser A Stat Soc","2020","2020/07/21","PMC7362893","","10.1111/rssa.12579"
"32679702","Nivolumab plus Ipilimumab versus Existing Immunotherapies in Patients with PD-L1-Positive Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis","Ando K, Kishino Y, Homma T, Kusumoto S, Yamaoka T, Tanaka A, Ohmori T, Ohnishi T, Sagara H.","Cancers (Basel). 2020 Jul 15;12(7):1905. doi: 10.3390/cancers12071905.","Ando K","Cancers (Basel)","2020","2020/07/19","PMC7409193","","10.3390/cancers12071905"
"32673969","A systematic review and indirect treatment comparison of perampanel versus brivaracetam as adjunctive therapy in patients with focal-onset seizures with or without secondary generalization","Trinka E, Tsong W, Toupin S, Patten A, Wilson K, Isojarvi J, James D.","Epilepsy Res. 2020 Oct;166:106403. doi: 10.1016/j.eplepsyres.2020.106403. Epub 2020 Jun 22.","Trinka E","Epilepsy Res","2020","2020/07/17","","","10.1016/j.eplepsyres.2020.106403"
"32669839","Efficacy and Safety of LAMA/LABA Fixed-Dose Combination Therapies in Chronic Obstructive Pulmonary Disease: A Systematic Review of Direct and Indirect Treatment Comparisons","Hurst JR, Gruffydd-Jones K, Biswas M, Guranlioglu D, Jenkins M, Stjepanovic N, Bamrara A.","Int J Chron Obstruct Pulmon Dis. 2020 Jul 1;15:1529-1543. doi: 10.2147/COPD.S230955. eCollection 2020.","Hurst JR","Int J Chron Obstruct Pulmon Dis","2020","2020/07/17","PMC7336124","","10.2147/COPD.S230955"
"32659160","Comparison of Methods for Estimating Therapy Effects by Indirect Comparisons: A Simulation Study","Weber D, Jensen K, Kieser M.","Med Decis Making. 2020 Jul;40(5):644-654. doi: 10.1177/0272989X20929309. Epub 2020 Jul 13.","Weber D","Med Decis Making","2020","2020/07/14","","","10.1177/0272989X20929309"
"32648475","Matching-adjusted indirect comparison: entrectinib versus crizotinib in ROS1 fusion-positive non-small cell lung cancer","Chu P, Antoniou M, Bhutani MK, Aziez A, Daigl M.","J Comp Eff Res. 2020 Aug;9(12):861-876. doi: 10.2217/cer-2020-0063. Epub 2020 Jul 10.","Chu P","J Comp Eff Res","2020","2020/07/11","","","10.2217/cer-2020-0063"
"32636183","Comparative effectiveness of biological medicines in rheumatoid arthritis: systematic review and network meta-analysis including aggregate results from reanalysed individual patient data","Janke K, Biester K, Krause D, Richter B, Schürmann C, Hirsch K, Hörn H, Kerekes MF, Kohlepp P, Wieseler B.","BMJ. 2020 Jul 7;370:m2288. doi: 10.1136/bmj.m2288.","Janke K","BMJ","2020","2020/07/09","PMC7338922","","10.1136/bmj.m2288"
"32627297","Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon-like peptide-1 receptor agonists: a systematic literature review and indirect treatment comparison","Home PD, Aroda VR, Blonde L, Guyot P, Shaunik A, Fazeli MS, Goswami H, Kalra S, Pourrahmat MM.","Diabetes Obes Metab. 2020 Nov;22(11):2170-2178. doi: 10.1111/dom.14136. Epub 2020 Jul 26.","Home PD","Diabetes Obes Metab","2020","2020/07/07","","","10.1111/dom.14136"
"32602756","Tisagenlecleucel versus historical standard therapies for pediatric relapsed/refractory acute lymphoblastic leukemia","Ma Q, Zhang J, O'Brien E, Martin AL, Agostinho AC.","J Comp Eff Res. 2020 Aug;9(12):849-860. doi: 10.2217/cer-2020-0069. Epub 2020 Jun 30.","Ma Q","J Comp Eff Res","2020","2020/07/01","","","10.2217/cer-2020-0069"
"32596834","Component network meta-analysis compared to a matching method in a disconnected network: A case study","Rücker G, Schmitz S, Schwarzer G.","Biom J. 2021 Feb;63(2):447-461. doi: 10.1002/bimj.201900339. Epub 2020 Jun 28.","Rücker G","Biom J","2021","2020/06/30","","","10.1002/bimj.201900339"
"32568666","Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review","Winkley K, Upsher R, Stahl D, Pollard D, Kasera A, Brennan A, Heller S, Ismail K.","Health Technol Assess. 2020 Jun;24(28):1-232. doi: 10.3310/hta24280.","Winkley K","Health Technol Assess","2020","2020/06/23","PMC7336224","","10.3310/hta24280"
"32561336","Comparing Efficacy, Safety, and Preinfusion Period of Axicabtagene Ciloleucel versus Tisagenlecleucel in Relapsed/Refractory Large B Cell Lymphoma","Oluwole OO, Jansen JP, Lin VW, Chan K, Keeping S, Navale L, Locke FL.","Biol Blood Marrow Transplant. 2020 Sep;26(9):1581-1588. doi: 10.1016/j.bbmt.2020.06.008. Epub 2020 Jun 17.","Oluwole OO","Biol Blood Marrow Transplant","2020","2020/06/21","","","10.1016/j.bbmt.2020.06.008"
"32550696","Rosacea Treatment Satisfaction: Matching Adjusted Indirect Treatment Comparison Analysis of Metronidazole Gel or Cream vs Azelaic Acid Foam","Williamson T, LaRose A, Cameron J, Lott J, Eaddy M, Hopson S, Shih HC, Tennant LT.","J Drugs Dermatol. 2020 Mar 1;19(3):295-304.","Williamson T","J Drugs Dermatol","2020","2020/06/19","","",""
"32540383","Unknown confounders did not bias the treatment effect when improving balance of known confounders in randomized trials","Kuss O, Miller M.","J Clin Epidemiol. 2020 Oct;126:9-16. doi: 10.1016/j.jclinepi.2020.06.012. Epub 2020 Jun 12.","Kuss O","J Clin Epidemiol","2020","2020/06/17","","","10.1016/j.jclinepi.2020.06.012"
"32540233","The Effects of Model Misspecification in Unanchored Matching-Adjusted Indirect Comparison: Results of a Simulation Study","Hatswell AJ, Freemantle N, Baio G.","Value Health. 2020 Jun;23(6):751-759. doi: 10.1016/j.jval.2020.02.008. Epub 2020 May 4.","Hatswell AJ","Value Health","2020","2020/06/17","","","10.1016/j.jval.2020.02.008"
"32524498","A Review of Two Regulatory Approved Anti-CD19 CAR T-Cell Therapies in Diffuse Large B-Cell Lymphoma: Why Are Indirect Treatment Comparisons Not Feasible?","Zhang J, Li J, Ma Q, Yang H, Signorovitch J, Wu E.","Adv Ther. 2020 Jul;37(7):3040-3058. doi: 10.1007/s12325-020-01397-9. Epub 2020 Jun 10.","Zhang J","Adv Ther","2020","2020/06/12","PMC7467403","","10.1007/s12325-020-01397-9"
"32499262","Early Psychosis Intervention-Spreading Evidence-based Treatment (EPI-SET): protocol for an effectiveness-implementation study of a structured model of care for psychosis in youth and emerging adults","Kozloff N, Foussias G, Durbin J, Sockalingam S, Addington J, Addington D, Ampofo A, Anderson KK, Barwick M, Bromley S, Cunningham JEA, Dahrouge S, Duda L, Ford C, Gallagher S, Haltigan JD, Henderson J, Jaouich A, Miranda D, Mitchell P, Morin J, de Oliveira C, Primeau V, Serhal E, Soklaridis S, Urajnik D, Whittard K, Zaheer J, Kurdyak P, Voineskos AN.","BMJ Open. 2020 Jun 3;10(6):e034280. doi: 10.1136/bmjopen-2019-034280.","Kozloff N","BMJ Open","2020","2020/06/06","PMC7282307","","10.1136/bmjopen-2019-034280"
"32490682","Causal inference and adjustment for reference-arm risk in indirect treatment comparison meta-analysis","Swallow E, Patterson-Lomba O, Ayyagari R, Pelletier C, Mehta R, Signorovitch J.","J Comp Eff Res. 2020 Jul;9(10):737-750. doi: 10.2217/cer-2020-0042. Epub 2020 Jun 3.","Swallow E","J Comp Eff Res","2020","2020/06/04","","","10.2217/cer-2020-0042"
"32475340","Statistical analyses and quality of individual participant data network meta-analyses were suboptimal: a cross-sectional study","Gao Y, Shi S, Li M, Luo X, Liu M, Yang K, Zhang J, Song F, Tian J.","BMC Med. 2020 Jun 1;18(1):120. doi: 10.1186/s12916-020-01591-0.","Gao Y","BMC Med","2020","2020/06/02","PMC7262764","","10.1186/s12916-020-01591-0"
"32470056","A framework to build similarity-based cohorts for personalized treatment advice - a standardized, but flexible workflow with the R package SimBaCo","Wirbka L, Haefeli WE, Meid AD.","PLoS One. 2020 May 29;15(5):e0233686. doi: 10.1371/journal.pone.0233686. eCollection 2020.","Wirbka L","PLoS One","2020","2020/05/30","PMC7259608","","10.1371/journal.pone.0233686"
"32456710","Testing whether the progression of Alzheimer's disease changes with the year of publication, additional design, and geographical area: a modeling analysis of literature aggregate data","Zhang N, Zheng X, Liu H, Zheng Q, Li L.","Alzheimers Res Ther. 2020 May 26;12(1):64. doi: 10.1186/s13195-020-00630-5.","Zhang N","Alzheimers Res Ther","2020","2020/05/28","PMC7251914","","10.1186/s13195-020-00630-5"
"32454812","Propranolol Is Associated with Lower Risk of Incidence of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Tertiary-Center Study and Indirect Comparison with Meta-Analysis","Li TH, Tsai YL, Hsu CF, Liu CW, Huang CC, Yang YY, Tsai HC, Huang SF, Hsieh YC, Liu HM, Lee TY, Hou MC, Tsai CY, Lin HC.","Gastroenterol Res Pract. 2020 Apr 9;2020:1892584. doi: 10.1155/2020/1892584. eCollection 2020.","Li TH","Gastroenterol Res Pract","2020","2020/05/27","PMC7238337","","10.1155/2020/1892584"
"32424805","Comparative Efficacy of Cabozantinib and Regorafenib for Advanced Hepatocellular Carcinoma","Kelley RK, Mollon P, Blanc JF, Daniele B, Yau T, Cheng AL, Valcheva V, Marteau F, Guerra I, Abou-Alfa GK.","Adv Ther. 2020 Jun;37(6):2678-2695. doi: 10.1007/s12325-020-01378-y. Epub 2020 May 18.","Kelley RK","Adv Ther","2020","2020/05/20","PMC7467441","","10.1007/s12325-020-01378-y"
"32412387","The cost effectiveness of pembrolizumab versus chemotherapy or atezolizumab as second-line therapy for advanced urothelial carcinoma in the United States","Slater RL, Lai Y, Zhong Y, Li H, Meng Y, Moreno BH, Godwin JL, Frenkl T, Sonpavde GP, Mamtani R.","J Med Econ. 2020 Sep;23(9):967-977. doi: 10.1080/13696998.2020.1770261. Epub 2020 Jun 12.","Slater RL","J Med Econ","2020","2020/05/16","","","10.1080/13696998.2020.1770261"
"32395870","Equivalence of entropy balancing and the method of moments for matching-adjusted indirect comparison","Phillippo DM, Dias S, Ades AE, Welton NJ.","Res Synth Methods. 2020 Jul;11(4):568-572. doi: 10.1002/jrsm.1416. Epub 2020 May 27.","Phillippo DM","Res Synth Methods","2020","2020/05/13","PMC7384548","","10.1002/jrsm.1416"
"32386269","Indirect comparison of anti-interleukin 17 targeted biological treatments for moderate-to-severe psoriasis","Díaz Acedo R, Galvan Banqueri M, Márquez Saavedra E.","J Clin Pharm Ther. 2020 Aug;45(4):715-721. doi: 10.1111/jcpt.13153. Epub 2020 May 9.","Díaz Acedo R","J Clin Pharm Ther","2020","2020/05/10","","","10.1111/jcpt.13153"
"32380428","Indirect treatment comparison of nivolumab versus placebo for the adjuvant treatment of melanoma","Hemstock M, Amadi A, Kupas K, Roskell N, Kotapati S, Gooden K, Middleton MR, Schadendorf D.","Eur J Cancer. 2020 Jun;132:176-186. doi: 10.1016/j.ejca.2020.03.011. Epub 2020 May 4.","Hemstock M","Eur J Cancer","2020","2020/05/08","","","10.1016/j.ejca.2020.03.011"
"32371431","Comparative effectiveness of improvement in pain and physical function for baricitinib versus adalimumab, tocilizumab and tofacitinib monotherapies in rheumatoid arthritis patients who are naïve to treatment with biologic or conventional synthetic disease-modifying antirheumatic drugs: a matching-adjusted indirect comparison","Fautrel B, Zhu B, Taylor PC, van de Laar M, Emery P, De Leonardis F, Kannowski CL, Nicolay C, Kadziola Z, De La Torre I, Fleischmann R.","RMD Open. 2020 Apr;6(1):e001131. doi: 10.1136/rmdopen-2019-001131.","Fautrel B","RMD Open","2020","2020/05/07","PMC7299519","","10.1136/rmdopen-2019-001131"
"32367407","Propensity score matching/reweighting analysis comparing intravenous golimumab to infliximab for ankylosing spondylitis using data from the GO-ALIVE and ASSERT trials","Gensler LS, Chakravarty SD, Cameron C, Peterson S, Spin P, Kafka S, Nair S, Deodhar A.","Clin Rheumatol. 2020 Oct;39(10):2907-2917. doi: 10.1007/s10067-020-05051-1. Epub 2020 May 4.","Gensler LS","Clin Rheumatol","2020","2020/05/06","PMC7497341","","10.1007/s10067-020-05051-1"
"32327161","Critical Appraisal of Published Indirect Comparisons and Network Meta-Analyses of Competing Interventions for Multiple Myeloma","Cope S, Toor K, Popoff E, Fonseca R, Landgren O, Mateos MV, Weisel K, Jansen JP.","Value Health. 2020 Apr;23(4):441-450. doi: 10.1016/j.jval.2019.11.003. Epub 2020 Apr 6.","Cope S","Value Health","2020","2020/04/25","PMC7480667","NIHMS1613292","10.1016/j.jval.2019.11.003"
"32308623","Combined Methods (Formal Adjusted Indirect Comparison, Meta-Analysis and Principal Component Analysis) Comparisons of the Safety and Efficacy of Ambrisentan, Bosentan, and Sildenafil in the Patients With Pulmonary Arterial Hypertension","Li X, Li T.","Front Pharmacol. 2020 Apr 3;11:400. doi: 10.3389/fphar.2020.00400. eCollection 2020.","Li X","Front Pharmacol","2020","2020/04/21","PMC7145892","","10.3389/fphar.2020.00400"
"32301116","Reweighting Randomized Controlled Trial Evidence to Better Reflect Real Life - A Case Study of the Innovative Medicines Initiative","Happich M, Brnabic A, Faries D, Abrams K, Winfree KB, Girvan A, Jonsson P, Johnston J, Belger M; IMI GetReal Work Package 1.","Clin Pharmacol Ther. 2020 Oct;108(4):817-825. doi: 10.1002/cpt.1854. Epub 2020 May 30.","Happich M","Clin Pharmacol Ther","2020","2020/04/18","PMC7540324","","10.1002/cpt.1854"
"32299269","Indirect comparisons of ixekizumab versus three interleukin-23 p19 inhibitors in patients with moderate-to-severe plaque psoriasis - efficacy findings up to week 12","Gottlieb AB, Saure D, Wilhelm S, Dossenbach M, Schuster C, Smith SD, Ramot Y, Thaçi D.","J Dermatolog Treat. 2022 Feb;33(1):54-61. doi: 10.1080/09546634.2020.1747592. Epub 2020 Apr 17.","Gottlieb AB","J Dermatolog Treat","2022","2020/04/18","","","10.1080/09546634.2020.1747592"
"32290309","Brigatinib and Alectinib for ALK Rearrangement-Positive Advanced Non-Small Cell Lung Cancer With or Without Central Nervous System Metastasis: A Systematic Review and Network Meta-Analysis","Ando K, Akimoto K, Sato H, Manabe R, Kishino Y, Homma T, Kusumoto S, Yamaoka T, Tanaka A, Ohmori T, Sagara H.","Cancers (Basel). 2020 Apr 10;12(4):942. doi: 10.3390/cancers12040942.","Ando K","Cancers (Basel)","2020","2020/04/16","PMC7226463","","10.3390/cancers12040942"
"32278674","Comparative Efficacy of Bortezomib, Melphalan, and Prednisone (VMP) With or Without Daratumumab Versus VMP Alone in the Treatment of Newly Diagnosed Multiple Myeloma: Propensity Score Matching of ALCYONE and VISTA Phase III Studies","Cavo M, Dimopoulos MA, San-Miguel J, Mateos MV, Jakubowiak A, Deraedt W, Lam A, Kampfenkel T, Qi M, He J.","Clin Lymphoma Myeloma Leuk. 2020 Jul;20(7):480-489. doi: 10.1016/j.clml.2020.02.018. Epub 2020 Mar 7.","Cavo M","Clin Lymphoma Myeloma Leuk","2020","2020/04/13","","","10.1016/j.clml.2020.02.018"
"32253560","The impact of intra-abdominal pressure on perioperative outcomes in laparoscopic cholecystectomy: a systematic review and network meta-analysis of randomized controlled trials","Raval AD, Deshpande S, Koufopoulou M, Rabar S, Neupane B, Iheanacho I, Bash LD, Horrow J, Fuchs-Buder T.","Surg Endosc. 2020 Jul;34(7):2878-2890. doi: 10.1007/s00464-020-07527-2. Epub 2020 Apr 6.","Raval AD","Surg Endosc","2020","2020/04/08","PMC7270984","","10.1007/s00464-020-07527-2"
"32222903","Efficacy and Treatment Burden of Intravitreal Aflibercept Versus Intravitreal Ranibizumab Treat-and-Extend Regimens at 2 Years: Network Meta-Analysis Incorporating Individual Patient Data Meta-Regression and Matching-Adjusted Indirect Comparison","Ohji M, Lanzetta P, Korobelnik JF, Wojciechowski P, Taieb V, Deschaseaux C, Janer D, Tuckmantel C.","Adv Ther. 2020 May;37(5):2184-2198. doi: 10.1007/s12325-020-01298-x. Epub 2020 Mar 28.","Ohji M","Adv Ther","2020","2020/03/31","PMC7467478","","10.1007/s12325-020-01298-x"
"32221596","A putative placebo analysis of the effects of sacubitril/valsartan in heart failure across the full range of ejection fraction","Vaduganathan M, Jhund PS, Claggett BL, Packer M, Widimský J, Seferovic P, Rizkala A, Lefkowitz M, Shi V, McMurray JJV, Solomon SD.","Eur Heart J. 2020 Jul 1;41(25):2356-2362. doi: 10.1093/eurheartj/ehaa184.","Vaduganathan M","Eur Heart J","2020","2020/03/30","PMC7327532","","10.1093/eurheartj/ehaa184"
"32220214","Matching-adjusted indirect treatment comparison of siponimod and other disease modifying treatments in secondary progressive multiple sclerosis","Samjoo IA, Worthington E, Haltner A, Cameron C, Nicholas R, Rouyrre N, Dahlke F, Adlard N.","Curr Med Res Opin. 2020 Jul;36(7):1157-1166. doi: 10.1080/03007995.2020.1747999. Epub 2020 Apr 14.","Samjoo IA","Curr Med Res Opin","2020","2020/03/30","","","10.1080/03007995.2020.1747999"
"32216597","The importance of considering differences in study and patient characteristics before undertaking indirect treatment comparisons: a case study of siponimod for secondary progressive multiple sclerosis","Samjoo IA, Worthington E, Haltner A, Cameron C, Nicholas R, Dahlke F, Adlard N.","Curr Med Res Opin. 2020 Jul;36(7):1145-1156. doi: 10.1080/03007995.2020.1747998. Epub 2020 Apr 14.","Samjoo IA","Curr Med Res Opin","2020","2020/03/29","","","10.1080/03007995.2020.1747998"
"32208038","A patient-level cost-effectiveness analysis of iron isomaltoside versus ferric carboxymaltose for the treatment of iron deficiency anemia in the United Kingdom","Pollock RF, Muduma G.","J Med Econ. 2020 Jul;23(7):751-759. doi: 10.1080/13696998.2020.1745535. Epub 2020 May 1.","Pollock RF","J Med Econ","2020","2020/03/26","","","10.1080/13696998.2020.1745535"
"32191592","Cost-Effectiveness of Brexanolone Versus Selective Serotonin Reuptake Inhibitors for the Treatment of Postpartum Depression in the United States","Eldar-Lissai A, Cohen JT, Meltzer-Brody S, Gerbasi ME, Chertavian E, Hodgkins P, Bond JC, Johnson SJ.","J Manag Care Spec Pharm. 2020 May;26(5):627-638. doi: 10.18553/jmcp.2020.19306. Epub 2020 Mar 19.","Eldar-Lissai A","J Manag Care Spec Pharm","2020","2020/03/20","","","10.18553/jmcp.2020.19306"
"32190414","Indirect comparison of azacitidine and decitabine for the therapy of elderly patients with acute myeloid leukemia: a systematic review and network meta-analysis","Wen B, You W, Yang S, Du X.","Exp Hematol Oncol. 2020 Mar 16;9:3. doi: 10.1186/s40164-020-00160-8. eCollection 2020.","Wen B","Exp Hematol Oncol","2020","2020/03/20","PMC7075015","","10.1186/s40164-020-00160-8"
"32185590","Comparative efficacy and cost-utility of combined cataract and minimally invasive glaucoma surgery in primary open-angle glaucoma","Bartelt-Hofer J, Flessa S.","Int Ophthalmol. 2020 Jun;40(6):1469-1479. doi: 10.1007/s10792-020-01314-7. Epub 2020 Mar 17.","Bartelt-Hofer J","Int Ophthalmol","2020","2020/03/19","PMC7242241","","10.1007/s10792-020-01314-7"
"32182248","Assessing the efficacy and safety of fecal microbiota transplantation and probiotic VSL#3 for active ulcerative colitis: A systematic review and meta-analysis","Dang X, Xu M, Liu D, Zhou D, Yang W.","PLoS One. 2020 Mar 17;15(3):e0228846. doi: 10.1371/journal.pone.0228846. eCollection 2020.","Dang X","PLoS One","2020","2020/03/18","PMC7077802","","10.1371/journal.pone.0228846"
"32122024","Accelerated convergence extended ptychographical iterative engine using multiple axial intensity constraints","Dou J, Wu J, Zhang Y, Hu Y, Yang Z.","Opt Express. 2020 Feb 3;28(3):3587-3597. doi: 10.1364/OE.386152.","Dou J","Opt Express","2020","2020/03/04","","","10.1364/OE.386152"
"32115845","Combination of several matching adjusted indirect comparisons (MAICs) with an application in psoriasis","Saure D, Schacht A, Kadziola Z, Brnabic AJM.","Pharm Stat. 2020 Sep;19(5):532-540. doi: 10.1002/pst.2011. Epub 2020 Mar 1.","Saure D","Pharm Stat","2020","2020/03/03","","","10.1002/pst.2011"
"32063399","From single-arm studies to externally controlled studies. Methodological considerations and guidelines","Cucherat M, Laporte S, Delaitre O, Behier JM; participants of Giens XXXV Round Table Clinical Research, d'Andon A, Binlich F, Bureau S, Cornu C, Fouret C, Hoog Labouret N, Laviolle B, Miadi-Fargier H, Paoletti X, Roustit M, Simon T, Varoqueaux N, Vicaut E, Westerloppe J.","Therapie. 2020 Jan-Feb;75(1):21-27. doi: 10.1016/j.therap.2019.11.007. Epub 2019 Dec 16.","Cucherat M","Therapie","2020","2020/02/18","","","10.1016/j.therap.2019.11.007"
"32057373","Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention","Madhavan MV, Kirtane AJ, Redfors B, Généreux P, Ben-Yehuda O, Palmerini T, Benedetto U, Biondi-Zoccai G, Smits PC, von Birgelen C, Mehran R, McAndrew T, Serruys PW, Leon MB, Pocock SJ, Stone GW.","J Am Coll Cardiol. 2020 Feb 18;75(6):590-604. doi: 10.1016/j.jacc.2019.11.058.","Madhavan MV","J Am Coll Cardiol","2020","2020/02/15","","","10.1016/j.jacc.2019.11.058"
"32049837","Efficacy and safety of oral traditional Chinese patent medicine in treatment of liver stagnation and spleen deficiency of depression: A protocol for systematic review","Yu Y, Zhang G, Han T, Huang H.","Medicine (Baltimore). 2020 Feb;99(7):e19142. doi: 10.1097/MD.0000000000019142.","Yu Y","Medicine (Baltimore)","2020","2020/02/13","PMC7035078","","10.1097/MD.0000000000019142"
"32019141","Comparative Efficacy and Safety of Dupilumab and Benralizumab in Patients with Inadequately Controlled Asthma: A Systematic Review","Ando K, Tanaka A, Sagara H.","Int J Mol Sci. 2020 Jan 30;21(3):889. doi: 10.3390/ijms21030889.","Ando K","Int J Mol Sci","2020","2020/02/06","PMC7037967","","10.3390/ijms21030889"
"32011182","The impact of clinical heterogeneity on conducting network meta-analyses in transthyretin amyloidosis with polyneuropathy","Samjoo IA, Salvo EM, Tran D, Amass L, Stewart M, Cameron C.","Curr Med Res Opin. 2020 May;36(5):799-808. doi: 10.1080/03007995.2020.1725742. Epub 2020 Feb 17.","Samjoo IA","Curr Med Res Opin","2020","2020/02/04","","","10.1080/03007995.2020.1725742"
"32007196","CAR T-cell product performance in haematological malignancies before and after marketing authorisation","Elsallab M, Levine BL, Wayne AS, Abou-El-Enein M.","Lancet Oncol. 2020 Feb;21(2):e104-e116. doi: 10.1016/S1470-2045(19)30729-6.","Elsallab M","Lancet Oncol","2020","2020/02/03","PMC7841982","NIHMS1653432","10.1016/S1470-2045(19)30729-6"
"31985301","Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matching-adjusted indirect comparative analysis","Wu JJ, Hansen JB, Patel DS, Nyholm N, Veverka KA, Swensen AR.","J Med Econ. 2020 Jun;23(6):641-649. doi: 10.1080/13696998.2020.1722139. Epub 2020 Mar 2.","Wu JJ","J Med Econ","2020","2020/01/28","","","10.1080/13696998.2020.1722139"
"31948278","Comparative safety and efficacy of ozanimod versus fingolimod for relapsing multiple sclerosis","Swallow E, Patterson-Lomba O, Yin L, Mehta R, Pelletier C, Kao D, Sheffield JK, Stonehouse T, Signorovitch J.","J Comp Eff Res. 2020 Mar;9(4):275-285. doi: 10.2217/cer-2019-0169. Epub 2020 Jan 17.","Swallow E","J Comp Eff Res","2020","2020/01/18","","","10.2217/cer-2019-0169"
"31943429","Matching-adjusted comparison of oral corticosteroid reduction in asthma: Systematic review of biologics","Bourdin A, Husereau D, Molinari N, Golam S, Siddiqui MK, Lindner L, Xu X.","Clin Exp Allergy. 2020 Apr;50(4):442-452. doi: 10.1111/cea.13561. Epub 2020 Mar 20.","Bourdin A","Clin Exp Allergy","2020","2020/01/17","PMC7204869","","10.1111/cea.13561"
"31940225","Cost per PASI-75 responder of calcipotriol plus betamethasone dipropionate cutaneous foam versus nonbiologic systemic therapies for the treatment of plaque psoriasis in seven European countries","Balak DMW, Carrascosa JM, Gregoriou S, Calzavara-Pinton P, Bewley A, Antunes J, Nyeland ME, Viola MG, Sawyer LM, Becla L.","J Dermatolog Treat. 2021 Nov;32(7):701-708. doi: 10.1080/09546634.2019.1707754. Epub 2020 Mar 6.","Balak DMW","J Dermatolog Treat","2021","2020/01/16","","","10.1080/09546634.2019.1707754"
"31932080","Cost-effectiveness of Dabigatran Compared With Rivaroxaban for Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in China","Dong SJ, Wu B, Zhai SD, Zhang YJ, Chu YB, Gupta P, Li YH.","Clin Ther. 2020 Jan;42(1):144-156.e1. doi: 10.1016/j.clinthera.2019.11.011. Epub 2020 Jan 10.","Dong SJ","Clin Ther","2020","2020/01/15","","","10.1016/j.clinthera.2019.11.011"
"31930460","After 20 Years of Using Economic Evaluation, Should NICE be Considered a Methods Innovator?","Sculpher M, Palmer S.","Pharmacoeconomics. 2020 Mar;38(3):247-257. doi: 10.1007/s40273-019-00882-6.","Sculpher M","Pharmacoeconomics","2020","2020/01/14","","","10.1007/s40273-019-00882-6"
"31919360","Genome-wide CRISPR screen identifies host dependency factors for influenza A virus infection","Li B, Clohisey SM, Chia BS, Wang B, Cui A, Eisenhaure T, Schweitzer LD, Hoover P, Parkinson NJ, Nachshon A, Smith N, Regan T, Farr D, Gutmann MU, Bukhari SI, Law A, Sangesland M, Gat-Viks I, Digard P, Vasudevan S, Lingwood D, Dockrell DH, Doench JG, Baillie JK, Hacohen N.","Nat Commun. 2020 Jan 9;11(1):164. doi: 10.1038/s41467-019-13965-x.","Li B","Nat Commun","2020","2020/01/11","PMC6952391","","10.1038/s41467-019-13965-x"
"31917873","Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis","Sbidian E, Chaimani A, Afach S, Doney L, Dressler C, Hua C, Mazaud C, Phan C, Hughes C, Riddle D, Naldi L, Garcia-Doval I, Le Cleach L.","Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.","Sbidian E","Cochrane Database Syst Rev","2020","2020/01/10","PMC6956468","","10.1002/14651858.CD011535.pub3"
"31916448","Effectiveness of durvalumab versus chemotherapy in metastatic urothelial cancer: an observational, indirect comparison","Nordstrom BL, Oguz M, Chu BC, Ouwens M, Arkenau HT, Klein AB.","J Comp Eff Res. 2020 Feb;9(3):191-199. doi: 10.2217/cer-2019-0163. Epub 2020 Jan 9.","Nordstrom BL","J Comp Eff Res","2020","2020/01/10","","","10.2217/cer-2019-0163"
"31872771","Comparative effectiveness of nivolumab versus clinical practice for advanced gastric or gastroesophageal junction cancer","Chau I, Ayers D, Goring S, Cope S, Korytowsky B, Abraham P.","J Comp Eff Res. 2020 Jan;9(2):103-114. doi: 10.2217/cer-2019-0145. Epub 2019 Dec 24.","Chau I","J Comp Eff Res","2020","2019/12/25","","","10.2217/cer-2019-0145"
"31871432","Abiraterone acetate and docetaxel with androgen deprivation therapy in high-volume metastatic hormone-sensitive prostate cancer in China: an indirect treatment comparison and cost analysis","Hu X, Qu S, Yao X, Li C, Liu Y, Wang J.","Cost Eff Resour Alloc. 2019 Dec 13;17:27. doi: 10.1186/s12962-019-0193-4. eCollection 2019.","Hu X","Cost Eff Resour Alloc","2019","2019/12/25","PMC6911273","","10.1186/s12962-019-0193-4"
"31865547","Treatment of Atrial Fibrillation Using Ablation Index-Guided Contact Force Ablation: A Matching-Adjusted Indirect Comparison to Cryoballoon Ablation","Hussein A, Gupta D, De Potter T, Spin P, Eaton K, Goldstein L, Velleca M, Costa G, Grima D, Patel L, Stabile G.","Adv Ther. 2020 Feb;37(2):785-799. doi: 10.1007/s12325-019-01173-4. Epub 2019 Dec 21.","Hussein A","Adv Ther","2020","2019/12/23","PMC7004430","","10.1007/s12325-019-01173-4"
"31856172","Efficacy of antimalarial drugs for treatment of uncomplicated falciparum malaria in Asian region: A network meta-analysis","Naing C, Whittaker MA, Htet NH, Aye SN, Mak JW.","PLoS One. 2019 Dec 19;14(12):e0225882. doi: 10.1371/journal.pone.0225882. eCollection 2019.","Naing C","PLoS One","2019","2019/12/20","PMC6922314","","10.1371/journal.pone.0225882"
"31838711","Response to Letter to the Editor Regarding: Indirect Treatment Comparison of Inotuzumab Ozogamicin versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia","Proskorovsky I, Vandendries E, Pagé V, Cappelleri JC, Stelljes M.","Adv Ther. 2020 Feb;37(2):958-962. doi: 10.1007/s12325-019-01169-0. Epub 2019 Dec 14.","Proskorovsky I","Adv Ther","2020","2019/12/16","PMC7004421","","10.1007/s12325-019-01169-0"
"31838710","Letter to the Editor Regarding: Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia, Proskorovsky et al. Adv Ther (2019);36(8):2147-2160. doi:10.1007/s12325-019-00991-w","Song J, Gao W, Xie J, Tiwana S.","Adv Ther. 2020 Feb;37(2):955-957. doi: 10.1007/s12325-019-01168-1. Epub 2019 Dec 14.","Song J","Adv Ther","2020","2019/12/16","PMC6999160","","10.1007/s12325-019-01168-1"
"31830264","Safety and efficacy of non-vitamin K antagonist oral anticoagulants in elderly patients with atrial fibrillation: systematic review and meta-analysis of 22 studies and 440 281 patients","Silverio A, Di Maio M, Prota C, De Angelis E, Radano I, Citro R, Carrizzo A, Ciccarelli M, Vecchione C, Capodanno D, Galasso G.","Eur Heart J Cardiovasc Pharmacother. 2021 Apr 9;7(FI1):f20-f29. doi: 10.1093/ehjcvp/pvz073.","Silverio A","Eur Heart J Cardiovasc Pharmacother","2021","2019/12/13","","","10.1093/ehjcvp/pvz073"
"31813087","Matching-Adjusted Indirect Comparison of Health-Related Quality of Life and Adverse Events of Apalutamide Versus Enzalutamide in Non-Metastatic Castration-Resistant Prostate Cancer","Chowdhury S, Oudard S, Uemura H, Joniau S, Pilon D, Lefebvre P, McQuarrie K, Liu J, Dearden L, Sermon J, Van Sanden S, Diels J, Hadaschik BA.","Adv Ther. 2020 Jan;37(1):512-526. doi: 10.1007/s12325-019-01157-4. Epub 2019 Dec 7.","Chowdhury S","Adv Ther","2020","2019/12/09","","","10.1007/s12325-019-01157-4"
"31813086","Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide with ADT in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer","Chowdhury S, Oudard S, Uemura H, Joniau S, Pilon D, Ladouceur M, Behl AS, Liu J, Dearden L, Sermon J, Van Sanden S, Diels J, Hadaschik BA.","Adv Ther. 2020 Jan;37(1):501-511. doi: 10.1007/s12325-019-01156-5. Epub 2019 Dec 7.","Chowdhury S","Adv Ther","2020","2019/12/09","PMC6979453","","10.1007/s12325-019-01156-5"
"31774340","A criterion-based approach to systematic and transparent comparative effectiveness: a case study in psoriatic arthritis","Tremblay G, Westley T, Forsythe A, Pelletier C, Briggs A.","J Comp Eff Res. 2019 Nov;8(15):1265-1298. doi: 10.2217/cer-2019-0064. Epub 2019 Sep 5.","Tremblay G","J Comp Eff Res","2019","2019/11/28","","","10.2217/cer-2019-0064"
"31745252","Evaluating the clinical effectiveness of autologous haematopoietic stem cell transplantation versus disease-modifying therapy in multiple sclerosis using a matching-adjusted indirect comparison: an exploratory study from the Autoimmune Diseases Working Party (ADWP) of the European Society of Bone and Marrow Transplantation (EBMT)","Tappenden P, Wang Y, Sharrack B, Burman J, Kazmi M, Saccardi R, Bermejo I, Harvey R, Badoglio M, Farge D, Snowden JA.","Bone Marrow Transplant. 2020 Jul;55(7):1473-1475. doi: 10.1038/s41409-019-0747-2. Epub 2019 Nov 19.","Tappenden P","Bone Marrow Transplant","2020","2019/11/21","","","10.1038/s41409-019-0747-2"
"31743962","Critical Points on the Use of Biologicals in Allergic Diseases and Asthma","Agache I, Cojanu C, Laculiceanu A, Rogozea L.","Allergy Asthma Immunol Res. 2020 Jan;12(1):24-41. doi: 10.4168/aair.2020.12.1.24.","Agache I","Allergy Asthma Immunol Res","2020","2019/11/20","PMC6875478","","10.4168/aair.2020.12.1.24"
"31719453","First records of the genera Neocylloepus and Pilielmis (Coleoptera: Elmidae: Elminae) from Venezuela, with the description of Pilielmis shepardi sp. nov","Polizei TTS, Barclay MVL.","Zootaxa. 2019 Oct 22;4688(2):zootaxa.4688.2.8. doi: 10.11646/zootaxa.4688.2.8.","Polizei TTS","Zootaxa","2019","2019/11/14","","","10.11646/zootaxa.4688.2.8"
"31699438","Matching-adjusted Indirect Comparisons of the Efficacy and Safety of Acalabrutinib Versus Other Targeted Therapies in Relapsed/Refractory Mantle Cell Lymphoma","Telford C, Kabadi SM, Abhyankar S, Song J, Signorovitch J, Zhao J, Yao Z.","Clin Ther. 2019 Nov;41(11):2357-2379.e1. doi: 10.1016/j.clinthera.2019.09.012. Epub 2019 Nov 4.","Telford C","Clin Ther","2019","2019/11/09","","","10.1016/j.clinthera.2019.09.012"
"31686561","The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparison","Mateos MV, San-Miguel J, Goldschmidt H, Sonneveld P, Dimopoulos MA, Heeg B, Hashim M, Deraedt W, Hu P, Lam A, He J.","Leuk Lymphoma. 2020 Mar;61(3):680-690. doi: 10.1080/10428194.2019.1675881. Epub 2019 Nov 5.","Mateos MV","Leuk Lymphoma","2020","2019/11/06","","","10.1080/10428194.2019.1675881"
"31686559","A matching-adjusted indirect treatment comparison (MAIC) of daratumumab-bortezomib-melphalan-prednisone (D-VMP) versus lenalidomide-dexamethasone continuous (Rd continuous), lenalidomide-dexamethasone 18 months (Rd 18), and melphalan-prednisone-thalidomide (MPT)","Dimopoulos MA, Cavo M, Mateos MV, Facon T, Heeg B, van Beekhuizen S, Gebregergish SB, Nair S, Pisini M, Lam A, Slavcev M.","Leuk Lymphoma. 2020 Mar;61(3):714-720. doi: 10.1080/10428194.2019.1682571. Epub 2019 Nov 5.","Dimopoulos MA","Leuk Lymphoma","2020","2019/11/06","","","10.1080/10428194.2019.1682571"
"31673882","Cost-Effectiveness Analysis of Apixaban Versus Edoxaban in Patients with Atrial Fibrillation for Stroke Prevention","Oyagüez I, Suárez C, López-Sendón JL, González-Juanatey JR, de Andrés-Nogales F, Suárez J, Polanco C, Soto J.","Pharmacoecon Open. 2020 Sep;4(3):485-497. doi: 10.1007/s41669-019-00186-7.","Oyagüez I","Pharmacoecon Open","2020","2019/11/02","PMC7426339","","10.1007/s41669-019-00186-7"
"31663466","Budget Impact of Dabrafenib and Trametinib in Combination as Adjuvant Treatment of BRAF V600E/K Mutation-Positive Melanoma from a U.S. Commercial Payer Perspective","Stellato D, Gerbasi ME, Ndife B, Ghate SR, Moynahan A, Mishra D, Gunda P, Koruth R, Delea TE.","J Manag Care Spec Pharm. 2019 Nov;25(11):1227-1237. doi: 10.18553/jmcp.2019.25.11.1227.","Stellato D","J Manag Care Spec Pharm","2019","2019/10/31","","","10.18553/jmcp.2019.25.11.1227"
"31652347","Adjusted treatment COMPArisons between guSelkumab and uStekinumab for treatment of moderate-to-severe plaque psoriasis: the COMPASS analysis","Diels J, Thilakarathne P, Cameron C, McElligott S, Schubert A, Puig L.","Br J Dermatol. 2020 Aug;183(2):276-284. doi: 10.1111/bjd.18634. Epub 2020 Jan 29.","Diels J","Br J Dermatol","2020","2019/10/26","PMC7496582","","10.1111/bjd.18634"
"31642037","Using Matching-Adjusted Indirect Comparisons and Network Meta-analyses to Compare Efficacy of Brexanolone Injection with Selective Serotonin Reuptake Inhibitors for Treating Postpartum Depression","Cooper MC, Kilvert HS, Hodgkins P, Roskell NS, Eldar-Lissai A.","CNS Drugs. 2019 Oct;33(10):1039-1052. doi: 10.1007/s40263-019-00672-w.","Cooper MC","CNS Drugs","2019","2019/10/24","PMC6825025","","10.1007/s40263-019-00672-w"
"31640567","BUGSnet: an R package to facilitate the conduct and reporting of Bayesian network Meta-analyses","Béliveau A, Boyne DJ, Slater J, Brenner D, Arora P.","BMC Med Res Methodol. 2019 Oct 22;19(1):196. doi: 10.1186/s12874-019-0829-2.","Béliveau A","BMC Med Res Methodol","2019","2019/10/24","PMC6805536","","10.1186/s12874-019-0829-2"
"31640435","Carfilzomib and dexamethasone versus eight cycles of bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma: an indirect comparison using data from the phase 3 ENDEAVOR and CASTOR trials","Weisel K, Majer I, DeCosta L, Oriol A, Goldschmidt H, Ludwig H, Campioni M, Szabo Z, Dimopoulos M.","Leuk Lymphoma. 2020 Jan;61(1):37-46. doi: 10.1080/10428194.2019.1648806. Epub 2019 Oct 22.","Weisel K","Leuk Lymphoma","2020","2019/10/24","","","10.1080/10428194.2019.1648806"
"31632108","Value For Money In The Treatment Of Patients With Type 2 Diabetes Mellitus: Assessing The Long-Term Cost-Effectiveness Of IDegLira Versus iGlarLixi In Italy","Pöhlmann J, Montagnoli R, Lastoria G, Parekh W, Markert M, Hunt B.","Clinicoecon Outcomes Res. 2019 Oct 7;11:605-614. doi: 10.2147/CEOR.S218746. eCollection 2019.","Pöhlmann J","Clinicoecon Outcomes Res","2019","2019/10/22","PMC6789179","","10.2147/CEOR.S218746"
"31607912","Histamine2-Receptor Antagonists, Proton Pump Inhibitors, or Potassium-Competitive Acid Blockers Preventing Delayed Bleeding After Endoscopic Submucosal Dissection: A Meta-Analysis","Jiang X, Li J, Xie J, Liang Z, Wan N, Jiang J, Zhang T, Wu Y.","Front Pharmacol. 2019 Sep 19;10:1055. doi: 10.3389/fphar.2019.01055. eCollection 2019.","Jiang X","Front Pharmacol","2019","2019/10/15","PMC6761621","","10.3389/fphar.2019.01055"
"31602601","Cost-Effectiveness Analysis of Empagliflozin in Comparison to Sitagliptin and Saxagliptin Based on Cardiovascular Outcome Trials in Patients with Type 2 Diabetes and Established Cardiovascular Disease","Ramos M, Foos V, Ustyugova A, Hau N, Gandhi P, Lamotte M.","Diabetes Ther. 2019 Dec;10(6):2153-2167. doi: 10.1007/s13300-019-00701-3. Epub 2019 Oct 10.","Ramos M","Diabetes Ther","2019","2019/10/12","PMC6848565","","10.1007/s13300-019-00701-3"
"31588564","Brentuximab vedotin for the treatment of patients with relapsed or refractory Hodgkin lymphoma after autologous stem cell transplantation","Kaloyannidis P, Hertzberg M, Webb K, Zomas A, Schrover R, Hurst M, Jacob I, Nikoglou T, Connors JM.","Br J Haematol. 2020 Feb;188(4):540-549. doi: 10.1111/bjh.16201. Epub 2019 Oct 6.","Kaloyannidis P","Br J Haematol","2020","2019/10/08","PMC7028067","","10.1111/bjh.16201"
"31587138","Modelling Survival of Patients Treated with Adjuvant Nivolumab Who Have Melanoma with Lymph Node Involvement or Metastatic Disease After Complete Resection","Batteson R, Hart R, Hemstock M, Gooden K, Kotapati S, Roze S, Lee D, Amadi A.","Pharmacoecon Open. 2020 Jun;4(2):343-351. doi: 10.1007/s41669-019-00181-y.","Batteson R","Pharmacoecon Open","2020","2019/10/07","PMC7248152","","10.1007/s41669-019-00181-y"
"31564931","Overall survival of glasdegib in combination with low-dose cytarabine, azacitidine, and decitabine among adult patients with previously untreated AML: comparative effectiveness using simulated treatment comparisons","Tremblay G, Westley T, Cappelleri JC, Arondekar B, Chan G, Bell TJ, Briggs A.","Clinicoecon Outcomes Res. 2019 Sep 6;11:551-565. doi: 10.2147/CEOR.S203482. eCollection 2019.","Tremblay G","Clinicoecon Outcomes Res","2019","2019/10/01","PMC6735653","","10.2147/CEOR.S203482"
"31555968","Assessment-Schedule Matching in Unanchored Indirect Treatment Comparisons of Progression-Free Survival in Cancer Studies","Kapetanakis V, Prawitz T, Schlichting M, Ishak KJ, Phatak H, Kearney M, Stevens JW, Benedict A, Bharmal M.","Pharmacoeconomics. 2019 Dec;37(12):1537-1551. doi: 10.1007/s40273-019-00831-3.","Kapetanakis V","Pharmacoeconomics","2019","2019/09/27","","","10.1007/s40273-019-00831-3"
"31512141","Response to: Alfred Sandrock, Wildon Farwell. Letter to the Editor, Comparisons Between Separately Conducted Clinical Trials: Letter to the Editor Regarding Dabbous O, Maru B, Jansen JP, Lorenzi M, Cloutier M, Guérin A, et al. Adv Ther (2019) 36(5):1164-76. doi:10.1007/s12325-019-00923-8","Dabbous O, Maru B, Jansen JP, Lorenzi M, Cloutier M, Guérin A, Pivneva I, Wu EQ, Arjunji R, Feltner D, Sproule DM.","Adv Ther. 2019 Nov;36(11):2982-2985. doi: 10.1007/s12325-019-01088-0. Epub 2019 Sep 11.","Dabbous O","Adv Ther","2019","2019/09/13","PMC6822794","","10.1007/s12325-019-01088-0"
"31489255","An indirect treatment comparison of the efficacy of pembrolizumab versus competing regimens for the adjuvant treatment of stage III melanoma","Lorenzi M, Arndorfer S, Aguiar-Ibañez R, Scherrer E, Liu FX, Krepler C.","J Drug Assess. 2019 Jul 26;8(1):135-145. doi: 10.1080/21556660.2019.1649266. eCollection 2019.","Lorenzi M","J Drug Assess","2019","2019/09/07","PMC6713115","","10.1080/21556660.2019.1649266"
"31464152","Indirect treatment comparison of valbenazine and deutetrabenazine efficacy and safety in tardive dyskinesia","Aggarwal S, Serbin M, Yonan C.","J Comp Eff Res. 2019 Oct;8(13):1077-1088. doi: 10.2217/cer-2019-0059. Epub 2019 Aug 29.","Aggarwal S","J Comp Eff Res","2019","2019/08/30","","","10.2217/cer-2019-0059"
"31440980","Indirect Treatment Comparison of Nivolumab Versus Observation or Ipilimumab as Adjuvant Therapy in Resected Melanoma Using Pooled Clinical Trial Data","Freeman M, Betts KA, Jiang S, Du EX, Gupte-Singh K, Lu Y, Rao S, Shoushtari AN.","Adv Ther. 2019 Oct;36(10):2783-2796. doi: 10.1007/s12325-019-01060-y. Epub 2019 Aug 22.","Freeman M","Adv Ther","2019","2019/08/24","PMC6822822","","10.1007/s12325-019-01060-y"
"31435770","Acupuncture versus propranolol in migraine prophylaxis: an indirect treatment comparison meta-analysis","Chen YY, Li J, Chen M, Yue L, She TW, Zheng H.","J Neurol. 2020 Jan;267(1):14-25. doi: 10.1007/s00415-019-09510-x. Epub 2019 Aug 21.","Chen YY","J Neurol","2020","2019/08/23","","","10.1007/s00415-019-09510-x"
"31417326","Matching-adjusted indirect comparisons of annualized bleeding rate and utilization of BAY 94-9027 versus three recombinant factor VIII agents for prophylaxis in patients with severe hemophilia A","Batt K, Gao W, Ayyagari R, Deschaseaux C, Vashi PB, Yao Z, Wang Y, Kessabi S, Klamroth R.","J Blood Med. 2019 Jun 20;10:147-159. doi: 10.2147/JBM.S206806. eCollection 2019.","Batt K","J Blood Med","2019","2019/08/17","PMC6592019","","10.2147/JBM.S206806"
"31412011","Cost-effectiveness of Pembrolizumab for Patients with Advanced, Unresectable, or Metastatic Urothelial Cancer Ineligible for Cisplatin-based Therapy","Patterson K, Prabhu V, Xu R, Li H, Meng Y, Zarabi N, Zhong Y, Batteson R, Pellissier J, Keefe S, Grivas P, de Wit R.","Eur Urol Oncol. 2019 Sep;2(5):565-571. doi: 10.1016/j.euo.2018.09.009. Epub 2018 Nov 8.","Patterson K","Eur Urol Oncol","2019","2019/08/15","","","10.1016/j.euo.2018.09.009"
"31390809","Choice of Methodology Impacts Outcome in Indirect Comparisons of Drugs for Idiopathic Pulmonary Fibrosis","Scott DA, Loveman E, Colquitt JL, O'Reilly K.","Medicina (Kaunas). 2019 Aug 6;55(8):443. doi: 10.3390/medicina55080443.","Scott DA","Medicina (Kaunas)","2019","2019/08/09","PMC6723644","","10.3390/medicina55080443"
"31368653","Assessing the impact of a matching-adjusted indirect comparison in a Bayesian network meta-analysis","Leahy J, Walsh C.","Res Synth Methods. 2019 Dec;10(4):546-568. doi: 10.1002/jrsm.1372. Epub 2019 Oct 14.","Leahy J","Res Synth Methods","2019","2019/08/02","","","10.1002/jrsm.1372"
"31364979","Comparative effectiveness of secukinumab and etanercept in biologic-naïve patients with psoriatic arthritis assessed by matching-adjusted indirect comparison","Mease P, Choy E, Nash P, Kalyvas C, Hunger M, Pricop L, Gandhi KK, Jugl SM, Thom H.","Eur J Rheumatol. 2018 Jul 1;6(3):113-121. doi: 10.5152/eurjrheum.2019.19057. Print 2019 Jul.","Mease P","Eur J Rheumatol","2018","2019/08/01","PMC6668637","","10.5152/eurjrheum.2019.19057"
"31355224","Comparing the efficacy of bag-valve mask, endotracheal intubation, and laryngeal mask airway for subjects with out-of-hospital cardiac arrest: an indirect meta-analysis","Yang Z, Liang H, Li J, Qiu S, He Z, Li J, Cao Z, Yan P, Liang Q, Zeng L, Liu R, Liang Z.","Ann Transl Med. 2019 Jun;7(12):257. doi: 10.21037/atm.2019.05.21.","Yang Z","Ann Transl Med","2019","2019/07/30","PMC6614327","","10.21037/atm.2019.05.21"
"31348264","Biomarkers for detecting prostate cancer: Protocol for an umbrella review with integrated network meta-analysis","Jia J, Sun Y, Ren J, Li M, Wang J, Li H; Cancer Biomarker Assessment Working Group.","Medicine (Baltimore). 2019 Jul;98(30):e16517. doi: 10.1097/MD.0000000000016517.","Jia J","Medicine (Baltimore)","2019","2019/07/27","PMC6708917","","10.1097/MD.0000000000016517"
"31290203","Systematic literature review of clinical trials of endocrine therapies for premenopausal women with metastatic HR+ HER2- breast cancer","Patterson-Lomba O, Dalal AA, Ayyagari R, Liu O, Dervishi E, Platt E, Chandiwana D, O'Shaughnessy JA.","Breast J. 2019 Sep;25(5):880-888. doi: 10.1111/tbj.13345. Epub 2019 Jul 9.","Patterson-Lomba O","Breast J","2019","2019/07/11","","","10.1111/tbj.13345"
"31258524","A Fast and Easy ATP-Based Approach Enables MIC Testing for Non-resuscitating VBNC Pathogens","Robben C, Witte AK, Schoder D, Stessl B, Rossmanith P, Mester P.","Front Microbiol. 2019 Jun 14;10:1365. doi: 10.3389/fmicb.2019.01365. eCollection 2019.","Robben C","Front Microbiol","2019","2019/07/02","PMC6587809","","10.3389/fmicb.2019.01365"
"31250534","Difficulties arising in reimbursement recommendations on new medicines due to inadequate reporting of population adjustment indirect comparison methods","Holmes EM, Leahy J, Walsh CD, White A, Donnan PT, Lamrock F.","Res Synth Methods. 2019 Dec;10(4):615-617. doi: 10.1002/jrsm.1368. Epub 2019 Jul 29.","Holmes EM","Res Synth Methods","2019","2019/06/29","","","10.1002/jrsm.1368"
"31218655","Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States","Delea TE, Zhang X, Amdahl J, Boyko D, Dirnberger F, Campioni M, Cong Z.","Pharmacoeconomics. 2019 Sep;37(9):1177-1193. doi: 10.1007/s40273-019-00812-6.","Delea TE","Pharmacoeconomics","2019","2019/06/21","PMC6830399","","10.1007/s40273-019-00812-6"
"31196844","Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials","Verhoeven MM, de Hair MJ, Tekstra J, Bijlsma JW, van Laar JM, Pethoe-Schramm A, Borm ME, Ter Borg EJ, Linn-Rasker SP, Teitsma XM, Lafeber FP, Jacobs JW, Welsing PM.","Ann Rheum Dis. 2019 Oct;78(10):1333-1338. doi: 10.1136/annrheumdis-2019-215304. Epub 2019 Jun 13.","Verhoeven MM","Ann Rheum Dis","2019","2019/06/15","","","10.1136/annrheumdis-2019-215304"
"31192959","The value of biomarkers in colorectal cancer: Protocol for an overview and a secondary analysis of systematic reviews of diagnostic test accuracy","Wang J, Liang W, Wang X, Min G, Chen W, Wang H, Yao N, Wang J; Cancer Biomarker Assessment Working Group.","Medicine (Baltimore). 2019 Jun;98(24):e16034. doi: 10.1097/MD.0000000000016034.","Wang J","Medicine (Baltimore)","2019","2019/06/14","PMC6587652","","10.1097/MD.0000000000016034"
"31192957","Biomarkers for detecting malignant pleural mesothelioma: Protocol for a reanalysis of published data based on systematic reviews of diagnostic test accuracy","Zan X, Wang Y, Shi J, Zhao L, Zhao Y, Liu R, Zhou Y, Wan Y; Cancer Biomarker Assessment Working Group.","Medicine (Baltimore). 2019 Jun;98(24):e16028. doi: 10.1097/MD.0000000000016028.","Zan X","Medicine (Baltimore)","2019","2019/06/14","PMC6587538","","10.1097/MD.0000000000016028"
"31190671","Population Adjustment Methods for Indirect Comparisons: A Review of National Institute for Health and Care Excellence Technology Appraisals","Phillippo DM, Dias S, Elsada A, Ades AE, Welton NJ.","Int J Technol Assess Health Care. 2019 Jan;35(3):221-228. doi: 10.1017/S0266462319000333. Epub 2019 Jun 13.","Phillippo DM","Int J Technol Assess Health Care","2019","2019/06/14","PMC6650293","EMS83347","10.1017/S0266462319000333"
"31168745","Cost Effectiveness of the Third-Generation Tyrosine Kinase Inhibitor (TKI) Ponatinib, vs. Second-Generation TKIs or Stem Cell Transplant, as Third-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia","Hirt C, Iannazzo S, Chiroli S, McGarry LJ, le Coutre P, Stenke L, Dahlén T, Lipton JH.","Appl Health Econ Health Policy. 2019 Aug;17(4):555-567. doi: 10.1007/s40258-019-00489-0.","Hirt C","Appl Health Econ Health Policy","2019","2019/06/07","","","10.1007/s40258-019-00489-0"
"31140620","Adjusted indirect comparisons to assess bioequivalence between generic clopidogrel products in Serbia","Pejčić Z, Vučićević K, García-Arieta A, Miljković B.","Br J Clin Pharmacol. 2019 Sep;85(9):2059-2065. doi: 10.1111/bcp.13997. Epub 2019 Jul 7.","Pejčić Z","Br J Clin Pharmacol","2019","2019/05/30","PMC6710521","","10.1111/bcp.13997"
"31140123","Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia","Proskorovsky I, Su Y, Fahrbach K, Vandendries E, Pagé V, Onyekwere U, Wang Y, Cappelleri JC, Stelljes M.","Adv Ther. 2019 Aug;36(8):2147-2160. doi: 10.1007/s12325-019-00991-w. Epub 2019 May 28.","Proskorovsky I","Adv Ther","2019","2019/05/30","PMC6822860","","10.1007/s12325-019-00991-w"
"31133348","Efficacy of enzalutamide and apalutamide in the treatment of non-metastasic castration-resistant prostate cancer: Indirect comparison","Nieto-Gómez P, Ubago-Pérez R, Cabeza-Barrera J.","Actas Urol Esp (Engl Ed). 2019 Sep;43(7):355-363. doi: 10.1016/j.acuro.2019.03.007. Epub 2019 May 24.","Nieto-Gómez P","Actas Urol Esp (Engl Ed)","2019","2019/05/29","","","10.1016/j.acuro.2019.03.007"
"31124741","Response to the letter to the editor on ""an indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy""","Lin H, Agarwal S, Betts M, Fahrbach K, Chitnis M, Polydefkis M.","Expert Opin Pharmacother. 2019 Aug;20(12):1529-1530. doi: 10.1080/14656566.2019.1620987. Epub 2019 May 24.","Lin H","Expert Opin Pharmacother","2019","2019/05/25","","","10.1080/14656566.2019.1620987"
"31124724","Letter to the editor concerning the article: ""An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy""","Salvo EM, Samjoo IA, Tran D, Cameron C.","Expert Opin Pharmacother. 2019 Aug;20(12):1527-1528. doi: 10.1080/14656566.2019.1620983. Epub 2019 May 24.","Salvo EM","Expert Opin Pharmacother","2019","2019/05/25","","","10.1080/14656566.2019.1620983"
"31102627","Advanced Androgen Blockage in Nonmetastatic Castration-resistant Prostate Cancer: An Indirect Comparison of Apalutamide and Enzalutamide","Wallis CJD, Chandrasekar T, Goldberg H, Klotz L, Fleshner N, Satkunasivam R, Klaassen Z.","Eur Urol Oncol. 2018 Aug;1(3):238-241. doi: 10.1016/j.euo.2018.04.004. Epub 2018 May 15.","Wallis CJD","Eur Urol Oncol","2018","2019/05/19","","","10.1016/j.euo.2018.04.004"
"31099402","Dupilumab Versus Cyclosporine for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults: Indirect Comparison Using the Eczema Area and Severity Index","Ariëns LFM, Gadkari A, van Os-Medendorp H, Ayyagari R, Terasawa E, Kuznik A, Chen Z, Bégo-Le Bagousse G, Lu Y, Rizova E, Graham NMH, Pirozzi G, De Bruin-Weller M, Eckert L.","Acta Derm Venereol. 2019 Sep 1;99(10):851-857. doi: 10.2340/00015555-3219.","Ariëns LFM","Acta Derm Venereol","2019","2019/05/18","","","10.2340/00015555-3219"
"31059803","Characteristics and methods of incorporating randomized and nonrandomized evidence in network meta-analyses: a scoping review","Zhang K, Arora P, Sati N, Béliveau A, Troke N, Veroniki AA, Rodrigues M, Rios P, Zarin W, Tricco AC.","J Clin Epidemiol. 2019 Sep;113:1-10. doi: 10.1016/j.jclinepi.2019.04.023. Epub 2019 May 3.","Zhang K","J Clin Epidemiol","2019","2019/05/07","","","10.1016/j.jclinepi.2019.04.023"
"31045839","Diagnostic performance of biomarkers for ovarian cancer: Protocol for an overview, evidence mapping, and adjusted indirect comparisons","Hua J, Liu J, Hua M, Cai R, Li M, Wang J, Wang J; Cancer Biomarker Assessment Working Group.","Medicine (Baltimore). 2019 May;98(18):e15508. doi: 10.1097/MD.0000000000015508.","Hua J","Medicine (Baltimore)","2019","2019/05/03","PMC6504260","","10.1097/MD.0000000000015508"
"31021449","Network meta-analysis of multicomponent interventions","Rücker G, Petropoulou M, Schwarzer G.","Biom J. 2020 May;62(3):808-821. doi: 10.1002/bimj.201800167. Epub 2019 Apr 25.","Rücker G","Biom J","2020","2019/04/26","PMC7217213","","10.1002/bimj.201800167"
"31018251","PD-(L)1 inhibitors vs. chemotherapy vs. their combination in front-line treatment for NSCLC: An indirect comparison","Liang H, Liu Z, Cai X, Pan Z, Chen D, Li C, Chen Y, He J, Liang W.","Int J Cancer. 2019 Dec 1;145(11):3011-3021. doi: 10.1002/ijc.32366. Epub 2019 May 10.","Liang H","Int J Cancer","2019","2019/04/25","","","10.1002/ijc.32366"
"30965114","Seven Hormonal Biomarkers for Diagnosing Endometriosis: Meta-Analysis and Adjusted Indirect Comparison of Diagnostic Test Accuracy","Gao Y, Shen M, Ma X, Li J, Wang B, Wang J, Tian J.","J Minim Invasive Gynecol. 2019 Sep-Oct;26(6):1026-1035.e4. doi: 10.1016/j.jmig.2019.04.004. Epub 2019 Apr 6.","Gao Y","J Minim Invasive Gynecol","2019","2019/04/10","","","10.1016/j.jmig.2019.04.004"
"30964361","Matching-adjusted indirect comparison of bosutinib, dasatinib and nilotinib effect on survival and major cytogenetic response in treatment of second-line chronic phase chronic myeloid leukemia","Cortes JE, Muresan B, Mamolo C, Cappelleri JC, Crescenzo RJ, Su Y, Gambacorti-Passerini C, Heeg B, Douglas Smith B.","Curr Med Res Opin. 2019 Sep;35(9):1615-1622. doi: 10.1080/03007995.2019.1605239. Epub 2019 May 15.","Cortes JE","Curr Med Res Opin","2019","2019/04/10","","","10.1080/03007995.2019.1605239"
"30963514","Indirect Comparison of Ropinirole and Pramipexole as Levodopa Adjunctive Therapy in Advanced Parkinson's Disease: A Systematic Review and Network Meta-Analysis","Zhao H, Ning Y, Cooper J, Refoios Camejo R, Ni X, Yi B, Parks D.","Adv Ther. 2019 Jun;36(6):1252-1265. doi: 10.1007/s12325-019-00938-1. Epub 2019 Apr 8.","Zhao H","Adv Ther","2019","2019/04/10","","","10.1007/s12325-019-00938-1"
"35157413","Evidence reviews for respiratory support: Specialist neonatal respiratory care for babies born preterm: Evidence review B","National Guideline Alliance (UK).","London: National Institute for Health and Care Excellence (NICE); 2019 Apr.","National Guideline Alliance (UK)","Evidence reviews for respiratory support: Specialist neonatal respiratory care for babies born preterm: Evidence review B","2019","2019/04/01","","",""
"30900099","The value of four imaging modalities in diagnosing lymph node involvement in rectal cancer: an overview and adjusted indirect comparison","Gao Y, Li J, Ma X, Wang J, Wang B, Tian J, Chen G.","Clin Exp Med. 2019 May;19(2):225-234. doi: 10.1007/s10238-019-00552-z. Epub 2019 Mar 21.","Gao Y","Clin Exp Med","2019","2019/03/23","","","10.1007/s10238-019-00552-z"
"30899278","Indirect comparison of intravenous vs. subcutaneous C1-inhibitor placebo-controlled trials for routine prevention of hereditary angioedema attacks","Bernstein JA, Li HH, Craig TJ, Manning ME, Lawo JP, Machnig T, Krishnarajah G, Fridman M.","Allergy Asthma Clin Immunol. 2019 Mar 7;15:13. doi: 10.1186/s13223-019-0328-3. eCollection 2019.","Bernstein JA","Allergy Asthma Clin Immunol","2019","2019/03/23","PMC6407188","","10.1186/s13223-019-0328-3"
"30879249","Survival, Motor Function, and Motor Milestones: Comparison of AVXS-101 Relative to Nusinersen for the Treatment of Infants with Spinal Muscular Atrophy Type 1","Dabbous O, Maru B, Jansen JP, Lorenzi M, Cloutier M, Guérin A, Pivneva I, Wu EQ, Arjunji R, Feltner D, Sproule DM.","Adv Ther. 2019 May;36(5):1164-1176. doi: 10.1007/s12325-019-00923-8. Epub 2019 Mar 16.","Dabbous O","Adv Ther","2019","2019/03/18","PMC6824368","","10.1007/s12325-019-00923-8"
"30864105","Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs","Choy E, Freemantle N, Proudfoot C, Chen CI, Pollissard L, Kuznik A, van Hoogstraten H, Mangan E, Carita P, Huynh TM.","Adv Ther. 2019 Apr;36(4):817-827. doi: 10.1007/s12325-019-00912-x. Epub 2019 Mar 12.","Choy E","Adv Ther","2019","2019/03/14","PMC6824353","","10.1007/s12325-019-00912-x"
"30852924","Comparative efficacy of combination immunotherapy and targeted therapy in the treatment of BRAF-mutant advanced melanoma: a matching-adjusted indirect comparison","Atkins MB, Tarhini A, Rael M, Gupte-Singh K, O'Brien E, Ritchings C, Rao S, McDermott DF.","Immunotherapy. 2019 May;11(7):617-629. doi: 10.2217/imt-2018-0208. Epub 2019 Mar 11.","Atkins MB","Immunotherapy","2019","2019/03/12","","","10.2217/imt-2018-0208"
"30835737","Indirect treatment comparisons including network meta-analysis: Lenvatinib plus everolimus for the second-line treatment of advanced/metastatic renal cell carcinoma","Tremblay G, McElroy HJ, Westley T, Meier G, Misurski D, Guo M.","PLoS One. 2019 Mar 5;14(3):e0212899. doi: 10.1371/journal.pone.0212899. eCollection 2019.","Tremblay G","PLoS One","2019","2019/03/06","PMC6400440","","10.1371/journal.pone.0212899"
"30806520","Matching-adjusted indirect comparison: secukinumab versus infliximab in biologic-naive patients with psoriatic arthritis","Strand V, McInnes I, Mease P, Nash P, Thom H, Kalyvas C, Hunger M, Gandhi K, Pricop L, Jugl S, Choy E.","J Comp Eff Res. 2019 May;8(7):497-510. doi: 10.2217/cer-2018-0141. Epub 2019 Feb 26.","Strand V","J Comp Eff Res","2019","2019/02/27","","","10.2217/cer-2018-0141"
"30786783","Estimating the comparative efficacy of cladribine tablets versus alternative disease modifying treatments in active relapsing-remitting multiple sclerosis: adjusting for patient characteristics using meta-regression and matching-adjusted indirect treatment comparison approaches","Berardi A, Siddiqui MK, Treharne C, Harty G, Wong SL.","Curr Med Res Opin. 2019 Aug;35(8):1371-1378. doi: 10.1080/03007995.2019.1585779. Epub 2019 Mar 29.","Berardi A","Curr Med Res Opin","2019","2019/02/22","","","10.1080/03007995.2019.1585779"
"30758745","Matching-Adjusted Indirect Comparison of Blinatumomab vs. Inotuzumab Ozogamicin for Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia","Song J, Ma Q, Gao W, Cong Z, Xie J, Zimmerman Z, Belton L, Franklin J, Palmer S.","Adv Ther. 2019 Apr;36(4):950-961. doi: 10.1007/s12325-019-0873-7. Epub 2019 Feb 13.","Song J","Adv Ther","2019","2019/02/14","PMC6824351","","10.1007/s12325-019-0873-7"
"30758237","Economic evaluation of sunitinib versus pazopanib and best supportive care for the treatment of metastatic renal cell carcinoma in Chile: cost-effectiveness analysis and a mixed treatment comparison","Vargas C, Balmaceda C, Rodríguez F, Rojas R, Giglio A, Espinoza MA.","Expert Rev Pharmacoecon Outcomes Res. 2019 Oct;19(5):609-617. doi: 10.1080/14737167.2019.1580572. Epub 2019 Mar 7.","Vargas C","Expert Rev Pharmacoecon Outcomes Res","2019","2019/02/14","","","10.1080/14737167.2019.1580572"
"30735443","Indirect comparison of vedolizumab and adalimumab for biologic-naive patients with ulcerative colitis","Dignass AU, Siegmund B, Goertz R, Schneidewind G, Fanter L.","Scand J Gastroenterol. 2019 Feb;54(2):178-187. doi: 10.1080/00365521.2019.1569124. Epub 2019 Feb 8.","Dignass AU","Scand J Gastroenterol","2019","2019/02/09","","","10.1080/00365521.2019.1569124"
"30727745","Treatment sequence network meta-analysis in Crohn's disease: a methodological case study","Varu A, Wilson FR, Dyrda P, Hazel M, Hutton B, Cameron C.","Curr Med Res Opin. 2019 May;35(5):733-756. doi: 10.1080/03007995.2019.1580094. Epub 2019 Mar 20.","Varu A","Curr Med Res Opin","2019","2019/02/08","","","10.1080/03007995.2019.1580094"
"30706364","Treating Patients with Type 2 Diabetes Mellitus Uncontrolled on Basal Insulin in the Czech Republic: Cost-Effectiveness of IDegLira Versus iGlarLixi","Pöhlmann J, Russel-Szymczyk M, Holík P, Rychna K, Hunt B.","Diabetes Ther. 2019 Apr;10(2):493-508. doi: 10.1007/s13300-019-0569-7. Epub 2019 Jan 31.","Pöhlmann J","Diabetes Ther","2019","2019/02/02","PMC6437226","","10.1007/s13300-019-0569-7"
"31211542","Common Drug Review New Combination Product: Ertugliflozin/Metformin Fixed-Dose Combination (Segluromet): Merck Canada Inc: Indication: Type 2 Diabetes Mellitus","","Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Feb.","","Common Drug Review New Combination Product: Ertugliflozin/Metformin Fixed-Dose Combination (Segluromet): Merck Canada Inc: Indication: Type 2 Diabetes Mellitus","2019","2019/02/01","","",""
"30698076","Creating historical controls using data from a previous line of treatment - Two non-standard approaches","Hatswell AJ, Sullivan WG.","Stat Methods Med Res. 2020 Jun;29(6):1563-1572. doi: 10.1177/0962280219826609. Epub 2019 Jan 30.","Hatswell AJ","Stat Methods Med Res","2020","2019/01/31","","","10.1177/0962280219826609"
"30689458","A systematic literature review and indirect comparison of iron isomaltoside and ferric carboxymaltose in iron deficiency anemia after failure or intolerance of oral iron treatment","Pollock RF, Muduma G.","Expert Rev Hematol. 2019 Feb;12(2):129-136. doi: 10.1080/17474086.2019.1575202. Epub 2019 Feb 19.","Pollock RF","Expert Rev Hematol","2019","2019/01/29","","","10.1080/17474086.2019.1575202"
"30670074","The need for comparative data in spondyloarthritis","Choy E, Baraliakos X, Behrens F, D'Angelo S, de Vlam K, Kirkham BW, Østergaard M, Schett GA, Rissler M, Chaouche-Teyara K, Perella C.","Arthritis Res Ther. 2019 Jan 22;21(1):32. doi: 10.1186/s13075-019-1812-3.","Choy E","Arthritis Res Ther","2019","2019/01/24","PMC6341745","","10.1186/s13075-019-1812-3"
"30661638","Alternative Weighting Approaches for Anchored Matching-Adjusted Indirect Comparisons via a Common Comparator","Petto H, Kadziola Z, Brnabic A, Saure D, Belger M.","Value Health. 2019 Jan;22(1):85-91. doi: 10.1016/j.jval.2018.06.018. Epub 2018 Aug 23.","Petto H","Value Health","2019","2019/01/22","","","10.1016/j.jval.2018.06.018"
"30649973","Cost-effectiveness of pembrolizumab in combination with chemotherapy versus chemotherapy and pembrolizumab monotherapy in the first-line treatment of squamous non-small-cell lung cancer in the US","Insinga RP, Vanness DJ, Feliciano JL, Vandormael K, Traore S, Ejzykowicz F, Burke T.","Curr Med Res Opin. 2019 Jul;35(7):1241-1256. doi: 10.1080/03007995.2019.1571297. Epub 2019 Jan 29.","Insinga RP","Curr Med Res Opin","2019","2019/01/17","","","10.1080/03007995.2019.1571297"
"30639473","Is Shouldice the best NON-MESH inguinal hernia repair technique? A systematic review and network metanalysis of randomized controlled trials comparing Shouldice and Desarda","Bracale U, Melillo P, Piaggio D, Pecchia L, Cuccurullo D, Milone M, De Palma GD, Cavallaro G, Campanelli G, Merola G, Stabilini C.","Int J Surg. 2019 Feb;62:12-21. doi: 10.1016/j.ijsu.2019.01.001. Epub 2019 Jan 9.","Bracale U","Int J Surg","2019","2019/01/15","","","10.1016/j.ijsu.2019.01.001"
"30639069","Indirect treatment comparison of asthma biologics fraught with methodology issues","Bourdin A, Molinari N.","J Allergy Clin Immunol. 2019 Mar;143(3):1266-1267. doi: 10.1016/j.jaci.2018.11.024. Epub 2019 Jan 11.","Bourdin A","J Allergy Clin Immunol","2019","2019/01/15","","","10.1016/j.jaci.2018.11.024"
"30635226","Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials","Heerspink HJL, Greene T, Tighiouart H, Gansevoort RT, Coresh J, Simon AL, Chan TM, Hou FF, Lewis JB, Locatelli F, Praga M, Schena FP, Levey AS, Inker LA; Chronic Kidney Disease Epidemiology Collaboration.","Lancet Diabetes Endocrinol. 2019 Feb;7(2):128-139. doi: 10.1016/S2213-8587(18)30314-0. Epub 2019 Jan 8.","Heerspink HJL","Lancet Diabetes Endocrinol","2019","2019/01/13","","","10.1016/S2213-8587(18)30314-0"
"30617044","Comparison of mHealth and Face-to-Face Interventions for Smoking Cessation Among People Living With HIV: Meta-Analysis","Uthman OA, Nduka CU, Abba M, Enriquez R, Nordenstedt H, Nalugoda F, Kengne AP, Ekström AM.","JMIR Mhealth Uhealth. 2019 Jan 7;7(1):e203. doi: 10.2196/mhealth.9329.","Uthman OA","JMIR Mhealth Uhealth","2019","2019/01/09","PMC6329415","","10.2196/mhealth.9329"
"30612667","Indirect treatment comparisons and biologics","Mauger D, Apter AJ.","J Allergy Clin Immunol. 2019 Jan;143(1):84-86. doi: 10.1016/j.jaci.2018.11.005.","Mauger D","J Allergy Clin Immunol","2019","2019/01/08","","","10.1016/j.jaci.2018.11.005"
"30610657","Modeling Covariate-Adjusted Survival for Economic Evaluations in Oncology","Majer IM, Castaigne JG, Palmer S, DeCosta L, Campioni M.","Pharmacoeconomics. 2019 May;37(5):727-737. doi: 10.1007/s40273-018-0759-6.","Majer IM","Pharmacoeconomics","2019","2019/01/06","","","10.1007/s40273-018-0759-6"
"30598174","Indirect Treatment Comparisons and Biologics","Mauger D, Apter AJ.","J Allergy Clin Immunol Pract. 2019 Jan;7(1):131-133. doi: 10.1016/j.jaip.2018.11.008.","Mauger D","J Allergy Clin Immunol Pract","2019","2019/01/02","","","10.1016/j.jaip.2018.11.008"
"30595674","Allowing for informative missingness in aggregate data meta-analysis with continuous or binary outcomes: Extensions to metamiss","Chaimani A, Mavridis D, Higgins JPT, Salanti G, White IR.","Stata J. 2018 Jul 1;18(3):716-740.","Chaimani A","Stata J","2018","2019/01/01","PMC6309174","EMS79895",""
"30591022","An efficacy comparison of anti-vascular growth factor agents and laser photocoagulation in diabetic macular edema: a network meta-analysis incorporating individual patient-level data","Muston D, Korobelnik JF, Reason T, Hawkins N, Chatzitheofilou I, Ryan F, Kaiser PK.","BMC Ophthalmol. 2018 Dec 27;18(1):340. doi: 10.1186/s12886-018-1006-9.","Muston D","BMC Ophthalmol","2018","2018/12/29","PMC6307247","","10.1186/s12886-018-1006-9"
"30588048","The number needed to treat and relevant between-trial comparisons of competing interventions","Jansen JP, Khalid JM, Smyth MD, Patel H.","Clinicoecon Outcomes Res. 2018 Dec 14;10:865-871. doi: 10.2147/CEOR.S180491. eCollection 2018.","Jansen JP","Clinicoecon Outcomes Res","2018","2018/12/28","PMC6298880","","10.2147/CEOR.S180491"
"30567533","Axitinib, cabozantinib, or everolimus in the treatment of prior sunitinib-treated patients with metastatic renal cell carcinoma: results of matching-adjusted indirect comparison analyses","Proskorovsky I, Benedict A, Negrier S, Bargo D, Sandin R, Ramaswamy K, Desai J, Cappelleri JC, Larkin J.","BMC Cancer. 2018 Dec 19;18(1):1271. doi: 10.1186/s12885-018-5157-0.","Proskorovsky I","BMC Cancer","2018","2018/12/21","PMC6300002","","10.1186/s12885-018-5157-0"
"30563395","Clinical and economic outcomes associated with treatment sequences in patients with BRAF-mutant advanced melanoma","Tarhini A, McDermott D, Ambavane A, Gupte-Singh K, Aponte-Ribero V, Ritchings C, Benedict A, Rao S, Regan MM, Atkins M.","Immunotherapy. 2019 Mar;11(4):283-295. doi: 10.2217/imt-2018-0168. Epub 2018 Dec 19.","Tarhini A","Immunotherapy","2019","2018/12/20","","","10.2217/imt-2018-0168"
"30547369","Pembrolizumab for Locally Advanced or Metastatic Urothelial Cancer Where Cisplatin is Unsuitable: An Evidence Review Group Perspective of a NICE Single Technology Appraisal","Ren S, Squires H, Hock E, Kaltenthaler E, Rawdin A, Alifrangis C.","Pharmacoeconomics. 2019 Sep;37(9):1073-1080. doi: 10.1007/s40273-018-0750-2.","Ren S","Pharmacoeconomics","2019","2018/12/15","","","10.1007/s40273-018-0750-2"
"30532569","Cost-effectiveness analysis of ribociclib versus palbociclib in the first-line treatment of HR+/HER2- advanced or metastatic breast cancer in Spain","Galve-Calvo E, González-Haba E, Gostkorzewicz J, Martínez I, Pérez-Mitru A.","Clinicoecon Outcomes Res. 2018 Nov 14;10:773-790. doi: 10.2147/CEOR.S178934. eCollection 2018.","Galve-Calvo E","Clinicoecon Outcomes Res","2018","2018/12/12","PMC6241542","","10.2147/CEOR.S178934"
"30489166","An indirect treatment comparison of the efficacy of patisiran and tafamidis for the treatment of hereditary transthyretin-mediated amyloidosis with polyneuropathy","Planté-Bordeneuve V, Lin H, Gollob J, Agarwal S, Betts M, Fahrbach K, Chitnis M, Polydefkis M.","Expert Opin Pharmacother. 2019 Mar;20(4):473-481. doi: 10.1080/14656566.2018.1554648. Epub 2018 Dec 12.","Planté-Bordeneuve V","Expert Opin Pharmacother","2019","2018/11/30","","","10.1080/14656566.2018.1554648"
"30474450","Budget impact analysis of secukinumab versus adalimumab in the treatment of ankylosing spondylitis","Purmonen T, Törmälehto S, Wahlman H, Puolakka K.","J Med Econ. 2019 Feb;22(2):151-157. doi: 10.1080/13696998.2018.1551227. Epub 2018 Dec 4.","Purmonen T","J Med Econ","2019","2018/11/27","","","10.1080/13696998.2018.1551227"
"30472749","Calcipotriol plus betamethasone dipropionate aerosol foam vs. apremilast, methotrexate, acitretin or fumaric acid esters for the treatment of plaque psoriasis: a matching-adjusted indirect comparison","Bewley AP, Shear NH, Calzavara-Pinton PG, Hansen JB, Nyeland ME, Signorovitch J.","J Eur Acad Dermatol Venereol. 2019 Jun;33(6):1107-1115. doi: 10.1111/jdv.15369. Epub 2019 Mar 19.","Bewley AP","J Eur Acad Dermatol Venereol","2019","2018/11/26","PMC6766948","","10.1111/jdv.15369"
"30465228","Dinutuximab Beta for Treating Neuroblastoma: An Evidence Review Group and Decision Support Unit Perspective of a NICE Single Technology Appraisal","Pennington B, Ren S, Barton S, Bacelar M, Edwards SJ.","Pharmacoeconomics. 2019 Aug;37(8):985-993. doi: 10.1007/s40273-018-0744-0.","Pennington B","Pharmacoeconomics","2019","2018/11/23","","","10.1007/s40273-018-0744-0"
"30464564","Cost-consequence model comparing eltrombopag and romiplostim in pediatric patients with chronic immune thrombocytopenia","Tremblay G, Dolph M, Bhor M, Said Q, Roy A, Elliott B, Briggs A.","Clinicoecon Outcomes Res. 2018 Nov 5;10:715-721. doi: 10.2147/CEOR.S177338. eCollection 2018.","Tremblay G","Clinicoecon Outcomes Res","2018","2018/11/23","PMC6223346","","10.2147/CEOR.S177338"
"30464563","Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia","Tremblay G, Dolph M, Bhor M, Said Q, Elliott B, Briggs A.","Clinicoecon Outcomes Res. 2018 Nov 1;10:705-713. doi: 10.2147/CEOR.S177324. eCollection 2018.","Tremblay G","Clinicoecon Outcomes Res","2018","2018/11/23","PMC6219311","","10.2147/CEOR.S177324"
"30429149","Effect of beta-blocker therapy on clinical outcomes, safety, health-related quality of life and functional capacity in patients with chronic obstructive pulmonary disease (COPD): a protocol for a systematic literature review and meta-analysis with multiple treatment comparison","Gulea C, Zakeri R, Quint JK.","BMJ Open. 2018 Nov 13;8(11):e024736. doi: 10.1136/bmjopen-2018-024736.","Gulea C","BMJ Open","2018","2018/11/16","PMC6252680","","10.1136/bmjopen-2018-024736"
"30426462","Autologous Chondrocyte Implantation with Chondrosphere for Treating Articular Cartilage Defects in the Knee: An Evidence Review Group Perspective of a NICE Single Technology Appraisal","Armoiry X, Cummins E, Connock M, Metcalfe A, Royle P, Johnston R, Rodrigues J, Waugh N, Mistry H.","Pharmacoeconomics. 2019 Jul;37(7):879-886. doi: 10.1007/s40273-018-0737-z.","Armoiry X","Pharmacoeconomics","2019","2018/11/15","","","10.1007/s40273-018-0737-z"
"30401604","Second-line cabozantinib versus nivolumab in advanced renal cell carcinoma: Systematic review and indirect treatment comparison","Porta C, Szczylik C, Casciano R, Fu S, Amzal B, Lister J, Karcher H, Meng J, Neumann M, Dinet J.","Crit Rev Oncol Hematol. 2019 Jul;139:143-148. doi: 10.1016/j.critrevonc.2018.10.004. Epub 2018 Oct 24.","Porta C","Crit Rev Oncol Hematol","2019","2018/11/08","","","10.1016/j.critrevonc.2018.10.004"
"30388073","Comparative effectiveness of secukinumab and adalimumab in ankylosing spondylitis as assessed by matching-adjusted indirect comparison","Maksymowych WP, Strand V, Nash P, Yazici Y, Thom H, Hunger M, Kalyvas C, Gandhi KK, Porter B, Jugl SM.","Eur J Rheumatol. 2018 Dec;5(4):216-223. doi: 10.5152/eurjrheum.2018.18162. Epub 2018 Oct 30.","Maksymowych WP","Eur J Rheumatol","2018","2018/11/03","PMC6267743","","10.5152/eurjrheum.2018.18162"
"30362839","Comparative efficacy of first-line ceritinib and crizotinib in advanced or metastatic anaplastic lymphoma kinase-positive non-small cell lung cancer: an adjusted indirect comparison with external controls","Li J, Knoll S, Bocharova I, Tang W, Signorovitch J.","Curr Med Res Opin. 2019 Jan;35(1):105-111. doi: 10.1080/03007995.2018.1541443. Epub 2018 Nov 15.","Li J","Curr Med Res Opin","2019","2018/10/27","","","10.1080/03007995.2018.1541443"
"30349228","Comparative efficacy of inhaled medications (ICS/LABA, LAMA, LAMA/LABA and SAMA) for COPD: a systematic review and network meta-analysis","Aziz MIA, Tan LE, Wu DB, Pearce F, Chua GSW, Lin L, Tan PT, Ng K.","Int J Chron Obstruct Pulmon Dis. 2018 Oct 9;13:3203-3231. doi: 10.2147/COPD.S173472. eCollection 2018.","Aziz MIA","Int J Chron Obstruct Pulmon Dis","2018","2018/10/24","PMC6186767","","10.2147/COPD.S173472"
"30314617","Focused Ultrasound Thalamotomy and Other Interventions for Medication-Refractory Essential Tremor: An Indirect Comparison of Short-Term Impact on Health-Related Quality of Life","Langford BE, Ridley CJA, Beale RC, Caseby SCL, Marsh WJ, Richard L.","Value Health. 2018 Oct;21(10):1168-1175. doi: 10.1016/j.jval.2018.03.015. Epub 2018 Jun 28.","Langford BE","Value Health","2018","2018/10/14","","","10.1016/j.jval.2018.03.015"
"30312378","Comparison of Methods to Generalize Randomized Clinical Trial Results Without Individual-Level Data for the Target Population","Hong JL, Webster-Clark M, Jonsson Funk M, Stürmer T, Dempster SE, Cole SR, Herr I, LoCasale R.","Am J Epidemiol. 2019 Feb 1;188(2):426-437. doi: 10.1093/aje/kwy233.","Hong JL","Am J Epidemiol","2019","2018/10/13","PMC6357813","","10.1093/aje/kwy233"
"30309978","Matching-adjusted indirect comparison of benralizumab versus interleukin-5 inhibitors for the treatment of severe asthma: a systematic review","Bourdin A, Husereau D, Molinari N, Golam S, Siddiqui MK, Lindner L, Xu X.","Eur Respir J. 2018 Nov 29;52(5):1801393. doi: 10.1183/13993003.01393-2018. Print 2018 Nov.","Bourdin A","Eur Respir J","2018","2018/10/13","PMC6277255","","10.1183/13993003.01393-2018"
"30304407","Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia","Whittington MD, McQueen RB, Ollendorf DA, Kumar VM, Chapman RH, Tice JA, Pearson SD, Campbell JD.","JAMA Pediatr. 2018 Dec 1;172(12):1161-1168. doi: 10.1001/jamapediatrics.2018.2530.","Whittington MD","JAMA Pediatr","2018","2018/10/11","PMC6583018","","10.1001/jamapediatrics.2018.2530"
"30303022","Cost-effectiveness of pembrolizumab versus brentuximab vedotin for patients with relapsed or refractory classical Hodgkin's lymphoma: a United States payer perspective","Large S, Hettle R, Balakumaran A, Wu E, Borse RH.","J Med Econ. 2018 Nov 13:1-10. doi: 10.1080/13696998.2018.1534738. Online ahead of print.","Large S","J Med Econ","2018","2018/10/11","","","10.1080/13696998.2018.1534738"
"30298279","Ceritinib for Untreated Anaplastic Lymphoma Kinase-Positive Advanced Non-Small-Cell Lung Cancer: An Evidence Review Group Evaluation of a NICE Single Technology Appraisal","Claxton L, O'Connor J, Woolacott N, Wright K, Hodgson R.","Pharmacoeconomics. 2019 May;37(5):645-654. doi: 10.1007/s40273-018-0720-8.","Claxton L","Pharmacoeconomics","2019","2018/10/10","","","10.1007/s40273-018-0720-8"
"30293207","Nivolumab for Treating Metastatic or Unresectable Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal","Grimm SE, Armstrong N, Ramaekers BLT, Pouwels X, Lang S, Petersohn S, Riemsma R, Worthy G, Stirk L, Ross J, Kleijnen J, Joore MA.","Pharmacoeconomics. 2019 May;37(5):655-667. doi: 10.1007/s40273-018-0723-5.","Grimm SE","Pharmacoeconomics","2019","2018/10/08","","","10.1007/s40273-018-0723-5"
"30286627","Comparative efficacy of brigatinib versus ceritinib and alectinib in patients with crizotinib-refractory anaplastic lymphoma kinase-positive non-small cell lung cancer","Reckamp K, Lin HM, Huang J, Proskorovsky I, Reichmann W, Krotneva S, Kerstein D, Huang H, Lee J.","Curr Med Res Opin. 2019 Apr;35(4):569-576. doi: 10.1080/03007995.2018.1520696. Epub 2018 Oct 5.","Reckamp K","Curr Med Res Opin","2019","2018/10/06","","","10.1080/03007995.2018.1520696"
"30277463","Paclitaxel density and clinical efficacy of drug-coated balloon angioplasty for femoropopliteal artery disease: meta-analysis and adjusted indirect comparison of 20 randomised trials","Cassese S, Ndrepepa G, Fusaro M, Kufner S, Xhepa E, Fusaro M.","EuroIntervention. 2019 Aug 9;15(6):e560-e562. doi: 10.4244/EIJ-D-18-00550.","Cassese S","EuroIntervention","2019","2018/10/03","","","10.4244/EIJ-D-18-00550"
"30942989","Pharmacoeconomic Review Report: Ozenoxacin 1% Cream (Ozanex): (Ferrer Internacional, S.A.): Indication: The topical treatment of impetigo in patients aged two months and older","","Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Oct.","","Pharmacoeconomic Review Report: Ozenoxacin 1% Cream (Ozanex): (Ferrer Internacional, S.A.): Indication: The topical treatment of impetigo in patients aged two months and older","2018","2018/10/01","","",""
"30227896","A systematic review and network meta-analysis comparing azacitidine and decitabine for the treatment of myelodysplastic syndrome","Almasri J, Alkhateeb HB, Firwana B, Sonbol MB, Damlaj M, Wang Z, Murad MH, Al-Kali A.","Syst Rev. 2018 Sep 19;7(1):144. doi: 10.1186/s13643-018-0805-7.","Almasri J","Syst Rev","2018","2018/09/20","PMC6145118","","10.1186/s13643-018-0805-7"
"30209002","Everolimus, lutetium-177 DOTATATE and sunitinib for advanced, unresectable or metastatic neuroendocrine tumours with disease progression: a systematic review and cost-effectiveness analysis","Mujica-Mota R, Varley-Campbell J, Tikhonova I, Cooper C, Griffin E, Haasova M, Peters J, Lucherini S, Talens-Bou J, Long L, Sherriff D, Napier M, Ramage J, Hoyle M.","Health Technol Assess. 2018 Sep;22(49):1-326. doi: 10.3310/hta22490.","Mujica-Mota R","Health Technol Assess","2018","2018/09/14","PMC6151360","","10.3310/hta22490"
"30205189","Anti-IL-5 treatments in patients with severe asthma by blood eosinophil thresholds: Indirect treatment comparison","Busse W, Chupp G, Nagase H, Albers FC, Doyle S, Shen Q, Bratton DJ, Gunsoy NB.","J Allergy Clin Immunol. 2019 Jan;143(1):190-200.e20. doi: 10.1016/j.jaci.2018.08.031. Epub 2018 Sep 8.","Busse W","J Allergy Clin Immunol","2019","2018/09/12","","","10.1016/j.jaci.2018.08.031"
"30188231","Cost-effectiveness of pembrolizumab in combination with chemotherapy in the 1st line treatment of non-squamous NSCLC in the US","Insinga RP, Vanness DJ, Feliciano JL, Vandormael K, Traore S, Burke T.","J Med Econ. 2018 Dec;21(12):1191-1205. doi: 10.1080/13696998.2018.1521416. Epub 2018 Sep 21.","Insinga RP","J Med Econ","2018","2018/09/07","","","10.1080/13696998.2018.1521416"
"30168349","Relative effectiveness of sunitinib versus everolimus in advanced pancreatic neuroendocrine tumors: an updated matching-adjusted indirect comparison","Ishak KJ, Rael M, Hicks M, Mittal S, Eatock M, Valle JW.","J Comp Eff Res. 2018 Oct;7(10):947-958. doi: 10.2217/cer-2018-0020. Epub 2018 Aug 31.","Ishak KJ","J Comp Eff Res","2018","2018/09/01","","","10.2217/cer-2018-0020"
"30101613","Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison","Li W, Qin Z, Gao J, Jiang Z, Chai Y, Guan L, Chen Y.","Chron Respir Dis. 2019 Jan-Dec;16:1479972318790269. doi: 10.1177/1479972318790269. Epub 2018 Aug 12.","Li W","Chron Respir Dis","2019","2018/08/14","PMC6302979","","10.1177/1479972318790269"
"30096625","Randomized controlled trials of antiepileptic drugs for the treatment of post-stroke seizures: A systematic review with network meta-analysis","Brigo F, Lattanzi S, Zelano J, Bragazzi NL, Belcastro V, Nardone R, Trinka E.","Seizure. 2018 Oct;61:57-62. doi: 10.1016/j.seizure.2018.08.001. Epub 2018 Aug 3.","Brigo F","Seizure","2018","2018/08/11","","","10.1016/j.seizure.2018.08.001"
"30086654","Benefits and risks of ponatinib versus bosutinib following treatment failure of two prior tyrosine kinase inhibitors in patients with chronic phase chronic myeloid leukemia: a matching-adjusted indirect comparison","Levy MY, McGarry LJ, Huang H, Lustgarten S, Chiroli S, Iannazzo S.","Curr Med Res Opin. 2019 Mar;35(3):479-487. doi: 10.1080/03007995.2018.1510225. Epub 2018 Aug 24.","Levy MY","Curr Med Res Opin","2019","2018/08/09","","","10.1080/03007995.2018.1510225"
"30052894","Real-world vs. randomized trial outcomes in similar populations of rivaroxaban-treated patients with non-valvular atrial fibrillation in ROCKET AF and XANTUS","Camm AJ, Amarenco P, Haas S, Hess S, Kirchhof P, Lambelet M, Bach M, Turpie AGG.","Europace. 2019 Mar 1;21(3):421-427. doi: 10.1093/europace/euy160.","Camm AJ","Europace","2019","2018/07/28","","","10.1093/europace/euy160"
"30030817","Pembrolizumab for Previously Treated Advanced or Metastatic Urothelial Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal","Gallacher D, Armoiry X, Auguste P, Court R, Mantopoulos T, Patterson J, De Santis M, Cresswell J, Mistry H.","Pharmacoeconomics. 2019 Jan;37(1):19-27. doi: 10.1007/s40273-018-0689-3.","Gallacher D","Pharmacoeconomics","2019","2018/07/22","","","10.1007/s40273-018-0689-3"
"29961001","History and publication trends in the diffusion and early uptake of indirect comparison meta-analytic methods to study drugs: animated coauthorship networks over time","Ban JK, Tadrous M, Lu AX, Cicinelli EA, Cadarette SM.","BMJ Open. 2018 Jun 30;8(6):e019110. doi: 10.1136/bmjopen-2017-019110.","Ban JK","BMJ Open","2018","2018/07/02","PMC6045745","","10.1136/bmjopen-2017-019110"
"29954828","Comparative effectiveness of treatment options for plantar heel pain: a systematic review with network meta-analysis","Babatunde OO, Legha A, Littlewood C, Chesterton LS, Thomas MJ, Menz HB, van der Windt D, Roddy E.","Br J Sports Med. 2019 Feb;53(3):182-194. doi: 10.1136/bjsports-2017-098998. Epub 2018 Jun 28.","Babatunde OO","Br J Sports Med","2019","2018/06/30","","","10.1136/bjsports-2017-098998"
"29954322","The use of single armed observational data to closing the gap in otherwise disconnected evidence networks: a network meta-analysis in multiple myeloma","Schmitz S, Maguire Á, Morris J, Ruggeri K, Haller E, Kuhn I, Leahy J, Homer N, Khan A, Bowden J, Buchanan V, O'Dwyer M, Cook G, Walsh C.","BMC Med Res Methodol. 2018 Jun 28;18(1):66. doi: 10.1186/s12874-018-0509-7.","Schmitz S","BMC Med Res Methodol","2018","2018/06/30","PMC6022299","","10.1186/s12874-018-0509-7"
"29949047","Comparative Efficacy of Treatments for Previously Treated Advanced or Metastatic Non-Small-Cell Lung Cancer: A Network Meta-Analysis","Li J, Sasane M, Zhao J, Horton VG, Zhang P, Ricculli ML, Zhou ZY, Signorovitch J.","Adv Ther. 2018 Jul;35(7):1035-1048. doi: 10.1007/s12325-018-0734-9. Epub 2018 Jun 15.","Li J","Adv Ther","2018","2018/06/28","","","10.1007/s12325-018-0734-9"
"29949014","Cardiovascular Safety of Empagliflozin Versus Dipeptidyl Peptidase-4 (DPP-4) Inhibitors in Type 2 Diabetes: Systematic Literature Review and Indirect Comparisons","Balijepalli C, Shirali R, Kandaswamy P, Ustyugova A, Pfarr E, Lund SS, Druyts E.","Diabetes Ther. 2018 Aug;9(4):1491-1500. doi: 10.1007/s13300-018-0456-7. Epub 2018 Jun 12.","Balijepalli C","Diabetes Ther","2018","2018/06/28","PMC6064600","","10.1007/s13300-018-0456-7"
"29861642","Matching-adjusted indirect treatment comparison of ribociclib and palbociclib in HR+, HER2- advanced breast cancer","Tremblay G, Chandiwana D, Dolph M, Hearnden J, Forsythe A, Monaco M.","Cancer Manag Res. 2018 May 22;10:1319-1327. doi: 10.2147/CMAR.S163478. eCollection 2018.","Tremblay G","Cancer Manag Res","2018","2018/06/05","PMC5968783","","10.2147/CMAR.S163478"
"29858770","Correction to: Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison","Nash P, McInnes IB, Mease PJ, Thom H, Hunger M, Karabis A, Gandhi K, Mpofu S, Jugl SM.","Rheumatol Ther. 2018 Dec;5(2):595. doi: 10.1007/s40744-018-0117-3.","Nash P","Rheumatol Ther","2018","2018/06/03","PMC6251848","","10.1007/s40744-018-0117-3"
"29788164","What is the optimal systemic treatment of men with metastatic, hormone-naive prostate cancer? A STOPCAP systematic review and network meta-analysis","Vale CL, Fisher DJ, White IR, Carpenter JR, Burdett S, Clarke NW, Fizazi K, Gravis G, James ND, Mason MD, Parmar MKB, Rydzewska LH, Sweeney CJ, Spears MR, Sydes MR, Tierney JF.","Ann Oncol. 2018 May 1;29(5):1249-1257. doi: 10.1093/annonc/mdy071.","Vale CL","Ann Oncol","2018","2018/05/23","PMC5961275","","10.1093/annonc/mdy071"
"29785685","Network meta-analysis: an introduction for pharmacists","Xu Y, Amiche MA, Tadrous M.","Int J Clin Pharm. 2018 Oct;40(5):942-947. doi: 10.1007/s11096-018-0656-2.","Xu Y","Int J Clin Pharm","2018","2018/05/23","","","10.1007/s11096-018-0656-2"
"29764245","Pembrolizumab versus the standard of care for relapsed and refractory classical Hodgkin's lymphoma progressing after brentuximab vedotin: an indirect treatment comparison","Keeping S, Wu E, Chan K, Mojebi A, Ferrante SA, Balakumaran A.","Expert Rev Hematol. 2018 Jun;11(6):503-511. doi: 10.1080/17474086.2018.1475226. Epub 2018 May 23.","Keeping S","Expert Rev Hematol","2018","2018/05/17","","","10.1080/17474086.2018.1475226"
"29753347","Economic Modeling Considerations for Rare Diseases","Pearson I, Rothwell B, Olaye A, Knight C.","Value Health. 2018 May;21(5):515-524. doi: 10.1016/j.jval.2018.02.008. Epub 2018 Apr 17.","Pearson I","Value Health","2018","2018/05/14","","","10.1016/j.jval.2018.02.008"
"31646068","Alternative metrics for assessing clinical benefit with immunotherapy in oncology","Chan E, Quinn C, Hirji I, Hillengass J, Anderson K, Oukessou A, Davis C.","Oncoimmunology. 2018 May 7;8(10):e1343774. doi: 10.1080/2162402X.2017.1343774. eCollection 2019.","Chan E","Oncoimmunology","2018","2019/10/25","PMC6791423","","10.1080/2162402X.2017.1343774"
"29692179","An indirect comparison of intravenous and subcutaneous belimumab efficacy in patients with SLE and high disease activity","Ramachandran S, Parks D, Kurtinecz M, Roth DA, Alfonso-Cristancho R.","J Comp Eff Res. 2018 Jun;7(6):581-593. doi: 10.2217/cer-2017-0085. Epub 2018 Apr 25.","Ramachandran S","J Comp Eff Res","2018","2018/04/26","","","10.2217/cer-2017-0085"
"29674504","Efficacy of bendamustine and rituximab as first salvage treatment in chronic lymphocytic leukemia and indirect comparison with ibrutinib: a GIMEMA, ERIC and UK CLL FORUM study","Cuneo A, Follows G, Rigolin GM, Piciocchi A, Tedeschi A, Trentin L, Perez AM, Coscia M, Laurenti L, Musuraca G, Farina L, Delgado AR, Orlandi EM, Galieni P, Mauro FR, Visco C, Amendola A, Billio A, Marasca R, Chiarenza A, Meneghini V, Ilariucci F, Marchetti M, Molica S, Re F, Gaidano G, Gonzalez M, Forconi F, Ciolli S, Cortelezzi A, Montillo M, Smolej L, Schuh A, Eyre TA, Kennedy B, Bowles KM, Vignetti M, de la Serna J, Moreno C, Foà R, Ghia P; GIMEMA, European Research Initiative on CLL (ERIC) and UK CLL forum.","Haematologica. 2018 Jul;103(7):1209-1217. doi: 10.3324/haematol.2018.189837. Epub 2018 Apr 19.","Cuneo A","Haematologica","2018","2018/04/21","PMC6029555","","10.3324/haematol.2018.189837"
"29645352","Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study)","Ray AF, Powell J, Speakman MJ, Longford NT, DasGupta R, Bryant T, Modi S, Dyer J, Harris M, Carolan-Rees G, Hacking N.","BJU Int. 2018 Aug;122(2):270-282. doi: 10.1111/bju.14249. Epub 2018 May 6.","Ray AF","BJU Int","2018","2018/04/13","","","10.1111/bju.14249"
"29641566","Indirect treatment comparison of cabazitaxel for patients with metastatic castrate-resistant prostate cancer who have been previously treated with a docetaxel-containing regimen","Fryzek JP, Reichert H, Summers N, Townes L, Deuson R, Alexander DD, Vanderpuye-Orgle J.","PLoS One. 2018 Apr 11;13(4):e0195790. doi: 10.1371/journal.pone.0195790. eCollection 2018.","Fryzek JP","PLoS One","2018","2018/04/12","PMC5895064","","10.1371/journal.pone.0195790"
"29630885","Vaginal progesterone is as effective as cervical cerclage to prevent preterm birth in women with a singleton gestation, previous spontaneous preterm birth, and a short cervix: updated indirect comparison meta-analysis","Conde-Agudelo A, Romero R, Da Fonseca E, O'Brien JM, Cetingoz E, Creasy GW, Hassan SS, Erez O, Pacora P, Nicolaides KH.","Am J Obstet Gynecol. 2018 Jul;219(1):10-25. doi: 10.1016/j.ajog.2018.03.028. Epub 2018 Apr 7.","Conde-Agudelo A","Am J Obstet Gynecol","2018","2018/04/10","PMC6449041","NIHMS958160","10.1016/j.ajog.2018.03.028"
"29627809","Antithrombotic therapy in patients receiving saphenous vein coronary artery bypass grafts: a protocol for a systematic review and network meta-analysis","Solo K, Martin J, Lavi S, Kabali C, John-Baptiste A, Nevis IF, Choudhury T, Mamas MA, Bagur R.","BMJ Open. 2018 Apr 7;8(4):e019555. doi: 10.1136/bmjopen-2017-019555.","Solo K","BMJ Open","2018","2018/04/09","PMC5892747","","10.1136/bmjopen-2017-019555"
"29621039","A generalized pairwise modelling framework for network meta-analysis","Doi SAR, Barendregt JJ.","Int J Evid Based Healthc. 2018 Dec;16(4):187-194. doi: 10.1097/XEB.0000000000000140.","Doi SAR","Int J Evid Based Healthc","2018","2018/04/06","","","10.1097/XEB.0000000000000140"
"29618273","Cost-effectiveness of cladribine tablets, alemtuzumab, and natalizumab in the treatment of relapsing-remitting multiple sclerosis with high disease activity in England","Hettle R, Harty G, Wong SL.","J Med Econ. 2018 Jul;21(7):676-686. doi: 10.1080/13696998.2018.1461630. Epub 2018 Apr 16.","Hettle R","J Med Econ","2018","2018/04/06","","","10.1080/13696998.2018.1461630"
"29605841","Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison","Nash P, McInnes IB, Mease PJ, Thom H, Hunger M, Karabis A, Gandhi K, Mpofu S, Jugl SM.","Rheumatol Ther. 2018 Jun;5(1):99-122. doi: 10.1007/s40744-018-0106-6. Epub 2018 Mar 31.","Nash P","Rheumatol Ther","2018","2018/04/02","PMC5935619","","10.1007/s40744-018-0106-6"
"29589873","Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial","Bansback N, Guh D, Oviedo-Joekes E, Brissette S, Harrison S, Janmohamed A, Krausz M, MacDonald S, Marsh DC, Schechter MT, Anis AH.","Addiction. 2018 Jul;113(7):1264-1273. doi: 10.1111/add.14171. Epub 2018 Mar 28.","Bansback N","Addiction","2018","2018/03/29","","","10.1111/add.14171"
"29589475","Analysis of indirect treatment comparisons in national health technology assessments and requirements for industry submissions","Es-Skali IJ, Spoors J.","J Comp Eff Res. 2018 Apr;7(4):397-409. doi: 10.2217/cer-2017-0092. Epub 2018 Mar 28.","Es-Skali IJ","J Comp Eff Res","2018","2018/03/29","","","10.2217/cer-2017-0092"
"29579174","Non-herbal tea consumption and ovarian cancer risk: a systematic review and meta-analysis of observational epidemiologic studies with indirect comparison and dose-response analysis","Zhang D, Kaushiva A, Xi Y, Wang T, Li N.","Carcinogenesis. 2018 May 28;39(6):808-818. doi: 10.1093/carcin/bgy048.","Zhang D","Carcinogenesis","2018","2018/03/27","","","10.1093/carcin/bgy048"
"29570121","Progression of Adjacent-level Degeneration After Lumbar Total Disc Replacement: Results of a Post-hoc Analysis of Patients With Available Radiographs From a Prospective Study With 5-year Follow-up","Zigler JE, Blumenthal SL, Guyer RD, Ohnmeiss DD, Patel L.","Spine (Phila Pa 1976). 2018 Oct 15;43(20):1395-1400. doi: 10.1097/BRS.0000000000002647.","Zigler JE","Spine (Phila Pa 1976)","2018","2018/03/24","PMC6203419","","10.1097/BRS.0000000000002647"
"29537878","Number needed to treat in indirect treatment comparison","Guyot P, Cheng W, Tremblay G, Copher R, Burnett H, Li X, Makin C.","J Comp Eff Res. 2018 Mar;7(3):259-269. doi: 10.2217/cer-2017-0023. Epub 2018 Mar 14.","Guyot P","J Comp Eff Res","2018","2018/03/15","","","10.2217/cer-2017-0023"
"29524005","The cost-effectiveness of nivolumab monotherapy for the treatment of advanced melanoma patients in England","Meng Y, Hertel N, Ellis J, Morais E, Johnson H, Philips Z, Roskell N, Walker A, Lee D.","Eur J Health Econ. 2018 Nov;19(8):1163-1172. doi: 10.1007/s10198-018-0964-4. Epub 2018 Mar 9.","Meng Y","Eur J Health Econ","2018","2018/03/11","","","10.1007/s10198-018-0964-4"
"29521644","Cost-effectiveness Analysis of Silver Delivery Approaches in the Management of Partial-thickness Burns","Nherera L, Trueman P, Roberts C, Berg L.","Wounds. 2018 Feb 23:WNDS20180223-3. Online ahead of print.","Nherera L","Wounds","2018","2018/03/10","","",""
"29513676","Mechanical endovascular therapy for acute ischemic stroke: An indirect treatment comparison between Solitaire and Penumbra thrombectomy devices","Caranfa JT, Nguyen E, Ali R, Francis I, Zichichi A, Bosco E, Coleman CI, Baker WL, Kohn CG.","PLoS One. 2018 Mar 7;13(3):e0191657. doi: 10.1371/journal.pone.0191657. eCollection 2018.","Caranfa JT","PLoS One","2018","2018/03/08","PMC5841644","","10.1371/journal.pone.0191657"
"29494348","Methodological challenges in indirect treatment comparisons: spotlight on a recent comparison of long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia","Singh A, Gopal S, Kim E, Mathews M, Kern-Sliwa J, Turkoz I, Wooller A, Berlin J.","Int Clin Psychopharmacol. 2018 Jul;33(4):213-216. doi: 10.1097/YIC.0000000000000215.","Singh A","Int Clin Psychopharmacol","2018","2018/03/02","PMC5991170","","10.1097/YIC.0000000000000215"
"29480454","Ponatinib for Treating Chronic Myeloid Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal","Pandor A, Stevenson M, Stevens J, James MM, Hamilton J, Byrne J, Rudin C, Rawdin A, Wong R.","Pharmacoeconomics. 2018 Aug;36(8):903-915. doi: 10.1007/s40273-018-0627-4.","Pandor A","Pharmacoeconomics","2018","2018/02/27","","","10.1007/s40273-018-0627-4"
"29458286","Cost-effectiveness of ceritinib in previously untreated anaplastic lymphoma kinase-positive metastatic non-small cell lung cancer in the United States","Zhou ZY, Mutebi A, Han S, Bensimon AG, Louise Ricculli M, Xie J, Dalal A, Culver K.","J Med Econ. 2018 Jun;21(6):577-586. doi: 10.1080/13696998.2018.1443111. Epub 2018 Mar 12.","Zhou ZY","J Med Econ","2018","2018/02/21","","","10.1080/13696998.2018.1443111"
"29408938","Cost-effectiveness of liraglutide versus lixisenatide as add-on therapies to basal insulin in type 2 diabetes","Ericsson Å, Glah D, Lorenzi M, Jansen JP, Fridhammar A.","PLoS One. 2018 Feb 6;13(2):e0191953. doi: 10.1371/journal.pone.0191953. eCollection 2018.","Ericsson Å","PLoS One","2018","2018/02/07","PMC5800677","","10.1371/journal.pone.0191953"
"29381246","Evidence in support of hyperkalaemia management strategies: A systematic literature review","Palaka E, Leonard S, Buchanan-Hughes A, Bobrowska A, Langford B, Grandy S.","Int J Clin Pract. 2018 Feb;72(2). doi: 10.1111/ijcp.13052. Epub 2018 Jan 30.","Palaka E","Int J Clin Pract","2018","2018/01/31","","","10.1111/ijcp.13052"
"29330217","A systematic review of network meta-analyses for pharmacological treatment of common mental disorders","Williams T, Stein DJ, Ipser J.","Evid Based Ment Health. 2018 Feb;21(1):7-11. doi: 10.1136/eb-2017-102718. Epub 2018 Jan 12.","Williams T","Evid Based Ment Health","2018","2018/01/14","","","10.1136/eb-2017-102718"
"29327372","Relative short-term efficacy and acceptability of agomelatine versus vortioxetine in adult patients suffering from major depressive disorder","Kennedy SH, Grouin JM, Cadour S, Robert V, Picarel-Blanchot F.","Hum Psychopharmacol. 2018 Jan;33(1). doi: 10.1002/hup.2646. Epub 2018 Jan 12.","Kennedy SH","Hum Psychopharmacol","2018","2018/01/13","","","10.1002/hup.2646"
"29304933","Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials","Papp KA, Yang M, Sundaram M, Jarvis J, Betts KA, Bao Y, Signorovitch JE.","Value Health. 2018 Jan;21(1):1-8. doi: 10.1016/j.jval.2017.05.025. Epub 2017 Aug 18.","Papp KA","Value Health","2018","2018/01/07","","","10.1016/j.jval.2017.05.025"
"29302193","Management of trauma pain in the emergency setting: low-dose methoxyflurane or nitrous oxide? A systematic review and indirect treatment comparison","Porter KM, Siddiqui MK, Sharma I, Dickerson S, Eberhardt A.","J Pain Res. 2017 Dec 20;11:11-21. doi: 10.2147/JPR.S150600. eCollection 2018.","Porter KM","J Pain Res","2017","2018/01/06","PMC5741984","","10.2147/JPR.S150600"
"29271481","Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis","Sbidian E, Chaimani A, Garcia-Doval I, Do G, Hua C, Mazaud C, Droitcourt C, Hughes C, Ingram JR, Naldi L, Chosidow O, Le Cleach L.","Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.","Sbidian E","Cochrane Database Syst Rev","2017","2017/12/23","PMC6486272","","10.1002/14651858.CD011535.pub2"
"29247383","Adjusted Indirect Comparison Using Propensity Score Matching of Osimertinib to Platinum-Based Doublet Chemotherapy in Patients with EGFRm T790M NSCLC Who Have Progressed after EGFR-TKI","Mann H, Andersohn F, Bodnar C, Mitsudomi T, Mok TSK, Yang JC, Hoyle C.","Clin Drug Investig. 2018 Apr;38(4):319-331. doi: 10.1007/s40261-017-0611-3.","Mann H","Clin Drug Investig","2018","2017/12/17","PMC5856890","","10.1007/s40261-017-0611-3"
"29234637","Efficacy and Safety of Systemic Therapies for Advanced Hepatocellular Carcinoma: A Network Meta-Analysis of Phase III Trials","Cucchetti A, Piscaglia F, Pinna AD, Djulbegovic B, Mazzotti F, Bolondi L.","Liver Cancer. 2017 Nov;6(4):337-348. doi: 10.1159/000481314. Epub 2017 Oct 19.","Cucchetti A","Liver Cancer","2017","2017/12/14","PMC5704710","","10.1159/000481314"
"29205421","Systematic review with network meta-analysis: comparative assessment of tofacitinib and biological therapies for moderate-to-severe ulcerative colitis","Bonovas S, Lytras T, Nikolopoulos G, Peyrin-Biroulet L, Danese S.","Aliment Pharmacol Ther. 2018 Feb;47(4):454-465. doi: 10.1111/apt.14449. Epub 2017 Dec 4.","Bonovas S","Aliment Pharmacol Ther","2018","2017/12/06","","","10.1111/apt.14449"
"29201386","Meta-research metrics matter: letter regarding article ""indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease""","Rodrigues FB, Duarte GS, Costa J, Ferreira JJ, Wild EJ.","J Clin Mov Disord. 2017 Nov 22;4:19. doi: 10.1186/s40734-017-0067-x. eCollection 2017.","Rodrigues FB","J Clin Mov Disord","2017","2017/12/05","PMC5698972","","10.1186/s40734-017-0067-x"
"29197667","Indirect comparison of third-generation antiepileptic drugs as adjunctive treatment for uncontrolled focal epilepsy","Li-Na Z, Deng C, Hai-Jiao W, Da X, Ge T, Ling L.","Epilepsy Res. 2018 Jan;139:60-72. doi: 10.1016/j.eplepsyres.2017.11.008. Epub 2017 Nov 26.","Li-Na Z","Epilepsy Res","2018","2017/12/04","","","10.1016/j.eplepsyres.2017.11.008"
"29192016","Comparative Efficacy of Daratumumab Monotherapy and Pomalidomide Plus Low-Dose Dexamethasone in the Treatment of Multiple Myeloma: A Matching Adjusted Indirect Comparison","Van Sanden S, Ito T, Diels J, Vogel M, Belch A, Oriol A.","Oncologist. 2018 Mar;23(3):279-287. doi: 10.1634/theoncologist.2017-0103. Epub 2017 Nov 30.","Van Sanden S","Oncologist","2018","2017/12/02","PMC5905688","","10.1634/theoncologist.2017-0103"
"32026346","A Network Meta-Analysis of Long-Acting Muscarinic Antagonist (LAMA) and Long-Acting β(2)-Agonist (LABA) Combinations in COPD","Sion KYJ, Huisman EL, Punekar YS, Naya I, Ismaila AS.","Pulm Ther. 2017 Dec;3(2):297-316. doi: 10.1007/s41030-017-0048-0. Epub 2017 Aug 22.","Sion KYJ","Pulm Ther","2017","2020/02/07","PMC6964204","","10.1007/s41030-017-0048-0"
"29178025","Pegylated Liposomal Irinotecan Hydrochloride Trihydrate for Treating Pancreatic Cancer After Gemcitabine: An Evidence Review Group Perspective of a NICE Single Technology Appraisal","Fleeman N, Abdulla A, Bagust A, Beale S, Richardson M, Stainthorpe A, Boland A, Kotas E, McEntee J, Palmer D.","Pharmacoeconomics. 2018 Mar;36(3):289-299. doi: 10.1007/s40273-017-0592-3.","Fleeman N","Pharmacoeconomics","2018","2017/11/28","","","10.1007/s40273-017-0592-3"
"29172760","Adjusted comparison of daratumumab monotherapy versus real-world historical control data from the Czech Republic in heavily pretreated and highly refractory multiple myeloma patients","Jelínek T, Maisnar V, Pour L, Špička I, Minařík J, Gregora E, Kessler P, Sýkora M, Fraňková H, Adamová D, Wróbel M, Mikula P, Jarkovský J, Diels J, Gatopoulou X, Veselá Š, Besson H, Brožová L, Ito T, Hájek R.","Curr Med Res Opin. 2018 May;34(5):775-783. doi: 10.1080/03007995.2017.1410121. Epub 2018 Feb 15.","Jelínek T","Curr Med Res Opin","2018","2017/11/28","","","10.1080/03007995.2017.1410121"
"29171861","Matching-adjusted indirect comparison of efficacy in patients with moderate-to-severe plaque psoriasis treated with ixekizumab vs. secukinumab","Warren RB, Brnabic A, Saure D, Langley RG, See K, Wu JJ, Schacht A, Mallbris L, Nast A.","Br J Dermatol. 2018 May;178(5):1064-1071. doi: 10.1111/bjd.16140. Epub 2018 Mar 1.","Warren RB","Br J Dermatol","2018","2017/11/25","","","10.1111/bjd.16140"
"29164973","An indirect treatment comparison of the efficacy of insulin degludec/liraglutide (IDegLira) and insulin glargine/lixisenatide (iGlarLixi) in patients with type 2 diabetes uncontrolled on basal insulin","Evans M, Billings LK, Håkan-Bloch J, Slothuus U, Abrahamsen TJ, Andersen A, Jansen JP.","J Med Econ. 2018 Apr;21(4):340-347. doi: 10.1080/13696998.2017.1409228. Epub 2017 Dec 3.","Evans M","J Med Econ","2018","2017/11/23","","","10.1080/13696998.2017.1409228"
"29139314","Cost-utility analysis of life-long prophylaxis with recombinant factor VIIIFc vs recombinant factor VIII for the management of severe hemophilia A in Sweden","Henry N, Jovanović J, Schlueter M, Kritikou P, Wilson K, Myrén KJ.","J Med Econ. 2018 Apr;21(4):318-325. doi: 10.1080/13696998.2017.1405816. Epub 2017 Dec 4.","Henry N","J Med Econ","2018","2017/11/16","","","10.1080/13696998.2017.1405816"
"29139001","The Assessment for Disinvestment of Intramuscular Interferon Beta for Relapsing-Remitting Multiple Sclerosis in Brazil","de Lemos LLP, Guerra Júnior AA, Santos M, Magliano C, Diniz I, Souza K, Pereira RG, Alvares J, Godman B, Bennie M, Zimmermann IR, Dos Santos VCC, Pretramale CA, Acurcio FA.","Pharmacoeconomics. 2018 Feb;36(2):161-173. doi: 10.1007/s40273-017-0579-0.","de Lemos LLP","Pharmacoeconomics","2018","2017/11/16","PMC5805817","","10.1007/s40273-017-0579-0"
"29126800","Nanoencapsulated Illicium verum Hook.f. essential oil as an effective novel plant-based preservative against aflatoxin B(1) production and free radical generation","Dwivedy AK, Singh VK, Prakash B, Dubey NK.","Food Chem Toxicol. 2018 Jan;111:102-113. doi: 10.1016/j.fct.2017.11.007. Epub 2017 Nov 8.","Dwivedy AK","Food Chem Toxicol","2018","2017/11/12","","","10.1016/j.fct.2017.11.007"
"30657401","Overcoming the Straw Man Effect in Oncology: Visualization and Ranking of Chemotherapy Regimens Using an Information Theoretic Approach","Warner JL, Yang PC, Alterovitz G.","JCO Clin Cancer Inform. 2017 Nov;1:1-9. doi: 10.1200/CCI.17.00079.","Warner JL","JCO Clin Cancer Inform","2017","2019/01/19","PMC6874021","","10.1200/CCI.17.00079"
"29086363","Pomalidomide with Dexamethasone for Treating Relapsed and Refractory Multiple Myeloma Previously Treated with Lenalidomide and Bortezomib: An Evidence Review Group Perspective of an NICE Single Technology Appraisal","Büyükkaramikli NC, de Groot S, Fayter D, Wolff R, Armstrong N, Stirk L, Worthy G, Albuquerque de Almeida F, Kleijnen J, Al MJ.","Pharmacoeconomics. 2018 Feb;36(2):145-159. doi: 10.1007/s40273-017-0581-6.","Büyükkaramikli NC","Pharmacoeconomics","2018","2017/11/01","PMC5805808","","10.1007/s40273-017-0581-6"
"29043538","Venous thromboembolism prophylaxis in medically ill patients: a mixed treatment comparison meta-analysis","Al Yami MS, Silva MA, Donovan JL, Kanaan AO.","J Thromb Thrombolysis. 2018 Jan;45(1):36-47. doi: 10.1007/s11239-017-1562-5.","Al Yami MS","J Thromb Thrombolysis","2018","2017/10/19","","","10.1007/s11239-017-1562-5"
"29037513","Comparison of Abiraterone Acetate and Docetaxel with Androgen Deprivation Therapy in High-risk and Metastatic Hormone-naïve Prostate Cancer: A Systematic Review and Network Meta-analysis","Wallis CJD, Klaassen Z, Bhindi B, Goldberg H, Chandrasekar T, Farrell AM, Boorjian SA, Kulkarni GS, Karnes RJ, Satkunasivam R.","Eur Urol. 2018 Jun;73(6):834-844. doi: 10.1016/j.eururo.2017.10.002. Epub 2017 Oct 14.","Wallis CJD","Eur Urol","2018","2017/10/18","","","10.1016/j.eururo.2017.10.002"
"28971316","Resveratrol, pterostilbene, and baicalein: plant-derived anti-biofilm agents","Kolouchová I, Maťátková O, Paldrychová M, Kodeš Z, Kvasničková E, Sigler K, Čejková A, Šmidrkal J, Demnerová K, Masák J.","Folia Microbiol (Praha). 2018 May;63(3):261-272. doi: 10.1007/s12223-017-0549-0. Epub 2017 Oct 2.","Kolouchová I","Folia Microbiol (Praha)","2018","2017/10/04","","","10.1007/s12223-017-0549-0"
"28967482","Cost-effectiveness of Pomalidomide, Carfilzomib, and Daratumumab for the Treatment of Patients with Heavily Pretreated Relapsed-refractory Multiple Myeloma in the United States","Pelligra CG, Parikh K, Guo S, Chandler C, Mouro J, Abouzaid S, Ailawadhi S.","Clin Ther. 2017 Oct;39(10):1986-2005.e5. doi: 10.1016/j.clinthera.2017.08.010. Epub 2017 Sep 28.","Pelligra CG","Clin Ther","2017","2017/10/03","","","10.1016/j.clinthera.2017.08.010"
"28920068","Tetrabenazine Versus Deutetrabenazine for Huntington's Disease: Twins or Distant Cousins?","Rodrigues FB, Duarte GS, Costa J, Ferreira JJ, Wild EJ.","Mov Disord Clin Pract. 2017 Jul-Aug;4(4):582-585. doi: 10.1002/mdc3.12483. Epub 2017 Mar 29.","Rodrigues FB","Mov Disord Clin Pract","2017","2017/09/19","PMC5573977","","10.1002/mdc3.12483"
"28901021","Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis","Franklin J, Eichenauer DA, Becker I, Monsef I, Engert A.","Cochrane Database Syst Rev. 2017 Sep 13;9(9):CD008814. doi: 10.1002/14651858.CD008814.pub2.","Franklin J","Cochrane Database Syst Rev","2017","2017/09/14","PMC6483617","","10.1002/14651858.CD008814.pub2"
"28880737","Cost-effectiveness of osimertinib in the UK for advanced EGFR-T790M non-small cell lung cancer","Bertranou E, Bodnar C, Dansk V, Greystoke A, Large S, Dyer M.","J Med Econ. 2018 Feb;21(2):113-121. doi: 10.1080/13696998.2017.1377718. Epub 2017 Sep 21.","Bertranou E","J Med Econ","2018","2017/09/08","","","10.1080/13696998.2017.1377718"
"28866822","Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer","Peters ML, de Meijer C, Wyndaele D, Noordzij W, Leliveld-Kors AM, van den Bosch J, van den Berg PH, Baka A, Gaultney JG.","Appl Health Econ Health Policy. 2018 Feb;16(1):133-143. doi: 10.1007/s40258-017-0350-x.","Peters ML","Appl Health Econ Health Policy","2018","2017/09/04","PMC5797195","","10.1007/s40258-017-0350-x"
"28864100","Optimal stump management in laparoscopic appendectomy: A network meta-analysis by the Minimally Invasive Surgery Synthesis of Interventions and Outcomes Network","Antoniou SA, Mavridis D, Hajibandeh S, Hajibandeh S, Antoniou GA, Gorter R, Tenhagen M, Koutras C, Pointner R, Chalkiadakis GE, Granderath FA, Fragiadakis GF, Philalithis AE, Bonjer HJ.","Surgery. 2017 Nov;162(5):994-1005. doi: 10.1016/j.surg.2017.07.013. Epub 2017 Aug 30.","Antoniou SA","Surgery","2017","2017/09/03","","","10.1016/j.surg.2017.07.013"
"28856580","Can Matching-Adjusted Indirect Comparison Methods Mitigate Placebo Response Differences Among Patient Populations in Adjunctive Trials of Brivaracetam and Levetiracetam?","Swallow E, Fang A, Signorovitch J, Plumb J, Borghs S.","CNS Drugs. 2017 Oct;31(10):899-910. doi: 10.1007/s40263-017-0462-8.","Swallow E","CNS Drugs","2017","2017/09/01","PMC5658476","","10.1007/s40263-017-0462-8"
"28854405","Newer antiepileptic drugs compared to levetiracetam as adjunctive treatments for uncontrolled focal epilepsy: An indirect comparison","Zhu LN, Chen D, Xu D, Tan G, Wang HJ, Liu L.","Seizure. 2017 Oct;51:121-132. doi: 10.1016/j.seizure.2017.07.017. Epub 2017 Aug 16.","Zhu LN","Seizure","2017","2017/08/31","","","10.1016/j.seizure.2017.07.017"
"28823204","Methods for Population-Adjusted Indirect Comparisons in Health Technology Appraisal","Phillippo DM, Ades AE, Dias S, Palmer S, Abrams KR, Welton NJ.","Med Decis Making. 2018 Feb;38(2):200-211. doi: 10.1177/0272989X17725740. Epub 2017 Aug 19.","Phillippo DM","Med Decis Making","2018","2017/08/22","PMC5774635","","10.1177/0272989X17725740"
"28762213","Comparative Effectiveness of Adalimumab versus Secukinumab for the Treatment of Psoriatic Arthritis: A Matching-Adjusted Indirect Comparison","Strand V, Betts KA, Mittal M, Song J, Skup M, Joshi A.","Rheumatol Ther. 2017 Dec;4(2):349-362. doi: 10.1007/s40744-017-0070-6. Epub 2017 Jul 31.","Strand V","Rheumatol Ther","2017","2017/08/02","PMC5696282","","10.1007/s40744-017-0070-6"
"28742235","Silver delivery approaches in the management of partial thickness burns: A systematic review and indirect treatment comparison","Nherera L, Trueman P, Roberts C, Berg L.","Wound Repair Regen. 2017 Aug;25(4):707-721. doi: 10.1111/wrr.12559. Epub 2017 Aug 17.","Nherera L","Wound Repair Regen","2017","2017/07/26","","","10.1111/wrr.12559"
"28736505","Estimating the cost-effectiveness of daclatasvir + sofosbuvir versus sofosbuvir + ribavirin for patients with genotype 3 hepatitis C virus","McEwan P, Webster S, Ward T, Brenner M, Kalsekar A, Yuan Y.","Cost Eff Resour Alloc. 2017 Jul 21;15:15. doi: 10.1186/s12962-017-0077-4. eCollection 2017.","McEwan P","Cost Eff Resour Alloc","2017","2017/07/25","PMC5521139","","10.1186/s12962-017-0077-4"
"28732142","Network meta-analysis including treatment by covariate interactions: Consistency can vary across covariate values","Donegan S, Welton NJ, Tudur Smith C, D'Alessandro U, Dias S.","Res Synth Methods. 2017 Dec;8(4):485-495. doi: 10.1002/jrsm.1257. Epub 2017 Aug 23.","Donegan S","Res Synth Methods","2017","2017/07/22","PMC5724666","","10.1002/jrsm.1257"
"28712616","Aripiprazole Lauroxil Compared with Paliperidone Palmitate in Patients with Schizophrenia: An Indirect Treatment Comparison","Cameron C, Zummo J, Desai DN, Drake C, Hutton B, Kotb A, Weiden PJ.","Value Health. 2017 Jul-Aug;20(7):876-885. doi: 10.1016/j.jval.2017.03.010. Epub 2017 May 9.","Cameron C","Value Health","2017","2017/07/18","","","10.1016/j.jval.2017.03.010"
"28708944","Indirect comparison of bronchial thermoplasty versus omalizumab for uncontrolled severe asthma","Niven RM, Simmonds MR, Cangelosi MJ, Tilden DP, Cottrell S, Shargill NS.","J Asthma. 2018 Apr;55(4):443-451. doi: 10.1080/02770903.2017.1337789. Epub 2017 Jul 14.","Niven RM","J Asthma","2018","2017/07/15","","","10.1080/02770903.2017.1337789"
"28680955","Second-line Treatments for Advanced Gastric Cancer: A Network Meta-Analysis of Overall Survival Using Parametric Modelling Methods","Harvey RC.","Oncol Ther. 2017;5(1):53-67. doi: 10.1007/s40487-017-0048-0. Epub 2017 Jun 6.","Harvey RC","Oncol Ther","2017","2017/07/07","PMC5488131","","10.1007/s40487-017-0048-0"
"28663124","Comparative evaluation of vortioxetine as a switch therapy in patients with major depressive disorder","Thase ME, Danchenko N, Brignone M, Florea I, Diamand F, Jacobsen PL, Vieta E.","Eur Neuropsychopharmacol. 2017 Aug;27(8):773-781. doi: 10.1016/j.euroneuro.2017.05.009. Epub 2017 Jun 27.","Thase ME","Eur Neuropsychopharmacol","2017","2017/07/01","","","10.1016/j.euroneuro.2017.05.009"
"28648305","Assessing the Budget Impact and Economic Outcomes of the Introduction of Daclatasvir + Asunaprevir and Sofosbuvir/Ledipasvir for the Treatment of Chronic Hepatitis C Virus Infection in Japan","Ward T, Webster S, Mishina S, McEwan P, Wygant G, Wang F.","Value Health Reg Issues. 2017 May;12:1-6. doi: 10.1016/j.vhri.2016.10.002. Epub 2016 Dec 24.","Ward T","Value Health Reg Issues","2017","2017/06/27","","","10.1016/j.vhri.2016.10.002"
"28646922","An investigation of the impact of using different methods for network meta-analysis: a protocol for an empirical evaluation","Karahalios AE, Salanti G, Turner SL, Herbison GP, White IR, Veroniki AA, Nikolakopoulou A, Mckenzie JE.","Syst Rev. 2017 Jun 24;6(1):119. doi: 10.1186/s13643-017-0511-x.","Karahalios AE","Syst Rev","2017","2017/06/26","PMC5483272","","10.1186/s13643-017-0511-x"
"28641997","Uterine Artery Embolization and Surgical Methods for the Treatment of Symptomatic Uterine Leiomyomas: A Systemic Review and Meta-analysis Followed by Indirect Treatment Comparison","Fonseca MCM, Castro R, Machado M, Conte T, Girao MJBC.","Clin Ther. 2017 Jul;39(7):1438-1455.e2. doi: 10.1016/j.clinthera.2017.05.346. Epub 2017 Jun 20.","Fonseca MCM","Clin Ther","2017","2017/06/24","","","10.1016/j.clinthera.2017.05.346"
"28614980","Meta-analysis and indirect treatment comparison of lipegfilgrastim with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced neutropenia-related events","Bond TC, Szabo E, Gabriel S, Klastersky J, Tomey O, Mueller U, Schwartzberg L, Tang B.","J Oncol Pharm Pract. 2018 Sep;24(6):412-423. doi: 10.1177/1078155217714859. Epub 2017 Jun 14.","Bond TC","J Oncol Pharm Pract","2018","2017/06/16","PMC6094503","","10.1177/1078155217714859"
"28607774","A Matching-Adjusted Indirect Comparison of Sonidegib and Vismodegib in Advanced Basal Cell Carcinoma","Odom D, Mladsi D, Purser M, Kaye JA, Palaka E, Charter A, Jensen JA, Sellami D.","J Skin Cancer. 2017;2017:6121760. doi: 10.1155/2017/6121760. Epub 2017 May 21.","Odom D","J Skin Cancer","2017","2017/06/14","PMC5457749","","10.1155/2017/6121760"
"28604117","Efficacy and safety of post-docetaxel therapies in metastatic castration-resistant prostate cancer: a systematic review of the literature","Summers N, Vanderpuye-Orgle J, Reinhart M, Gallagher M, Sartor O.","Curr Med Res Opin. 2017 Nov;33(11):1995-2008. doi: 10.1080/03007995.2017.1341869. Epub 2017 Jul 10.","Summers N","Curr Med Res Opin","2017","2017/06/13","","","10.1080/03007995.2017.1341869"
"28603010","Deficiencies in addressing effect modification in network meta-analyses: a meta-epidemiological survey","Kovic B, Zoratti MJ, Michalopoulos S, Silvestre C, Thorlund K, Thabane L.","J Clin Epidemiol. 2017 Aug;88:47-56. doi: 10.1016/j.jclinepi.2017.06.004. Epub 2017 Jun 8.","Kovic B","J Clin Epidemiol","2017","2017/06/13","","","10.1016/j.jclinepi.2017.06.004"
"28573505","Comparative Efficacy of Ibrutinib Versus Obinutuzumab + Chlorambucil in First-Line Treatment of Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison","Van Sanden S, Baculea S, Diels J, Cote S.","Adv Ther. 2017 Jul;34(7):1650-1661. doi: 10.1007/s12325-017-0564-1. Epub 2017 Jun 1.","Van Sanden S","Adv Ther","2017","2017/06/03","PMC5504213","","10.1007/s12325-017-0564-1"
"28556675","A new modeling approach allowing prediction and comparison of the long-term outcomes of treatments for hemophilia B","Keep MV, Hoxer CS, Hemstock M, Groth AV, Knight C.","J Comp Eff Res. 2018 Jan;7(1):39-48. doi: 10.2217/cer-2017-0028. Epub 2017 May 30.","Keep MV","J Comp Eff Res","2018","2017/05/31","","","10.2217/cer-2017-0028"
"28552513","Chemically characterized Mentha cardiaca L. essential oil as plant based preservative in view of efficacy against biodeteriorating fungi of dry fruits, aflatoxin secretion, lipid peroxidation and safety profile assessment","Dwivedy AK, Prakash B, Chanotiya CS, Bisht D, Dubey NK.","Food Chem Toxicol. 2017 Aug;106(Pt A):175-184. doi: 10.1016/j.fct.2017.05.043. Epub 2017 May 24.","Dwivedy AK","Food Chem Toxicol","2017","2017/05/30","","","10.1016/j.fct.2017.05.043"
"28549125","Transfemoral, transapical and transcatheter aortic valve implantation and surgical aortic valve replacement: a meta-analysis of direct and adjusted indirect comparisons of early and mid-term deaths","Ando T, Takagi H, Grines CL.","Interact Cardiovasc Thorac Surg. 2017 Sep 1;25(3):484-492. doi: 10.1093/icvts/ivx150.","Ando T","Interact Cardiovasc Thorac Surg","2017","2017/05/27","","","10.1093/icvts/ivx150"
"28522221","Comparative efficacy and safety of different circumcisions for patients with redundant prepuce or phimosis: A network meta-analysis","Huang C, Song P, Xu C, Wang R, Wei L, Zhao X.","Int J Surg. 2017 Jul;43:17-25. doi: 10.1016/j.ijsu.2017.04.060. Epub 2017 May 15.","Huang C","Int J Surg","2017","2017/05/20","","","10.1016/j.ijsu.2017.04.060"
"28497561","On assessing bioequivalence and interchangeability between generics based on indirect comparisons","Zheng J, Chow SC, Yuan M.","Stat Med. 2017 Aug 30;36(19):2978-2993. doi: 10.1002/sim.7326. Epub 2017 May 11.","Zheng J","Stat Med","2017","2017/05/13","","","10.1002/sim.7326"
"28474745","Daratumumab monotherapy compared with historical control data in heavily pretreated and highly refractory patients with multiple myeloma: An adjusted treatment comparison","Usmani SZ, Diels J, Ito T, Mehra M, Khan I, Lam A.","Am J Hematol. 2017 Aug;92(8):E146-E152. doi: 10.1002/ajh.24781. Epub 2017 Jun 5.","Usmani SZ","Am J Hematol","2017","2017/05/06","PMC5518219","","10.1002/ajh.24781"
"28430670","Comparison between long-acting injectable aripiprazole versus paliperidone palmitate in the treatment of schizophrenia: systematic review and indirect treatment comparison","Pae CU, Wang SM, Han C, Bahk WM, Lee SJ, Patkar AA, Masand PS, Serretti A, Emsley R.","Int Clin Psychopharmacol. 2017 Sep;32(5):235-248. doi: 10.1097/YIC.0000000000000177.","Pae CU","Int Clin Psychopharmacol","2017","2017/04/22","","","10.1097/YIC.0000000000000177"
"28415774","Chemoprevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia (HGPIN): a systematic review and adjusted indirect treatment comparison","Cui K, Li X, Du Y, Tang X, Arai S, Geng Y, Xi Y, Xu H, Zhou Y, Ma W, Zhang T.","Oncotarget. 2017 May 30;8(22):36674-36684. doi: 10.18632/oncotarget.16230.","Cui K","Oncotarget","2017","2017/04/19","PMC5482687","","10.18632/oncotarget.16230"
"28382213","Integrated services and early intervention in the vocational rehabilitation of people with spinal cord injuries","Bloom J, Dorsett P, McLennan V.","Spinal Cord Ser Cases. 2017 Feb 2;3:16042. doi: 10.1038/scsandc.2016.42. eCollection 2017.","Bloom J","Spinal Cord Ser Cases","2017","2017/04/07","PMC5289269","","10.1038/scsandc.2016.42"
"28361519","Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients","Kim SJ, Shin IS, Eun SJ, Whangbo TK, Kim JW, Cho YS, Kim JC.","Int Neurourol J. 2017 Mar 24;21(1):29-37. doi: 10.5213/inj.1734826.413.","Kim SJ","Int Neurourol J","2017","2017/04/01","PMC5380825","","10.5213/inj.1734826.413"
"28361159","Evaluation of Adjusted and Unadjusted Indirect Comparison Methods in Benefit Assessment. A Simulation Study for Time-to-event Endpoints","Kühnast S, Schiffner-Rohe J, Rahnenführer J, Leverkus F.","Methods Inf Med. 2017 May 18;56(3):261-267. doi: 10.3414/ME15-02-0016. Epub 2017 Mar 31.","Kühnast S","Methods Inf Med","2017","2017/04/01","","","10.3414/ME15-02-0016"
"28350241","Comparative effectiveness of delayed-release dimethyl fumarate versus glatiramer acetate in multiple sclerosis patients: results of a matching-adjusted indirect comparison","Chan A, Cutter G, Fox RJ, Xiao J, Lewin JB, Edwards MR.","J Comp Eff Res. 2017 Jun;6(4):313-323. doi: 10.2217/cer-2016-0085. Epub 2017 Mar 28.","Chan A","J Comp Eff Res","2017","2017/03/29","","","10.2217/cer-2016-0085"
"28294636","Indirect treatment comparison of two non-invasive patient-controlled analgesia treatments for acute post-operative pain management","Katz P, Takyar S, Palmer P, Liedgens H.","Curr Med Res Opin. 2017 May;33(5):911-918. doi: 10.1080/03007995.2017.1294560. Epub 2017 Mar 15.","Katz P","Curr Med Res Opin","2017","2017/03/16","","","10.1080/03007995.2017.1294560"
"28283987","Evaluating the Feasibility of Use of a Foreign Reference Product for Generic Drug Applications: A Retrospective Pilot Study","Wang YL, Hsu LF.","Eur J Drug Metab Pharmacokinet. 2017 Dec;42(6):935-942. doi: 10.1007/s13318-017-0409-y.","Wang YL","Eur J Drug Metab Pharmacokinet","2017","2017/03/12","","","10.1007/s13318-017-0409-y"
"28273772","Indirect comparisons of treatment effects: Network meta-analyses","Sormani MP.","Mult Scler. 2017 Apr;23(4):510-512. doi: 10.1177/1352458517690272. Epub 2017 Feb 17.","Sormani MP","Mult Scler","2017","2017/03/10","","","10.1177/1352458517690272"
"28272725","[Comparison of the cost-utility of direct oral anticoagulants for the prevention of stroke in patients with atrial fibrillation in Spain]","Monreal-Bosch M, Soulard S, Crespo C, Brand S, Kansal A.","Rev Neurol. 2017 Mar 16;64(6):247-256.","Monreal-Bosch M","Rev Neurol","2017","2017/03/09","","",""
"28265459","Indirect tolerability comparison of Deutetrabenazine and Tetrabenazine for Huntington disease","Claassen DO, Carroll B, De Boer LM, Wu E, Ayyagari R, Gandhi S, Stamler D.","J Clin Mov Disord. 2017 Mar 1;4:3. doi: 10.1186/s40734-017-0051-5. eCollection 2017.","Claassen DO","J Clin Mov Disord","2017","2017/03/08","PMC5331691","","10.1186/s40734-017-0051-5"
"28220521","Indirect treatment comparison (ITC) of medical therapies for an overactive bladder","Obloza A, Kirby J, Yates D, Toozs-Hobson P.","Neurourol Urodyn. 2017 Sep;36(7):1824-1831. doi: 10.1002/nau.23189. Epub 2017 Feb 21.","Obloza A","Neurourol Urodyn","2017","2017/02/22","","","10.1002/nau.23189"
"28137490","Comparative effectiveness of mepolizumab and omalizumab in severe asthma: An indirect treatment comparison","Cockle SM, Stynes G, Gunsoy NB, Parks D, Alfonso-Cristancho R, Wex J, Bradford ES, Albers FC, Willson J.","Respir Med. 2017 Feb;123:140-148. doi: 10.1016/j.rmed.2016.12.009. Epub 2016 Dec 21.","Cockle SM","Respir Med","2017","2017/02/01","","","10.1016/j.rmed.2016.12.009"
"28122640","Rational and design of an individual participant data meta-analysis of spinal manipulative therapy for chronic low back pain-a protocol","de Zoete A, de Boer MR, van Tulder MW, Rubinstein SM, Underwood M, Hayden JA, Kalter J, Ostelo R.","Syst Rev. 2017 Jan 26;6(1):21. doi: 10.1186/s13643-017-0413-y.","de Zoete A","Syst Rev","2017","2017/01/27","PMC5267437","","10.1186/s13643-017-0413-y"
"28096283","LABA/LAMA combination in COPD: a meta-analysis on the duration of treatment","Calzetta L, Rogliani P, Ora J, Puxeddu E, Cazzola M, Matera MG.","Eur Respir Rev. 2017 Jan 17;26(143):160043. doi: 10.1183/16000617.0043-2016. Print 2017 Jan.","Calzetta L","Eur Respir Rev","2017","2017/01/19","","","10.1183/16000617.0043-2016"
"28063135","Cost Effectiveness of Insulin Degludec Plus Liraglutide (IDegLira) in a Fixed Combination for Uncontrolled Type 2 Diabetes Mellitus in Sweden","Ericsson Å, Lundqvist A.","Appl Health Econ Health Policy. 2017 Apr;15(2):237-248. doi: 10.1007/s40258-016-0301-y.","Ericsson Å","Appl Health Econ Health Policy","2017","2017/01/08","PMC5343072","","10.1007/s40258-016-0301-y"
"28062113","Indirect Treatment Comparisons of Ibrutinib Versus Physician's Choice and Idelalisib Plus Ofatumumab in Patients With Previously Treated Chronic Lymphocytic Leukemia","Sorensen S, Wildgust M, Sengupta N, Trambitas C, Diels J, van Sanden S, Xu Y, Dorman E.","Clin Ther. 2017 Jan;39(1):178-189.e5. doi: 10.1016/j.clinthera.2016.12.001. Epub 2017 Jan 3.","Sorensen S","Clin Ther","2017","2017/01/08","","","10.1016/j.clinthera.2016.12.001"
"28052762","Indirect treatment comparison of dabrafenib plus trametinib versus vemurafenib plus cobimetinib in previously untreated metastatic melanoma patients","Daud A, Gill J, Kamra S, Chen L, Ahuja A.","J Hematol Oncol. 2017 Jan 4;10(1):3. doi: 10.1186/s13045-016-0369-8.","Daud A","J Hematol Oncol","2017","2017/01/06","PMC5209913","","10.1186/s13045-016-0369-8"
"28000169","Relative Efficacy of Granulocyte-Macrophage Colony-Stimulating Factor, Dacarbazine, and Glycoprotein 100 in Metastatic Melanoma: An Indirect Treatment Comparison","Quinn C, Ma Q, Kudlac A, Palmer S, Barber B, Zhao Z.","Adv Ther. 2017 Feb;34(2):495-512. doi: 10.1007/s12325-016-0464-9. Epub 2016 Dec 20.","Quinn C","Adv Ther","2017","2016/12/22","PMC5331084","","10.1007/s12325-016-0464-9"
"27882214","Efficacy and safety of different doses of evolocumab in reducing low-density lipoprotein cholesterol levels: A meta-analysis","Cheng C, Sun S, Zhou Y, Yang X.","Biomed Rep. 2016 Nov;5(5):541-547. doi: 10.3892/br.2016.766. Epub 2016 Sep 29.","Cheng C","Biomed Rep","2016","2016/11/25","PMC5103663","","10.3892/br.2016.766"
"27868341","A single-arm trial indirect comparison investigation: a proof-of-concept method to predict venous leg ulcer healing time for a new acellular synthetic matrix matched to standard care control","Shannon R, Nelson A.","Int Wound J. 2017 Aug;14(4):729-741. doi: 10.1111/iwj.12687. Epub 2016 Nov 20.","Shannon R","Int Wound J","2017","2016/11/22","PMC7949811","","10.1111/iwj.12687"
"27866023","Direct and adjusted indirect comparisons of perioperative mortality after sutureless or rapid-deployment aortic valve replacement versus transcatheter aortic valve implantation","Takagi H, Ando T, Umemoto T; ALICE (All-Literature Investigation of Cardiovascular Evidence) Group.","Int J Cardiol. 2017 Feb 1;228:327-334. doi: 10.1016/j.ijcard.2016.11.253. Epub 2016 Nov 12.","Takagi H","Int J Cardiol","2017","2016/11/21","","","10.1016/j.ijcard.2016.11.253"
"27848997","Epidemiology Characteristics, Methodological Assessment and Reporting of Statistical Analysis of Network Meta-Analyses in the Field of Cancer","Ge L, Tian JH, Li XX, Song F, Li L, Zhang J, Li G, Pei GQ, Qiu X, Yang KH.","Sci Rep. 2016 Nov 16;6:37208. doi: 10.1038/srep37208.","Ge L","Sci Rep","2016","2016/11/17","PMC5111127","","10.1038/srep37208"
"27806087","Cost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China","Gu S, Mu Y, Zhai S, Zeng Y, Zhen X, Dong H.","PLoS One. 2016 Nov 2;11(11):e0165629. doi: 10.1371/journal.pone.0165629. eCollection 2016.","Gu S","PLoS One","2016","2016/11/03","PMC5091768","","10.1371/journal.pone.0165629"
"27734713","Lenvatinib for the treatment of radioiodine-refractory differentiated thyroid carcinoma: a systematic review and indirect comparison with sorafenib","Kawalec P, Malinowska-Lipień I, Brzostek T, Kózka M.","Expert Rev Anticancer Ther. 2016 Dec;16(12):1303-1309. doi: 10.1080/14737140.2016.1247697. Epub 2016 Oct 28.","Kawalec P","Expert Rev Anticancer Ther","2016","2016/10/14","","","10.1080/14737140.2016.1247697"
"27543806","A common reference-based indirect comparison meta-analysis of eslicarbazepine versus lacosamide as add on treatments for focal epilepsy","Brigo F, Trinka E, Bragazzi NL, Nardone R, Milan A, Grillo E.","Epilepsy Res. 2016 Nov;127:12-18. doi: 10.1016/j.eplepsyres.2016.08.006. Epub 2016 Aug 11.","Brigo F","Epilepsy Res","2016","2016/08/21","","","10.1016/j.eplepsyres.2016.08.006"
"27352420","Bucher's indirect comparison of daylight photodynamic therapy with methyl aminolevulinate cream versus diclofenac plus hyaluronic acid gel for the treatment of multiple actinic keratosis","Calzavara-Pinton P, Zane C, Pacou M, Szeimies RM.","Eur J Dermatol. 2016 Oct 1;26(5):487-492. doi: 10.1684/ejd.2016.2822.","Calzavara-Pinton P","Eur J Dermatol","2016","2016/06/29","","","10.1684/ejd.2016.2822"
"27657652","Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands","Blommestein HM, de Groot S, Aarts MJ, Vemer P, de Vries R, van Abeelen AF, Posthuma EF, Uyl-de Groot CA.","Leuk Res. 2016 Nov;50:37-45. doi: 10.1016/j.leukres.2016.09.005. Epub 2016 Sep 3.","Blommestein HM","Leuk Res","2016","2016/09/23","","","10.1016/j.leukres.2016.09.005"
"27778240","Economic Evaluations of Pharmaceuticals Granted a Marketing Authorisation Without the Results of Randomised Trials: A Systematic Review and Taxonomy","Hatswell AJ, Freemantle N, Baio G.","Pharmacoeconomics. 2017 Feb;35(2):163-176. doi: 10.1007/s40273-016-0460-6.","Hatswell AJ","Pharmacoeconomics","2017","2016/10/26","","","10.1007/s40273-016-0460-6"
"27736657","Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus","Brigo F, Bragazzi N, Nardone R, Trinka E.","Epilepsy Behav. 2016 Nov;64(Pt A):110-115. doi: 10.1016/j.yebeh.2016.09.030. Epub 2016 Oct 11.","Brigo F","Epilepsy Behav","2016","2016/10/14","","","10.1016/j.yebeh.2016.09.030"
"27733070","Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of multiple sclerosis","Fox RJ, Chan A, Zhang A, Xiao J, Levison D, Lewin JB, Edwards MR, Marantz JL.","Curr Med Res Opin. 2017 Feb;33(2):175-183. doi: 10.1080/03007995.2016.1248380. Epub 2016 Nov 10.","Fox RJ","Curr Med Res Opin","2017","2016/10/14","","","10.1080/03007995.2016.1248380"
"27716074","Methods for network meta-analysis of continuous outcomes using individual patient data: a case study in acupuncture for chronic pain","Saramago P, Woods B, Weatherly H, Manca A, Sculpher M, Khan K, Vickers AJ, MacPherson H.","BMC Med Res Methodol. 2016 Oct 6;16(1):131. doi: 10.1186/s12874-016-0224-1.","Saramago P","BMC Med Res Methodol","2016","2016/10/08","PMC5053345","","10.1186/s12874-016-0224-1"
"27710868","Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs","Brigo F, Bragazzi NL, Nardone R, Trinka E.","Seizure. 2016 Nov;42:29-37. doi: 10.1016/j.seizure.2016.08.007. Epub 2016 Sep 24.","Brigo F","Seizure","2016","2016/10/07","","","10.1016/j.seizure.2016.08.007"
"27676174","Post-gemcitabine therapy for patients with advanced pancreatic cancer - A comparative review of randomized trials evaluating oxaliplatin- and/or irinotecan-containing regimens","Vogel A, Ciardiello F, Hubner RA, Blanc JF, Carrato A, Yang Y, Patel DA, Ektare V, de Jong FA, Gill S.","Cancer Treat Rev. 2016 Nov;50:142-147. doi: 10.1016/j.ctrv.2016.09.001. Epub 2016 Sep 9.","Vogel A","Cancer Treat Rev","2016","2016/09/28","","","10.1016/j.ctrv.2016.09.001"
"27646863","Interchangeability between first-line generic antiretroviral products prequalified by WHO using adjusted indirect comparisons","Gwaza L, Gordon J, Welink J, Potthast H, Leufkens H, Stahl M, García-Arieta A.","Antivir Ther. 2017;22(2):135-144. doi: 10.3851/IMP3089. Epub 2016 Sep 20.","Gwaza L","Antivir Ther","2017","2016/09/21","","","10.3851/IMP3089"
"27620206","Evaluating Matching-Adjusted Indirect Comparisons in Practice: A Case Study of Patients with Attention-Deficit/Hyperactivity Disorder","Shafrin J, Shrestha A, Chandra A, Erder MH, Sikirica V.","Health Econ. 2017 Nov;26(11):1459-1466. doi: 10.1002/hec.3408. Epub 2016 Sep 13.","Shafrin J","Health Econ","2017","2016/09/14","","","10.1002/hec.3408"
"27565278","Cost-Effectiveness of Eltrombopag versus Romiplostim for the Treatment of Chronic Immune Thrombocytopenia in England and Wales","Allen R, Bryden P, Grotzinger KM, Stapelkamp C, Woods B.","Value Health. 2016 Jul-Aug;19(5):614-22. doi: 10.1016/j.jval.2016.03.1856. Epub 2016 May 11.","Allen R","Value Health","2016","2016/08/28","","","10.1016/j.jval.2016.03.1856"
"27562480","Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus (90)Y-radioembolization for hepatocellular carcinoma","Ludwig JM, Zhang D, Xing M, Kim HS.","Eur Radiol. 2017 May;27(5):2031-2041. doi: 10.1007/s00330-016-4548-3. Epub 2016 Aug 25.","Ludwig JM","Eur Radiol","2017","2016/08/27","","","10.1007/s00330-016-4548-3"
"27550239","Panobinostat Plus Bortezomib Versus Lenalidomide in Patients with Relapsed and/or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Treatment Comparison of Survival Outcomes using Patient-level Data","Majer I, van de Wetering G, Polanyi Z, Krishna A, Gray E, Roy A.","Appl Health Econ Health Policy. 2017 Feb;15(1):45-55. doi: 10.1007/s40258-016-0271-0.","Majer I","Appl Health Econ Health Policy","2017","2016/08/24","","","10.1007/s40258-016-0271-0"
"27529762","GetReal in mathematical modelling: a review of studies predicting drug effectiveness in the real world","Panayidou K, Gsteiger S, Egger M, Kilcher G, Carreras M, Efthimiou O, Debray TP, Trelle S, Hummel N; GetReal methods review group.","Res Synth Methods. 2016 Sep;7(3):264-77. doi: 10.1002/jrsm.1202. Epub 2016 Aug 16.","Panayidou K","Res Synth Methods","2016","2016/08/17","PMC5129568","","10.1002/jrsm.1202"
"27487843","An overview of methods for network meta-analysis using individual participant data: when do benefits arise?","Debray TP, Schuit E, Efthimiou O, Reitsma JB, Ioannidis JP, Salanti G, Moons KG; GetReal Workpackage.","Stat Methods Med Res. 2018 May;27(5):1351-1364. doi: 10.1177/0962280216660741. Epub 2016 Aug 11.","Debray TP","Stat Methods Med Res","2018","2016/08/05","","","10.1177/0962280216660741"
"27583319","Wounds research for patient benefit: a 5-year programme of research","Cullum N, Buckley H, Dumville J, Hall J, Lamb K, Madden M, Morley R, O’Meara S, Goncalves PS, Soares M, Stubbs N.","Southampton (UK): NIHR Journals Library; 2016 Aug.","Cullum N","Wounds research for patient benefit: a 5-year programme of research","2016","2016/08/01","","","10.3310/pgfar04130"
"27445511","Matching-adjusted indirect comparisons of efficacy of BAY 81-8973 vs two recombinant factor VIII for the prophylactic treatment of severe hemophilia A","Pocoski J, Li N, Ayyagari R, Church N, Maas Enriquez M, Xiang Q, Kelkar S, Du EX, Wu EQ, Xie J.","J Blood Med. 2016 Jul 4;7:129-37. doi: 10.2147/JBM.S104074. eCollection 2016.","Pocoski J","J Blood Med","2016","2016/07/23","PMC4938137","","10.2147/JBM.S104074"
"27384635","[Network meta-analysis: mixed and indirect treatment comparisons. a new method to the service of clinical epidemiology and public health]","García-Perdomo HA, Tobías A.","Rev Peru Med Exp Salud Publica. 2016 Mar;33(1):149-53.","García-Perdomo HA","Rev Peru Med Exp Salud Publica","2016","2016/07/08","","",""
"27366049","Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials","Dugel PU, Hillenkamp J, Sivaprasad S, Vögeler J, Mousseau MC, Wenzel A, Margaron P, Hashmonay R, Massin P.","Clin Ophthalmol. 2016 Jun 14;10:1103-10. doi: 10.2147/OPTH.S100764. eCollection 2016.","Dugel PU","Clin Ophthalmol","2016","2016/07/02","PMC4913960","","10.2147/OPTH.S100764"
"27325329","Cost-Effectiveness Model for Chemoimmunotherapy Options in Patients with Previously Untreated Chronic Lymphocytic Leukemia Unsuitable for Full-Dose Fludarabine-Based Therapy","Becker U, Briggs AH, Moreno SG, Ray JA, Ngo P, Samanta K.","Value Health. 2016 Jun;19(4):374-82. doi: 10.1016/j.jval.2015.12.018. Epub 2016 Mar 4.","Becker U","Value Health","2016","2016/06/22","","","10.1016/j.jval.2015.12.018"
"27289476","The Clinical and Cost Effectiveness of Vortioxetine for the Treatment of a Major Depressive Episode in Patients With Failed Prior Antidepressant Therapy: A Critique of the Evidence","Lomas J, Llewellyn A, Soares M, Simmonds M, Wright K, Eastwood A, Palmer S.","Pharmacoeconomics. 2016 Sep;34(9):901-12. doi: 10.1007/s40273-016-0417-9.","Lomas J","Pharmacoeconomics","2016","2016/06/13","","","10.1007/s40273-016-0417-9"
"27288979","Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK-Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls","Tan DS, Araújo A, Zhang J, Signorovitch J, Zhou ZY, Cai X, Liu G.","J Thorac Oncol. 2016 Sep;11(9):1550-7. doi: 10.1016/j.jtho.2016.05.029. Epub 2016 Jun 8.","Tan DS","J Thorac Oncol","2016","2016/06/12","","","10.1016/j.jtho.2016.05.029"
"27278217","Daclatasvir for the Treatment of Chronic Hepatitis C: A Critique of the Clinical and Economic Evidence","Llewellyn A, Faria R, Woods B, Simmonds M, Lomas J, Woolacott N, Griffin S.","Pharmacoeconomics. 2016 Oct;34(10):981-92. doi: 10.1007/s40273-016-0418-8.","Llewellyn A","Pharmacoeconomics","2016","2016/06/10","","","10.1007/s40273-016-0418-8"
"27189910","Biologic Therapies and Risk of Infection and Malignancy in Patients With Inflammatory Bowel Disease: A Systematic Review and Network Meta-analysis","Bonovas S, Fiorino G, Allocca M, Lytras T, Nikolopoulos GK, Peyrin-Biroulet L, Danese S.","Clin Gastroenterol Hepatol. 2016 Oct;14(10):1385-1397.e10. doi: 10.1016/j.cgh.2016.04.039. Epub 2016 May 14.","Bonovas S","Clin Gastroenterol Hepatol","2016","2016/05/19","","","10.1016/j.cgh.2016.04.039"
"27155214","Comparison between SGLT2 inhibitors and DPP4 inhibitors added to insulin therapy in type 2 diabetes: a systematic review with indirect comparison meta-analysis","Min SH, Yoon JH, Hahn S, Cho YM.","Diabetes Metab Res Rev. 2017 Jan;33(1). doi: 10.1002/dmrr.2818. Epub 2016 Jun 8.","Min SH","Diabetes Metab Res Rev","2017","2016/05/08","","","10.1002/dmrr.2818"
"27142793","Network Meta-analysis to Synthesize Evidence for Decision Making in Cardiovascular Research","Roever L, Biondi-Zoccai G.","Arq Bras Cardiol. 2016 Apr;106(4):333-7. doi: 10.5935/abc.20160052.","Roever L","Arq Bras Cardiol","2016","2016/05/05","PMC4845707","","10.5935/abc.20160052"
"27135404","The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation","Shepherd J, Cooper K, Harris P, Picot J, Rose M.","Health Technol Assess. 2016 Apr;20(34):1-222. doi: 10.3310/hta20340.","Shepherd J","Health Technol Assess","2016","2016/05/03","PMC4867422","","10.3310/hta20340"
"27116943","A scoping review of indirect comparison methods and applications using individual patient data","Veroniki AA, Straus SE, Soobiah C, Elliott MJ, Tricco AC.","BMC Med Res Methodol. 2016 Apr 27;16:47. doi: 10.1186/s12874-016-0146-y.","Veroniki AA","BMC Med Res Methodol","2016","2016/04/28","PMC4847203","","10.1186/s12874-016-0146-y"
"27091732","Efficacy and Safety Profile of Anti-tumor Necrosis Factor-α Versus Anti-integrin Agents for the Treatment of Crohn's Disease: A Network Meta-analysis of Indirect Comparisons","Miligkos M, Papamichael K, Vande Casteele N, Mantzaris GJ, Gils A, Levesque BG, Zintzaras E.","Clin Ther. 2016 Jun;38(6):1342-1358.e6. doi: 10.1016/j.clinthera.2016.03.018. Epub 2016 Apr 16.","Miligkos M","Clin Ther","2016","2016/04/20","","","10.1016/j.clinthera.2016.03.018"
"27082558","Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma: A PRISMA-compliant Systematic Review and Network Meta-analysis","Lan T, Chang L, Mn R, Wu L, Yuan YF.","Medicine (Baltimore). 2016 Apr;95(15):e3185. doi: 10.1097/MD.0000000000003185.","Lan T","Medicine (Baltimore)","2016","2016/04/16","PMC4839802","","10.1097/MD.0000000000003185"
"27079278","The relative clinical efficacy of trametinib-dabrafenib and cobimetinib-vemurafenib in advanced melanoma: an indirect comparison","Galván-Banqueri M, Ubago-Pérez R, Molina-López T.","J Clin Pharm Ther. 2016 Jun;41(3):285-9. doi: 10.1111/jcpt.12390. Epub 2016 Apr 15.","Galván-Banqueri M","J Clin Pharm Ther","2016","2016/04/16","","","10.1111/jcpt.12390"
"26979173","Indirect Treatment Comparison of Talimogene Laherparepvec Compared with Ipilimumab and Vemurafenib for the Treatment of Patients with Metastatic Melanoma","Quinn C, Ma Q, Kudlac A, Palmer S, Barber B, Zhao Z.","Adv Ther. 2016 Apr;33(4):643-57. doi: 10.1007/s12325-016-0313-x. Epub 2016 Mar 15.","Quinn C","Adv Ther","2016","2016/03/17","PMC4846697","","10.1007/s12325-016-0313-x"
"26971303","Network Meta-Analysis Comparing Overall Survival for Fulvestrant 500 mg Versus Alternative Therapies for Treatment of Postmenopausal, Estrogen Receptor-Positive Advanced Breast Cancer Following Failure on Prior Endocrine Therapy","Telford C, Jones N, Livings C, Batson S.","Clin Breast Cancer. 2016 Jun;16(3):188-95. doi: 10.1016/j.clbc.2016.02.007. Epub 2016 Feb 11.","Telford C","Clin Breast Cancer","2016","2016/03/14","","","10.1016/j.clbc.2016.02.007"
"26967930","Review and comparison of methodologies for indirect comparison of clinical trial results: an illustration with ranibizumab and aflibercept","Regnier SA, Alsop J, Wright J, Nixon R, Staines H, Fajnkuchen F.","Expert Rev Pharmacoecon Outcomes Res. 2016 Dec;16(6):793-801. doi: 10.1586/14737167.2016.1165609. Epub 2016 Mar 25.","Regnier SA","Expert Rev Pharmacoecon Outcomes Res","2016","2016/03/12","","","10.1586/14737167.2016.1165609"
"26949899","Meta-analysis and adjusted indirect comparison of direct oral anticoagulants in prevention of acute limb ischemia in patients with atrial fibrillation","De Haro J, Bleda S, Varela C, Cañibano C, Acin F.","Curr Med Res Opin. 2016 Jun;32(6):1167-73. doi: 10.1185/03007995.2016.1163256. Epub 2016 Apr 7.","De Haro J","Curr Med Res Opin","2016","2016/03/08","","","10.1185/03007995.2016.1163256"
"26933827","Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation","Riemsma R, Corro Ramos I, Birnie R, Büyükkaramikli N, Armstrong N, Ryder S, Duffy S, Worthy G, Al M, Severens J, Kleijnen J.","Health Technol Assess. 2016 Feb;20(17):v-xxxi, 1-251. doi: 10.3310/hta20170.","Riemsma R","Health Technol Assess","2016","2016/03/03","PMC4809467","","10.3310/hta20170"
"26908514","Comparative assessment of onabotulinumtoxinA and mirabegron for overactive bladder: an indirect treatment comparison","Freemantle N, Ginsberg DA, McCool R, Fleetwood K, Arber M, Khalaf K, Loveman C, Ni Q, Glanville J.","BMJ Open. 2016 Feb 23;6(2):e009122. doi: 10.1136/bmjopen-2015-009122.","Freemantle N","BMJ Open","2016","2016/02/25","PMC4769403","","10.1136/bmjopen-2015-009122"
"26907083","Indirect treatment comparison of belatacept versus tacrolimus from a systematic review of immunosuppressive therapies for kidney transplant patients","Muduma G, Hart WM, Patel S, Odeyemi AO.","Curr Med Res Opin. 2016 Jun;32(6):1065-72. doi: 10.1185/03007995.2016.1157463. Epub 2016 Mar 30.","Muduma G","Curr Med Res Opin","2016","2016/02/25","","","10.1185/03007995.2016.1157463"
"26886011","First-line therapy for treatment-naive patients with advanced/metastatic renal cell carcinoma: a systematic review of published randomized controlled trials","Takyar S, Diaz J, Sehgal M, Sapunar F, Pandha H.","Anticancer Drugs. 2016 Jun;27(5):383-97. doi: 10.1097/CAD.0000000000000335.","Takyar S","Anticancer Drugs","2016","2016/02/18","","","10.1097/CAD.0000000000000335"
"26883661","Efficacy and Safety of Aclidinium/Formoterol versus Tiotropium in COPD: Results of an Indirect Treatment Comparison","Medic G, Lindner L, van der Weijden M, Karabis A.","Adv Ther. 2016 Mar;33(3):379-99. doi: 10.1007/s12325-016-0299-4. Epub 2016 Feb 16.","Medic G","Adv Ther","2016","2016/02/18","PMC4833795","","10.1007/s12325-016-0299-4"
"26841367","Testing moderation in network meta-analysis with individual participant data","Dagne GA, Brown CH, Howe G, Kellam SG, Liu L.","Stat Med. 2016 Jul 10;35(15):2485-502. doi: 10.1002/sim.6883. Epub 2016 Feb 2.","Dagne GA","Stat Med","2016","2016/02/04","PMC4893003","NIHMS750384","10.1002/sim.6883"
"26839044","Daclatasvir and Sofosbuvir Versus Sofosbuvir and Ribavirin in Patients with Chronic Hepatitis C Coinfected with HIV: A Matching-adjusted Indirect Comparison","Swallow E, Song J, Yuan Y, Kalsekar A, Kelley C, Peeples M, Mu F, Ackerman P, Signorovitch J.","Clin Ther. 2016 Feb;38(2):404-12. doi: 10.1016/j.clinthera.2015.12.017. Epub 2016 Feb 3.","Swallow E","Clin Ther","2016","2016/02/04","","","10.1016/j.clinthera.2015.12.017"
"26836914","Drug Treatment of Idiopathic Pulmonary Fibrosis: Systematic Review and Network Meta-Analysis","Canestaro WJ, Forrester SH, Raghu G, Ho L, Devine BE.","Chest. 2016 Mar;149(3):756-66. doi: 10.1016/j.chest.2015.11.013. Epub 2016 Jan 13.","Canestaro WJ","Chest","2016","2016/02/03","","","10.1016/j.chest.2015.11.013"
"26824145","Parameterization of a disease progression simulation model for sequentially treated metastatic human epidermal growth factor receptor 2 positive breast cancer patients","Diaby V, Ali AA, Adunlin G, Kohn CG, Montero AJ.","Curr Med Res Opin. 2016 Jun;32(6):991-6. doi: 10.1185/03007995.2016.1149056. Epub 2016 Mar 2.","Diaby V","Curr Med Res Opin","2016","2016/01/30","PMC4959115","NIHMS804456","10.1185/03007995.2016.1149056"
"26804561","Efficacy of two noninvasive weaning strategies in intubated patients with chronic obstructive pulmonary disease: A meta-analysis and indirect treatment comparison","Li PJ, Wang T, Xiao J, Jiang FM, Luo J, Shi CL, Liu GJ, Liang ZA.","Heart Lung. 2016 Mar-Apr;45(2):132-9. doi: 10.1016/j.hrtlng.2015.12.008. Epub 2016 Jan 21.","Li PJ","Heart Lung","2016","2016/01/26","","","10.1016/j.hrtlng.2015.12.008"
"26793987","Daclatasvir + asunaprevir versus sofosbuvir/ledipasvir for hepatitis C genotype 1 in Japanese patients: an indirect comparison","Swallow E, Kelley C, Signorovitch J, Wygant G, McPhee F.","J Comp Eff Res. 2016 May;5(3):273-9. doi: 10.2217/cer.15.69. Epub 2016 Jan 21.","Swallow E","J Comp Eff Res","2016","2016/01/23","","","10.2217/cer.15.69"
"26780905","Lipophilic Statin Versus Rosuvastatin (Hydrophilic) Treatment for Heart Failure: a Meta-Analysis and Adjusted Indirect Comparison of Randomised Trials","Bonsu KO, Reidpath DD, Kadirvelu A.","Cardiovasc Drugs Ther. 2016 Apr;30(2):177-88. doi: 10.1007/s10557-015-6636-z.","Bonsu KO","Cardiovasc Drugs Ther","2016","2016/01/20","","","10.1007/s10557-015-6636-z"
"26769792","Comparative safety and effectiveness of cognitive enhancers for Alzheimer's dementia: protocol for a systematic review and individual patient data network meta-analysis","Veroniki AA, Straus SE, Ashoor HM, Hamid JS, Hemmelgarn BR, Holroyd-Leduc J, Majumdar SR, McAuley G, Tricco AC.","BMJ Open. 2016 Jan 13;6(1):e010251. doi: 10.1136/bmjopen-2015-010251.","Veroniki AA","BMJ Open","2016","2016/01/16","PMC4735316","","10.1136/bmjopen-2015-010251"
"26754852","GetReal in network meta-analysis: a review of the methodology","Efthimiou O, Debray TP, van Valkenhoef G, Trelle S, Panayidou K, Moons KG, Reitsma JB, Shang A, Salanti G; GetReal Methods Review Group.","Res Synth Methods. 2016 Sep;7(3):236-63. doi: 10.1002/jrsm.1195. Epub 2016 Jan 11.","Efthimiou O","Res Synth Methods","2016","2016/01/13","","","10.1002/jrsm.1195"
"26733020","Meta-analysis supporting noninferiority of oxaliplatin plus S-1 to cisplatin plus S-1 in first-line treatment of advanced gastric cancer (G-SOX study): indirect comparison with S-1 alone","Hamada C, Yamada Y, Azuma M, Nishikawa K, Gotoh M, Bando H, Sugimoto N, Nishina T, Amagai K, Chin K, Niwa Y, Tsuji A, Imamura H, Tsuda M, Yasui H, Fujii H, Yamaguchi K, Yasui H, Hironaka S, Shimada K, Miwa H, Hyodo I.","Int J Clin Oncol. 2016 Aug;21(4):668-675. doi: 10.1007/s10147-015-0938-9. Epub 2016 Jan 5.","Hamada C","Int J Clin Oncol","2016","2016/01/07","","","10.1007/s10147-015-0938-9"
"26729046","Once-daily liraglutide (1.2 mg) compared with twice-daily exenatide (10 μg) in the treatment of type 2 diabetes patients: An indirect treatment comparison meta-analysis","Twigg SM, Daja MM, O'leary BA, Adena MA.","J Diabetes. 2016 Nov;8(6):866-876. doi: 10.1111/1753-0407.12372. Epub 2016 Apr 4.","Twigg SM","J Diabetes","2016","2016/01/06","","","10.1111/1753-0407.12372"
"26719325","Safety and effectiveness of long-acting versus intermediate-acting insulin for patients with type 1 diabetes: protocol for a systematic review and individual patient data network meta-analysis","Veroniki AA, Straus SE, Ashoor HM, Hamid JS, Yu C, Tricco AC.","BMJ Open. 2015 Dec 30;5(12):e010160. doi: 10.1136/bmjopen-2015-010160.","Veroniki AA","BMJ Open","2015","2016/01/01","PMC4710824","","10.1136/bmjopen-2015-010160"
"26671239","First-line therapy for non-transplant eligible patients with multiple myeloma: direct and adjusted indirect comparison of treatment regimens on the existing market in Germany","Kuhr K, Wirth D, Srivastava K, Lehmacher W, Hellmich M.","Eur J Clin Pharmacol. 2016 Mar;72(3):257-65. doi: 10.1007/s00228-015-1998-5. Epub 2015 Dec 16.","Kuhr K","Eur J Clin Pharmacol","2016","2015/12/17","","","10.1007/s00228-015-1998-5"
"26637048","Efficacy and tolerability of switching therapy to vortioxetine versus other antidepressants in patients with major depressive disorder","Brignone M, Diamand F, Painchault C, Takyar S.","Curr Med Res Opin. 2016;32(2):351-66. doi: 10.1185/03007995.2015.1128404.","Brignone M","Curr Med Res Opin","2016","2015/12/05","","","10.1185/03007995.2015.1128404"
"26602976","An Indirect Comparison of Everolimus Versus Axitinib in US Patients With Advanced Renal Cell Carcinoma in Whom Prior Sunitinib Therapy Failed","Sherman S, Amzal B, Calvo E, Wang X, Park J, Liu Z, Lin C, Casciano R.","Clin Ther. 2015 Oct 22:S0149-2918(15)01144-3. doi: 10.1016/j.clinthera.2015.09.013. Online ahead of print.","Sherman S","Clin Ther","2015","2015/11/26","","","10.1016/j.clinthera.2015.09.013"
"26586608","A small n sequential multiple assignment randomized trial design for use in rare disease research","Tamura RN, Krischer JP, Pagnoux C, Micheletti R, Grayson PC, Chen YF, Merkel PA.","Contemp Clin Trials. 2016 Jan;46:48-51. doi: 10.1016/j.cct.2015.11.010. Epub 2015 Nov 14.","Tamura RN","Contemp Clin Trials","2016","2015/11/21","PMC4695231","NIHMS740778","10.1016/j.cct.2015.11.010"
"26495961","Trial-based cost-effectiveness of abatacept for rheumatoid arthritis patients in Italy","Gaultney J, Benucci M, Iannazzo S, Nappi C, Sion K, Sabater FJ.","Expert Rev Pharmacoecon Outcomes Res. 2016 Jun;16(3):409-17. doi: 10.1586/14737167.2016.1102636. Epub 2015 Oct 23.","Gaultney J","Expert Rev Pharmacoecon Outcomes Res","2016","2015/10/27","","","10.1586/14737167.2016.1102636"
"26477648","Cost-effectiveness of Apixaban Compared With Edoxaban for Stroke Prevention in Nonvalvular Atrial Fibrillation","Lip GY, Lanitis T, Kongnakorn T, Phatak H, Chalkiadaki C, Liu X, Kuznik A, Lawrence J, Dorian P.","Clin Ther. 2015 Nov 1;37(11):2476-2488.e27. doi: 10.1016/j.clinthera.2015.09.005. Epub 2015 Oct 23.","Lip GY","Clin Ther","2015","2015/10/20","","","10.1016/j.clinthera.2015.09.005"
"26455472","Indirect comparison of the antiviral efficacy of peginterferon alpha 2a plus ribavirin used with or without simeprevir in genotype 4 hepatitis C virus infection, where common comparator study arms are lacking: a special application of the matching adjusted indirect comparison methodology","Van Sanden S, Pisini M, Duchesne I, Mehnert A, Belsey J.","Curr Med Res Opin. 2016;32(1):147-54. doi: 10.1185/03007995.2015.1106934. Epub 2015 Oct 29.","Van Sanden S","Curr Med Res Opin","2016","2015/10/13","","","10.1185/03007995.2015.1106934"
"29144701","Vortioxetine (Addendum to Commission A15-16)","Institute for Quality and Efficiency in Health Care.","Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Sep 24. Extract of Dossier Assessment No. A15-37.","Institute for Quality and Efficiency in Health Care","Vortioxetine (Addendum to Commission A15-16)","2015","2015/09/24","","",""
"26390233","Daclatasvir + sofosbuvir versus standard of care for hepatitis C genotype 3: a matching-adjusted indirect comparison","Swallow E, Song J, Yuan Y, Kalsekar A, Kelley C, Mu F, Kim S, Noviello S, Signorovitch J.","J Comp Eff Res. 2016 Mar;5(2):129-39. doi: 10.2217/cer.15.49. Epub 2015 Sep 21.","Swallow E","J Comp Eff Res","2016","2015/09/22","","","10.2217/cer.15.49"
"26382309","Comparative efficacy and safety of estradiol transdermal preparations for the treatment of vasomotor symptoms in postmenopausal women: an indirect comparison meta-analysis","Derzko C, Sergerie M, Siliman G, Alberton M, Thorlund K.","Menopause. 2016 Mar;23(3):294-303. doi: 10.1097/GME.0000000000000552.","Derzko C","Menopause","2016","2015/09/19","","","10.1097/GME.0000000000000552"
"26363775","New methods for treatment effect calibration, with applications to non-inferiority trials","Zhang Z, Nie L, Soon G, Hu Z.","Biometrics. 2016 Mar;72(1):20-9. doi: 10.1111/biom.12388. Epub 2015 Sep 13.","Zhang Z","Biometrics","2016","2015/09/14","","","10.1111/biom.12388"
"26355679","Efficacy of Supplementation with B Vitamins for Stroke Prevention: A Network Meta-Analysis of Randomized Controlled Trials","Dong H, Pi F, Ding Z, Chen W, Pang S, Dong W, Zhang Q.","PLoS One. 2015 Sep 10;10(9):e0137533. doi: 10.1371/journal.pone.0137533. eCollection 2015.","Dong H","PLoS One","2015","2015/09/11","PMC4565665","","10.1371/journal.pone.0137533"
"26352650","Comparative efficacy of antiviral therapy in preventing vertical transmission of hepatitis B: a network meta-analysis","Njei B, Gupta N, Ewelukwa O, Ditah I, Foma M, Lim JK.","Liver Int. 2016 May;36(5):634-41. doi: 10.1111/liv.12959. Epub 2015 Oct 1.","Njei B","Liver Int","2016","2015/09/10","PMC4824664","NIHMS773241","10.1111/liv.12959"
"26346974","Meta-analysis of postoperative adjuvant chemotherapy without radiotherapy in early stage non-small cell lung cancer","Chen YY, Wang LW, Wang SY, Wu BB, Wang ZM, Chen FF, Xiong B.","Onco Targets Ther. 2015 Aug 4;8:2033-43. doi: 10.2147/OTT.S88700. eCollection 2015.","Chen YY","Onco Targets Ther","2015","2015/09/09","PMC4531011","","10.2147/OTT.S88700"
"26331530","Adjuvant antiviral therapy for hepatitis B virus-related hepatocellular carcinoma after curative treatment: A systematic review and meta-analysis","Liu GM, Huang XY, Shen SL, Hu WJ, Peng BG.","Hepatol Res. 2016 Jan;46(1):100-10. doi: 10.1111/hepr.12584. Epub 2015 Oct 6.","Liu GM","Hepatol Res","2016","2015/09/03","","","10.1111/hepr.12584"
"26320127","Randomized controlled trials in relapsed/refractory follicular lymphoma: a systematic review and meta-analysis","Police RL, Trask PC, Wang J, Olivares R, Khan S, Abbe A, Colosia A, Njue A, Sherril B, Ruiz-Soto R, Kaye JA, Hamadani M.","J Oncol Pharm Pract. 2016 Oct;22(5):666-78. doi: 10.1177/1078155215603230. Epub 2015 Aug 28.","Police RL","J Oncol Pharm Pract","2016","2015/08/31","","","10.1177/1078155215603230"
"26297097","When Does FDAMA Section 114 Apply? Ten Case Studies","Neumann PJ, Saret CJ.","Value Health. 2015 Jul;18(5):682-9. doi: 10.1016/j.jval.2015.02.013. Epub 2015 Apr 16.","Neumann PJ","Value Health","2015","2015/08/23","","","10.1016/j.jval.2015.02.013"
"26293745","A Common Reference-Based Indirect Comparison Meta-Analysis of Buccal versus Intranasal Midazolam for Early Status Epilepticus","Brigo F, Nardone R, Tezzon F, Trinka E.","CNS Drugs. 2015 Sep;29(9):741-57. doi: 10.1007/s40263-015-0271-x.","Brigo F","CNS Drugs","2015","2015/08/22","","","10.1007/s40263-015-0271-x"
"26287812","Get real in individual participant data (IPD) meta-analysis: a review of the methodology","Debray TP, Moons KG, van Valkenhoef G, Efthimiou O, Hummel N, Groenwold RH, Reitsma JB; GetReal Methods Review Group.","Res Synth Methods. 2015 Dec;6(4):293-309. doi: 10.1002/jrsm.1160. Epub 2015 Aug 19.","Debray TP","Res Synth Methods","2015","2015/08/20","PMC5042043","","10.1002/jrsm.1160"
"26280110","Effects of Statin Treatment on Inflammation and Cardiac Function in Heart Failure: An Adjusted Indirect Comparison Meta-Analysis of Randomized Trials","Bonsu KO, Reidpath DD, Kadirvelu A.","Cardiovasc Ther. 2015 Dec;33(6):338-46. doi: 10.1111/1755-5922.12150.","Bonsu KO","Cardiovasc Ther","2015","2015/08/18","","","10.1111/1755-5922.12150"
"26189925","Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysis","Singh S, Khera R, Allen AM, Murad MH, Loomba R.","Hepatology. 2015 Nov;62(5):1417-32. doi: 10.1002/hep.27999. Epub 2015 Oct 1.","Singh S","Hepatology","2015","2015/07/21","","","10.1002/hep.27999"
"26159375","Comparative efficacy and safety of daclatasvir/asunaprevir versus IFN-based regimens in genotype 1b hepatitis C virus infection","Signorovitch JE, Betts KA, Song Y, Sorg RA, Li J, Behl AS, Kalsekar A.","J Comp Eff Res. 2015 Nov;4(6):593-605. doi: 10.2217/cer.15.33. Epub 2015 Jul 10.","Signorovitch JE","J Comp Eff Res","2015","2015/07/11","","","10.2217/cer.15.33"
"26124700","Cost-utility analysis of certolizumab pegol versus alternative tumour necrosis factor inhibitors available for the treatment of moderate-to-severe active rheumatoid arthritis in Spain","Hidalgo-Vega Á, Villoro R, Blasco JA, Talavera P, Ferro B, Purcaru O.","Cost Eff Resour Alloc. 2015 Jun 9;13:11. doi: 10.1186/s12962-015-0037-9. eCollection 2015.","Hidalgo-Vega Á","Cost Eff Resour Alloc","2015","2015/07/01","PMC4484891","","10.1186/s12962-015-0037-9"
"29144655","Dulaglutide (Addendum to Commission A15-07)","Institute for Quality and Efficiency in Health Care.","Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Jun 25. Extract of Dossier Assessment No. A15-22.","Institute for Quality and Efficiency in Health Care","Dulaglutide (Addendum to Commission A15-07)","2015","2015/06/25","","",""
"28609085","Dasabuvir and Ombitasvir / Paritaprevir / Ritonavir (Addendum to Commissions A15-03 and A15-04)","Institute for Quality and Efficiency in Health Care.","Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2015 Jun 25. Extract of Dossier Assessment No. A15-21.","Institute for Quality and Efficiency in Health Care","Dasabuvir and Ombitasvir / Paritaprevir / Ritonavir (Addendum to Commissions A15-03 and A15-04)","2015","2015/06/25","","",""
"26105964","Influence of point estimates and study power of bioequivalence studies on establishing bioequivalence between generics by adjusted indirect comparisons","Gwaza L, Gordon J, Potthast H, Welink J, Leufkens H, Stahl M, García-Arieta A.","Eur J Clin Pharmacol. 2015 Sep;71(9):1083-9. doi: 10.1007/s00228-015-1889-9. Epub 2015 Jun 24.","Gwaza L","Eur J Clin Pharmacol","2015","2015/06/25","","","10.1007/s00228-015-1889-9"
"26099484","Multivariate meta-analysis using individual participant data","Riley RD, Price MJ, Jackson D, Wardle M, Gueyffier F, Wang J, Staessen JA, White IR.","Res Synth Methods. 2015 Jun;6(2):157-74. doi: 10.1002/jrsm.1129. Epub 2014 Nov 21.","Riley RD","Res Synth Methods","2015","2015/06/24","PMC4847645","EMS67641","10.1002/jrsm.1129"
"26091937","Comparative Effectiveness of Pharmacological Interventions for Severe Alcoholic Hepatitis: A Systematic Review and Network Meta-analysis","Singh S, Murad MH, Chandar AK, Bongiorno CM, Singal AK, Atkinson SR, Thursz MR, Loomba R, Shah VH.","Gastroenterology. 2015 Oct;149(4):958-70.e12. doi: 10.1053/j.gastro.2015.06.006. Epub 2015 Jun 16.","Singh S","Gastroenterology","2015","2015/06/21","","","10.1053/j.gastro.2015.06.006"
"26062932","Investigation into the interchangeability of generic formulations using immunosuppressants and a broad selection of medicines","Yu Y, Teerenstra S, Neef C, Burger D, Maliepaard M.","Eur J Clin Pharmacol. 2015 Aug;71(8):979-90. doi: 10.1007/s00228-015-1878-z. Epub 2015 Jun 12.","Yu Y","Eur J Clin Pharmacol","2015","2015/06/12","PMC4500859","","10.1007/s00228-015-1878-z"
"25985265","Cost-effectiveness of lurasidone vs quetiapine extended-release (XR) in patients with bipolar depression","Rajagopalan K, Meyer K, O'Day K, Denno M, Loebel A.","J Med Econ. 2015;18(10):821-7. doi: 10.3111/13696998.2015.1052462. Epub 2015 Jul 27.","Rajagopalan K","J Med Econ","2015","2015/05/19","","","10.3111/13696998.2015.1052462"
"25961824","Comparison of glucose lowering effect of metformin and acarbose in type 2 diabetes mellitus: a meta-analysis","Gu S, Shi J, Tang Z, Sawhney M, Hu H, Shi L, Fonseca V, Dong H.","PLoS One. 2015 May 11;10(5):e0126704. doi: 10.1371/journal.pone.0126704. eCollection 2015.","Gu S","PLoS One","2015","2015/05/12","PMC4427275","","10.1371/journal.pone.0126704"
"25926144","Methods and characteristics of published network meta-analyses using individual patient data: protocol for a scoping review","Veroniki AA, Soobiah C, Tricco AC, Elliott MJ, Straus SE.","BMJ Open. 2015 Apr 29;5(4):e007103. doi: 10.1136/bmjopen-2014-007103.","Veroniki AA","BMJ Open","2015","2015/05/01","PMC4420933","","10.1136/bmjopen-2014-007103"
"25924975","Incorporation of individual-patient data in network meta-analysis for multiple continuous endpoints, with application to diabetes treatment","Hong H, Fu H, Price KL, Carlin BP.","Stat Med. 2015 Sep 10;34(20):2794-819. doi: 10.1002/sim.6519. Epub 2015 Apr 30.","Hong H","Stat Med","2015","2015/05/01","","","10.1002/sim.6519"
"25906420","Dabrafenib for Treating Unresectable, Advanced or Metastatic BRAF V600 Mutation-Positive Melanoma: An Evidence Review Group Perspective","Fleeman N, Bagust A, Beale S, Boland A, Dickson R, Dwan K, Richardson M, Dundar Y, Davis H, Banks L.","Pharmacoeconomics. 2015 Sep;33(9):893-904. doi: 10.1007/s40273-015-0276-9.","Fleeman N","Pharmacoeconomics","2015","2015/04/24","","","10.1007/s40273-015-0276-9"
"25887646","Network meta-analysis combining individual patient and aggregate data from a mixture of study designs with an application to pulmonary arterial hypertension","Thom HH, Capkun G, Cerulli A, Nixon RM, Howard LS.","BMC Med Res Methodol. 2015 Apr 12;15:34. doi: 10.1186/s12874-015-0007-0.","Thom HH","BMC Med Res Methodol","2015","2015/04/19","PMC4403724","","10.1186/s12874-015-0007-0"
"25817087","Indirect comparison for Anti-TNF drugs in moderate to severe ulcerative colitis","Galván-Banqueri M, Vega-Coca MD, Castillo-Muñoz MA, Beltrán Calvo C, Molina López T.","Farm Hosp. 2015 Mar 1;39(2):80-91. doi: 10.7399/fh.2015.39.2.8218.","Galván-Banqueri M","Farm Hosp","2015","2015/03/31","","","10.7399/fh.2015.39.2.8218"
"25795232","Simulation and matching-based approaches for indirect comparison of treatments","Ishak KJ, Proskorovsky I, Benedict A.","Pharmacoeconomics. 2015 Jun;33(6):537-49. doi: 10.1007/s40273-015-0271-1.","Ishak KJ","Pharmacoeconomics","2015","2015/03/22","","","10.1007/s40273-015-0271-1"
"25773559","Critical appraisal of network meta-analyses evaluating the efficacy and safety of new oral anticoagulants in atrial fibrillation stroke prevention trials","Cope S, Clemens A, Hammès F, Noack H, Jansen JP.","Value Health. 2015 Mar;18(2):234-49. doi: 10.1016/j.jval.2014.10.012. Epub 2015 Jan 28.","Cope S","Value Health","2015","2015/03/17","","","10.1016/j.jval.2014.10.012"
"25624763","Efficacy comparison of duloxetine and SSRIs at doses approved in Japan","Harada E, Schacht A, Koyama T, Marangell LB, Tsuji T, Escobar R.","Neuropsychiatr Dis Treat. 2015 Jan 12;11:115-23. doi: 10.2147/NDT.S72642. eCollection 2015.","Harada E","Neuropsychiatr Dis Treat","2015","2015/01/28","PMC4296960","","10.2147/NDT.S72642"
"25585376","Network meta-analysis for evidence synthesis: what is it and why is it posed to dominate cardiovascular decision making?","Biondi-Zoccai G, Abbate A, Benedetto U, Palmerini T, D'Ascenzo F, Frati G.","Int J Cardiol. 2015 Mar 1;182:309-14. doi: 10.1016/j.ijcard.2015.01.023. Epub 2015 Jan 7.","Biondi-Zoccai G","Int J Cardiol","2015","2015/01/14","","","10.1016/j.ijcard.2015.01.023"
"25565891","Incorporating alternative design clinical trials in network meta-analyses","Thorlund K, Druyts E, Toor K, Jansen JP, Mills EJ.","Clin Epidemiol. 2014 Dec 23;7:29-35. doi: 10.2147/CLEP.S70853. eCollection 2015.","Thorlund K","Clin Epidemiol","2014","2015/01/08","PMC4278731","","10.2147/CLEP.S70853"
"25559771","Relative efficacy and safety of simeprevir and telaprevir in treatment-naïve hepatitis C-infected patients in a Japanese population: A Bayesian network meta-analysis","Quigley JM, Bryden PA, Scott DA, Kuwabara H, Cerri K.","Hepatol Res. 2015 Oct;45(10):E89-98. doi: 10.1111/hepr.12467. Epub 2015 Mar 3.","Quigley JM","Hepatol Res","2015","2015/01/07","","","10.1111/hepr.12467"
"25555272","Safety of short-term dual antiplatelet therapy after drug-eluting stents: An updated meta-analysis with direct and adjusted indirect comparison of randomized control trials","Bulluck H, Kwok CS, Ryding AD, Loke YK.","Int J Cardiol. 2015 Feb 15;181:331-9. doi: 10.1016/j.ijcard.2014.12.037. Epub 2014 Dec 13.","Bulluck H","Int J Cardiol","2015","2015/01/03","","","10.1016/j.ijcard.2014.12.037"
"26962372","Failure Rate of Direct High-Viscosity Glass-Ionomer Versus Hybrid Resin Composite Restorations in Posterior Permanent Teeth - a Systematic Review","Mickenautsch S, Yengopal V.","Open Dent J. 2015 Dec 22;9:438-48. doi: 10.2174/1874210601509010438. eCollection 2015.","Mickenautsch S","Open Dent J","2015","2016/03/11","PMC4768657","","10.2174/1874210601509010438"
"25534216","The efficacy and safety of different anticoagulants on patients with severe sepsis and derangement of coagulation: a protocol for network meta-analysis of randomised controlled trials","Jiang L, Jiang S, Feng X, Ma Y, Zhang M.","BMJ Open. 2014 Dec 22;4(12):e006770. doi: 10.1136/bmjopen-2014-006770.","Jiang L","BMJ Open","2014","2014/12/24","PMC4275679","","10.1136/bmjopen-2014-006770"
"25533141","Comparative efficiency research (COMER): meta-analysis of cost-effectiveness studies","Crespo C, Monleon A, Díaz W, Ríos M.","BMC Med Res Methodol. 2014 Dec 22;14:139. doi: 10.1186/1471-2288-14-139.","Crespo C","BMC Med Res Methodol","2014","2014/12/24","PMC4292992","","10.1186/1471-2288-14-139"
"25530283","Overview review: Comparative efficacy of oral ibuprofen and paracetamol (acetaminophen) across acute and chronic pain conditions","Moore RA, Derry S, Wiffen PJ, Straube S, Aldington DJ.","Eur J Pain. 2015 Oct;19(9):1213-23. doi: 10.1002/ejp.649. Epub 2014 Dec 22.","Moore RA","Eur J Pain","2015","2014/12/23","","","10.1002/ejp.649"
"25491892","Survival benefit and additional value of preoperative chemoradiotherapy in resectable gastric and gastro-oesophageal junction cancer: a direct and adjusted indirect comparison meta-analysis","Kumagai K, Rouvelas I, Tsai JA, Mariosa D, Lind PA, Lindblad M, Ye W, Lundell L, Schuhmacher C, Mauer M, Burmeister BH, Thomas JM, Stahl M, Nilsson M.","Eur J Surg Oncol. 2015 Mar;41(3):282-94. doi: 10.1016/j.ejso.2014.11.039. Epub 2014 Nov 27.","Kumagai K","Eur J Surg Oncol","2015","2014/12/11","","","10.1016/j.ejso.2014.11.039"
"25475365","Using individual patient data to adjust for indirectness did not successfully remove the bias in this case of comparative test accuracy","Wang J, Bossuyt P, Geskus R, Zwinderman A, Dolleman M, Broer S, Broekmans F, Mol BW, Leeflang M; IMPORT Study Group.","J Clin Epidemiol. 2015 Mar;68(3):290-8. doi: 10.1016/j.jclinepi.2014.10.005. Epub 2014 Dec 2.","Wang J","J Clin Epidemiol","2015","2014/12/06","","","10.1016/j.jclinepi.2014.10.005"
"25445467","Randomized controlled trials in relapsed/refractory chronic lymphocytic leukemia: a systematic review and meta-analysis","Police RL, Trask PC, Wang J, Olivares R, Khan S, Abbe A, Colosia A, Njue A, Sherrill B, Ruiz-Soto R, Kaye JA, Hamadani M.","Clin Lymphoma Myeloma Leuk. 2015 Apr;15(4):199-207. doi: 10.1016/j.clml.2014.09.008. Epub 2014 Oct 2.","Police RL","Clin Lymphoma Myeloma Leuk","2015","2014/12/03","","","10.1016/j.clml.2014.09.008"
"25438722","Comparison of the cost-effectiveness of new oral anticoagulants for the prevention of stroke and systemic embolism in atrial fibrillation in a UK setting","Zheng Y, Sorensen SV, Gonschior AK, Noack H, Heinrich-Nols J, Sunderland T, Kansal AR.","Clin Ther. 2014 Dec 1;36(12):2015-2028.e2. doi: 10.1016/j.clinthera.2014.09.015. Epub 2014 Oct 23.","Zheng Y","Clin Ther","2014","2014/12/03","","","10.1016/j.clinthera.2014.09.015"
"25414048","No evidence of disease activity: indirect comparisons of oral therapies for the treatment of relapsing-remitting multiple sclerosis","Nixon R, Bergvall N, Tomic D, Sfikas N, Cutter G, Giovannoni G.","Adv Ther. 2014 Nov;31(11):1134-54. doi: 10.1007/s12325-014-0167-z. Epub 2014 Nov 21.","Nixon R","Adv Ther","2014","2014/11/22","PMC4245493","","10.1007/s12325-014-0167-z"
"25387478","Comparative evaluation of group-based mindfulness-based stress reduction and cognitive behavioral therapy for the treatment and management of chronic pain disorders: protocol for a systematic review and meta-analysis with indirect comparisons","Hatchard T, Lepage C, Hutton B, Skidmore B, Poulin PA.","Syst Rev. 2014 Nov 10;3:134. doi: 10.1186/2046-4053-3-134.","Hatchard T","Syst Rev","2014","2014/11/13","PMC4230908","","10.1186/2046-4053-3-134"
"25361361","A systematic review and adjusted indirect comparison of oral anticoagulants","Cui J, Wu B, Liu C, Li Z.","Orthopedics. 2014 Nov;37(11):763-71. doi: 10.3928/01477447-20141023-07.","Cui J","Orthopedics","2014","2014/11/01","","","10.3928/01477447-20141023-07"
"27202690","Cost Minimization Analysis Of Clinical Option Scenarios For Metformin And Acarbose In Treatment Of Type 2 Diabetes: Based On Direct And Indirect Treatment Comparison Results","Gu S, Xu X, Shi L, Sawhney M, Hu H, Dong H.","Value Health. 2014 Nov;17(7):A745. doi: 10.1016/j.jval.2014.08.165. Epub 2014 Oct 26.","Gu S","Value Health","2014","2016/05/21","","","10.1016/j.jval.2014.08.165"
"27202160","Comparison of Mean Overall Survival (OS) and Radiographic Progression Free Survival (RPFS) Based on Matching Adjusted Indirect Comparison of Abiraterone Acetate and Enzalutamide for the Treatment of Castration-Resistant Prostate Cancer in Chemotherapy Naïve Patients","Dearden L, Majer I, Heeg B, Liwing J, Sandstrom K, Diels J.","Value Health. 2014 Nov;17(7):A616. doi: 10.1016/j.jval.2014.08.2170. Epub 2014 Oct 26.","Dearden L","Value Health","2014","2016/05/21","","","10.1016/j.jval.2014.08.2170"
"27202157","An Indirect Treatment Comparison of Cabozantinib Verse Vandetanib in Progressive Medullary Thyroid Cancer (MTC)","Rinciog C, Myrén KJ, Aldén M, Diamantopoulos A, LeReun C.","Value Health. 2014 Nov;17(7):A616-7. doi: 10.1016/j.jval.2014.08.2173. Epub 2014 Oct 26.","Rinciog C","Value Health","2014","2016/05/21","","","10.1016/j.jval.2014.08.2173"
"27202151","Comparative Effectiveness of Treatments for Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL), Using Matching Adjusted Indirect Comparison","Tongbram V, Sengupta N, Gaudig M, Sidhu M, Exuzides A, Colby C, Sanden SV, McGovern A.","Value Health. 2014 Nov;17(7):A614-5. doi: 10.1016/j.jval.2014.08.2163. Epub 2014 Oct 26.","Tongbram V","Value Health","2014","2016/05/21","","","10.1016/j.jval.2014.08.2163"
"27201950","Methodological Assessment of Matching-Adjusted Indirect Comparisons: Case Study Application To Attention Deficit/Hyperactivity Disorder (Adhd)","Shafrin J, Sikirica V, Shrestha A, Henkhaus LE, Erder MH, Chandra A.","Value Health. 2014 Nov;17(7):A579. doi: 10.1016/j.jval.2014.08.1959. Epub 2014 Oct 26.","Shafrin J","Value Health","2014","2016/05/21","","","10.1016/j.jval.2014.08.1959"
"25356603","One-year and long-term molecular response to nilotinib and dasatinib for newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison","Signorovitch JE, Betts KA, Reichmann WM, Thomason D, Galebach P, Wu EQ, Chen L, DeAngelo DJ.","Curr Med Res Opin. 2015 Feb;31(2):315-22. doi: 10.1185/03007995.2014.977992. Epub 2014 Nov 7.","Signorovitch JE","Curr Med Res Opin","2015","2014/10/31","","","10.1185/03007995.2014.977992"
"25332702","Indirect comparison of lixisenatide versus neutral protamine Hagedorn insulin as add-on to metformin and sulphonylurea in patients with type 2 diabetes mellitus","Fournier M, Germe M, Theobald K, Scholz GH, Lehmacher W.","Ger Med Sci. 2014 Oct 16;12:Doc14. doi: 10.3205/000199. eCollection 2014.","Fournier M","Ger Med Sci","2014","2014/10/22","PMC4202665","","10.3205/000199"
"25276624","Multiple treatment and indirect treatment comparisons: An overview of network meta-analysis","Bhatnagar N, Lakshmi PV, Jeyashree K.","Perspect Clin Res. 2014 Oct;5(4):154-8. doi: 10.4103/2229-3485.140550.","Bhatnagar N","Perspect Clin Res","2014","2014/10/03","PMC4170532","","10.4103/2229-3485.140550"
"25263803","Comparative efficacy of pharmacologic interventions in preventing relapse of Crohn's disease after surgery: a systematic review and network meta-analysis","Singh S, Garg SK, Pardi DS, Wang Z, Murad MH, Loftus EV Jr.","Gastroenterology. 2015 Jan;148(1):64-76.e2; quiz e14. doi: 10.1053/j.gastro.2014.09.031. Epub 2014 Sep 26.","Singh S","Gastroenterology","2015","2014/09/30","PMC4274207","NIHMS631440","10.1053/j.gastro.2014.09.031"
"25177813","[Cost-effectiveness of apixaban compared to other new oral anticoagulants in patients with non-valvular atrial fibrillation]","Rudakova AV, Tatarskiĭ BA.","Kardiologiia. 2014;54(7):43-52. doi: 10.18565/cardio.2014.7.43-52.","Rudakova AV","Kardiologiia","2014","2014/09/02","","","10.18565/cardio.2014.7.43-52"
"25275206","Core Needle and Open Surgical Biopsy for Diagnosis of Breast Lesions: An Update to the 2009 Report","Dahabreh IJ, Wieland LS, Adam GP, Halladay C, Lau J, Trikalinos TA.","Rockville (MD): Agency for Healthcare Research and Quality (US); 2014 Sep. Report No.: 14-EHC040-EF.","Dahabreh IJ","Core Needle and Open Surgical Biopsy for Diagnosis of Breast Lesions: An Update to the 2009 Report","2014","2014/09/01","","",""
"25114521","Once-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterol","Roskell NS, Anzueto A, Hamilton A, Disse B, Becker K.","Int J Chron Obstruct Pulmon Dis. 2014 Jul 31;9:813-24. doi: 10.2147/COPD.S59673. eCollection 2014.","Roskell NS","Int J Chron Obstruct Pulmon Dis","2014","2014/08/13","PMC4124050","","10.2147/COPD.S59673"
"25074856","Clinical efficacy of fidaxomicin compared with vancomycin and metronidazole in Clostridium difficile infections: a meta-analysis and indirect treatment comparison","Cornely OA, Nathwani D, Ivanescu C, Odufowora-Sita O, Retsa P, Odeyemi IA.","J Antimicrob Chemother. 2014 Nov;69(11):2892-900. doi: 10.1093/jac/dku261. Epub 2014 Jul 28.","Cornely OA","J Antimicrob Chemother","2014","2014/07/31","","","10.1093/jac/dku261"
"25056161","Dabigatran, rivaroxaban and apixaban for extended venous thromboembolism treatment: network meta-analysis","Alotaibi G, Alsaleh K, Wu C, Mcmurtry MS.","Int Angiol. 2014 Aug;33(4):301-8.","Alotaibi G","Int Angiol","2014","2014/07/25","","",""
"25054058","Indirect comparisons of efficacy and safety between seven newer targeted agents for metastatic renal cell carcinoma: A network meta-analysis of randomised clinical trials","Leung HW, Chan AL, Lin SJ.","Mol Clin Oncol. 2014 Sep;2(5):858-864. doi: 10.3892/mco.2014.323. Epub 2014 Jun 23.","Leung HW","Mol Clin Oncol","2014","2014/07/24","PMC4106731","","10.3892/mco.2014.323"
"24987832","Adjusted indirect treatment comparison of the bioavailability of WHO-prequalified first-line generic antituberculosis medicines","Gwaza L, Gordon J, Welink J, Potthast H, Leufkens H, Stahl M, García-Arieta A.","Clin Pharmacol Ther. 2014 Nov;96(5):580-8. doi: 10.1038/clpt.2014.144. Epub 2014 Jul 2.","Gwaza L","Clin Pharmacol Ther","2014","2014/07/03","","","10.1038/clpt.2014.144"
"24972449","Chemotherapy regimens for advanced pancreatic cancer: a systematic review and network meta-analysis","Gresham GK, Wells GA, Gill S, Cameron C, Jonker DJ.","BMC Cancer. 2014 Jun 27;14:471. doi: 10.1186/1471-2407-14-471.","Gresham GK","BMC Cancer","2014","2014/06/29","PMC4097092","","10.1186/1471-2407-14-471"
"24969003","Bazedoxifene versus oral bisphosphonates for the prevention of nonvertebral fractures in postmenopausal women with osteoporosis at higher risk of fracture: a network meta-analysis","Ellis AG, Reginster JY, Luo X, Cappelleri JC, Chines A, Sutradhar S, Jansen JP.","Value Health. 2014 Jun;17(4):424-32. doi: 10.1016/j.jval.2014.01.008. Epub 2014 May 5.","Ellis AG","Value Health","2014","2014/06/28","PMC5583519","NIHMS897299","10.1016/j.jval.2014.01.008"
"24969002","Searching for indirect evidence and extending the network of studies for network meta-analysis: case study in venous thromboembolic events prevention following elective total knee replacement surgery","Dequen P, Sutton AJ, Scott DA, Abrams KR.","Value Health. 2014 Jun;17(4):416-23. doi: 10.1016/j.jval.2014.02.013. Epub 2014 May 5.","Dequen P","Value Health","2014","2014/06/28","","","10.1016/j.jval.2014.02.013"
"24967519","Medication effectiveness with the use of tumor necrosis factor inhibitors among Texas Medicaid patients diagnosed with rheumatoid arthritis","Oladapo A, Barner JC, Lawson KA, Novak S, Rascati KL, Richards KM, Harrison DJ.","J Manag Care Spec Pharm. 2014 Jul;20(7):657-67. doi: 10.18553/jmcp.2014.20.7.657.","Oladapo A","J Manag Care Spec Pharm","2014","2014/06/27","","","10.18553/jmcp.2014.20.7.657"
"24909191","Uterine-sparing minimally invasive interventions in women with uterine fibroids: a systematic review and indirect treatment comparison meta-analysis","Panagiotopoulou N, Nethra S, Karavolos S, Ahmad G, Karabis A, Burls A.","Acta Obstet Gynecol Scand. 2014 Sep;93(9):858-67. doi: 10.1111/aogs.12441. Epub 2014 Jul 23.","Panagiotopoulou N","Acta Obstet Gynecol Scand","2014","2014/06/10","","","10.1111/aogs.12441"
"24895141","Preservative-free latanoprost eye drops in patients with primary open-angle glaucoma/ocular hypertension","Sanford M.","Clin Drug Investig. 2014 Jul;34(7):521-8. doi: 10.1007/s40261-014-0203-4.","Sanford M","Clin Drug Investig","2014","2014/06/05","","","10.1007/s40261-014-0203-4"
"24887172","Investigation of continuous effect modifiers in a meta-analysis on higher versus lower PEEP in patients requiring mechanical ventilation--protocol of the ICEM study","Kasenda B, Sauerbrei W, Royston P, Briel M.","Syst Rev. 2014 May 20;3:46. doi: 10.1186/2046-4053-3-46.","Kasenda B","Syst Rev","2014","2014/06/03","PMC4035853","","10.1186/2046-4053-3-46"
"24869718","Risk of serious opportunistic infections after solid organ transplantation: interleukin-2 receptor antagonists versus polyclonal antibodies. A meta-analysis","Kalil AC, Florescu MC, Grant W, Miles C, Morris M, Stevens RB, Langnas AN, Florescu DF.","Expert Rev Anti Infect Ther. 2014 Jul;12(7):881-96. doi: 10.1586/14787210.2014.917046. Epub 2014 May 29.","Kalil AC","Expert Rev Anti Infect Ther","2014","2014/05/30","","","10.1586/14787210.2014.917046"
"24824144","Incidence of Severe Nephrotoxicity With Cisplatin Based on Renal Function Eligibility Criteria: Indirect Comparison Meta-analysis","Dahal A, Bellows BK, Sonpavde G, Tantravahi SK, Choueiri TK, Galsky MD, Agarwal N.","Am J Clin Oncol. 2016 Oct;39(5):497-506. doi: 10.1097/COC.0000000000000081.","Dahal A","Am J Clin Oncol","2016","2014/05/15","","","10.1097/COC.0000000000000081"
"24796656","[Basic concepts for network meta-analysis]","Catalá-López F, Tobías A, Roqué M.","Aten Primaria. 2014 Dec;46(10):573-81. doi: 10.1016/j.aprim.2014.01.006. Epub 2014 May 5.","Catalá-López F","Aten Primaria","2014","2014/05/07","PMC6985611","","10.1016/j.aprim.2014.01.006"
"24773456","Indirect comparison of bazedoxifene vs oral bisphosphonates for the prevention of vertebral fractures in postmenopausal osteoporotic women","Ellis AG, Reginster JY, Luo X, Bushmakin AG, Williams R, Sutradhar S, Mirkin S, Jansen JP.","Curr Med Res Opin. 2014 Aug;30(8):1617-26. doi: 10.1185/03007995.2014.908279. Epub 2014 May 2.","Ellis AG","Curr Med Res Opin","2014","2014/04/30","","","10.1185/03007995.2014.908279"
"24713109","Indirect treatment comparison of new oral anticoagulants for the treatment of acute venous thromboembolism","Kang N, Sobieraj DM.","Thromb Res. 2014 Jun;133(6):1145-51. doi: 10.1016/j.thromres.2014.03.035. Epub 2014 Mar 24.","Kang N","Thromb Res","2014","2014/04/10","","","10.1016/j.thromres.2014.03.035"
"24691560","Network meta-analysis for comparing treatment effects of multiple interventions: an introduction","Catalá-López F, Tobías A, Cameron C, Moher D, Hutton B.","Rheumatol Int. 2014 Nov;34(11):1489-96. doi: 10.1007/s00296-014-2994-2. Epub 2014 Apr 2.","Catalá-López F","Rheumatol Int","2014","2014/04/03","","","10.1007/s00296-014-2994-2"
"24671099","The quality of reporting methods and results in network meta-analyses: an overview of reviews and suggestions for improvement","Hutton B, Salanti G, Chaimani A, Caldwell DM, Schmid C, Thorlund K, Mills E, Catalá-López F, Turner L, Altman DG, Moher D.","PLoS One. 2014 Mar 26;9(3):e92508. doi: 10.1371/journal.pone.0092508. eCollection 2014.","Hutton B","PLoS One","2014","2014/03/28","PMC3966807","","10.1371/journal.pone.0092508"
"24659260","Dyspnea and reversibility profile of P2Y₁₂ antagonists: systematic review of new antiplatelet drugs","Caldeira D, Pinto FJ, Ferreira JJ.","Am J Cardiovasc Drugs. 2014 Aug;14(4):303-11. doi: 10.1007/s40256-014-0071-6.","Caldeira D","Am J Cardiovasc Drugs","2014","2014/03/25","","","10.1007/s40256-014-0071-6"
"24653837","Clinical and Contrast-Enhanced Ultrasound Echography Outcomes in Psoriatic Arthritis Patients after One Year of Continuous Therapy with Anti-TNF Drugs","Bonifati C, Elia F, Graceffa D, Ceralli F, Maiani E, De Mutiis C, Solivetti FM.","ISRN Dermatol. 2014 Feb 6;2014:932721. doi: 10.1155/2014/932721. eCollection 2014.","Bonifati C","ISRN Dermatol","2014","2014/03/22","PMC3933554","","10.1155/2014/932721"
"24643323","Cost-effectiveness analyses in multiple sclerosis: a review of modelling approaches","Guo S, Pelligra C, Saint-Laurent Thibault C, Hernandez L, Kansal A.","Pharmacoeconomics. 2014 Jun;32(6):559-72. doi: 10.1007/s40273-014-0150-1.","Guo S","Pharmacoeconomics","2014","2014/03/20","","","10.1007/s40273-014-0150-1"
"24640991","Analgesic efficacy of opioids in chronic pain: recent meta-analyses","Reinecke H, Weber C, Lange K, Simon M, Stein C, Sorgatz H.","Br J Pharmacol. 2015 Jan;172(2):324-33. doi: 10.1111/bph.12634. Epub 2014 Jul 1.","Reinecke H","Br J Pharmacol","2015","2014/03/20","PMC4292950","","10.1111/bph.12634"
"24636374","Indirect treatment comparison/network meta-analysis study questionnaire to assess relevance and credibility to inform health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report","Jansen JP, Trikalinos T, Cappelleri JC, Daw J, Andes S, Eldessouki R, Salanti G.","Value Health. 2014 Mar;17(2):157-73. doi: 10.1016/j.jval.2014.01.004.","Jansen JP","Value Health","2014","2014/03/19","","","10.1016/j.jval.2014.01.004"
"24627974","Systematic evidence synthesis of treatments for ADHD in children and adolescents: indirect treatment comparisons of lisdexamfetamine with methylphenidate and atomoxetine","Roskell NS, Setyawan J, Zimovetz EA, Hodgkins P.","Curr Med Res Opin. 2014 Aug;30(8):1673-85. doi: 10.1185/03007995.2014.904772. Epub 2014 Apr 15.","Roskell NS","Curr Med Res Opin","2014","2014/03/18","","","10.1185/03007995.2014.904772"
"24617578","Comparative coronary risks of apixaban, rivaroxaban and dabigatran: a meta-analysis and adjusted indirect comparison","Loke YK, Pradhan S, Yeong JK, Kwok CS.","Br J Clin Pharmacol. 2014 Oct;78(4):707-17. doi: 10.1111/bcp.12376.","Loke YK","Br J Clin Pharmacol","2014","2014/03/13","PMC4239965","","10.1111/bcp.12376"
"24599922","What drives the comparative effectiveness of biologics vs. methotrexate in rheumatoid arthritis? Meta-regression and graphical inspection of suspected clinical factors","Kanters S, Druyts E, Mills EJ, Thorlund K.","Rheumatology (Oxford). 2014 Jul;53(7):1264-73. doi: 10.1093/rheumatology/ket492. Epub 2014 Mar 5.","Kanters S","Rheumatology (Oxford)","2014","2014/03/07","","","10.1093/rheumatology/ket492"
"24596112","Concomitant chemoradiotherapy versus altered fractionation radiotherapy in the radiotherapeutic management of locoregionally advanced head and neck squamous cell carcinoma: An adjusted indirect comparison meta-analysis","Gupta T, Kannan S, Ghosh-Laskar S, Agarwal JP.","Head Neck. 2015 May;37(5):670-6. doi: 10.1002/hed.23661. Epub 2014 Apr 30.","Gupta T","Head Neck","2015","2014/03/06","","","10.1002/hed.23661"
"24587319","The efficacy and safety of different kinds of laparoscopic cholecystectomy: a network meta analysis of 43 randomized controlled trials","Li L, Tian J, Tian H, Sun R, Wang Q, Yang K.","PLoS One. 2014 Feb 28;9(2):e90313. doi: 10.1371/journal.pone.0090313. eCollection 2014.","Li L","PLoS One","2014","2014/03/04","PMC3938681","","10.1371/journal.pone.0090313"
"24574729","Chemotherapy for patients with gastric cancer after complete resection: a network meta-analysis","Zhang YW, Zhang YL, Pan H, Wei FX, Zhang YC, Shao Y, Han W, Liu HP, Wang ZY, Yang SH.","World J Gastroenterol. 2014 Jan 14;20(2):584-92. doi: 10.3748/wjg.v20.i2.584.","Zhang YW","World J Gastroenterol","2014","2014/02/28","PMC3923035","","10.3748/wjg.v20.i2.584"
"24508420","Cost-effectiveness of apixaban versus other new oral anticoagulants for stroke prevention in atrial fibrillation","Lip GY, Kongnakorn T, Phatak H, Kuznik A, Lanitis T, Liu LZ, Iloeje U, Hernandez L, Dorian P.","Clin Ther. 2014 Feb 1;36(2):192-210.e20. doi: 10.1016/j.clinthera.2013.12.011. Epub 2014 Feb 6.","Lip GY","Clin Ther","2014","2014/02/11","","","10.1016/j.clinthera.2013.12.011"
"24493117","Meta-analysis of postoperative morbidity and perioperative mortality in patients receiving neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal and gastro-oesophageal junctional cancers","Kumagai K, Rouvelas I, Tsai JA, Mariosa D, Klevebro F, Lindblad M, Ye W, Lundell L, Nilsson M.","Br J Surg. 2014 Mar;101(4):321-38. doi: 10.1002/bjs.9418. Epub 2014 Feb 3.","Kumagai K","Br J Surg","2014","2014/02/05","","","10.1002/bjs.9418"
"24491514","Adalimumab versus infliximab for the treatment of moderate to severe ulcerative colitis in adult patients naïve to anti-TNF therapy: an indirect treatment comparison meta-analysis","Thorlund K, Druyts E, Mills EJ, Fedorak RN, Marshall JK.","J Crohns Colitis. 2014 Jul;8(7):571-81. doi: 10.1016/j.crohns.2014.01.010. Epub 2014 Feb 1.","Thorlund K","J Crohns Colitis","2014","2014/02/05","","","10.1016/j.crohns.2014.01.010"
"24460615","Indirect treatment comparison between fixed-dose-combinations of amlodipine/losartan and amlodipine/valsartan in blood pressure control","Lawrence Gould A, Unniachan S, Wu D.","Int J Clin Pract. 2014 Feb;68(2):163-72. doi: 10.1111/ijcp.12343.","Lawrence Gould A","Int J Clin Pract","2014","2014/01/28","","","10.1111/ijcp.12343"
"24314093","Everolimus and sunitinib for advanced pancreatic neuroendocrine tumors: a matching-adjusted indirect comparison","Signorovitch J, Swallow E, Kantor E, Wang X, Klimovsky J, Haas T, Devine B, Metrakos P.","Exp Hematol Oncol. 2013 Dec 6;2(1):32. doi: 10.1186/2162-3619-2-32.","Signorovitch J","Exp Hematol Oncol","2013","2013/12/10","PMC4175512","","10.1186/2162-3619-2-32"
"24308372","Bendamustine-rituximab: a cost-utility analysis in first-line treatment of indolent non-Hodgkin's lymphoma in England and Wales","Dewilde S, Woods B, Castaigne JG, Parker C, Dunlop W.","J Med Econ. 2014 Feb;17(2):111-24. doi: 10.3111/13696998.2013.873044. Epub 2014 Jan 13.","Dewilde S","J Med Econ","2014","2013/12/07","","","10.3111/13696998.2013.873044"
"24304656","Aliskiren/amlodipine vs. aliskiren/hydrochlorothiazide in hypertension: indirect meta-analysis of trials comparing the two combinations vs. monotherapy","Liu Y, Yan R, Song A, Niu X, Cao C, Wei J, Dong X, Gao D.","Am J Hypertens. 2014 Feb;27(2):268-78. doi: 10.1093/ajh/hpt210. Epub 2013 Dec 4.","Liu Y","Am J Hypertens","2014","2013/12/06","","","10.1093/ajh/hpt210"
"24281768","Effectiveness and cost-effectiveness of erlotinib versus gefitinib in first-line treatment of epidermal growth factor receptor-activating mutation-positive non-small-cell lung cancer patients in Hong Kong","Lee VW, Schwander B, Lee VH.","Hong Kong Med J. 2014 Jun;20(3):178-86. doi: 10.12809/hkmj133986. Epub 2013 Nov 22.","Lee VW","Hong Kong Med J","2014","2013/11/28","","","10.12809/hkmj133986"
"24204920","New oral anticoagulants are not superior to warfarin in secondary prevention of stroke or transient ischemic attacks, but lower the risk of intracranial bleeding: insights from a meta-analysis and indirect treatment comparisons","Sardar P, Chatterjee S, Wu WC, Lichstein E, Ghosh J, Aikat S, Mukherjee D.","PLoS One. 2013 Oct 25;8(10):e77694. doi: 10.1371/journal.pone.0077694. eCollection 2013.","Sardar P","PLoS One","2013","2013/11/09","PMC3808395","","10.1371/journal.pone.0077694"
"24114396","β-Adrenergic receptor antagonists and fracture risk: a meta-analysis of selectivity, gender, and site-specific effects","Toulis KA, Hemming K, Stergianos S, Nirantharakumar K, Bilezikian JP.","Osteoporos Int. 2014 Jan;25(1):121-9. doi: 10.1007/s00198-013-2498-z. Epub 2013 Oct 10.","Toulis KA","Osteoporos Int","2014","2013/10/12","","","10.1007/s00198-013-2498-z"
"24112715","Systematic literature review and meta-analysis of the efficacy and safety of prescription opioids, including abuse-deterrent formulations, in non-cancer pain management","Michna E, Cheng WY, Korves C, Birnbaum H, Andrews R, Zhou Z, Joshi AV, Schaaf D, Mardekian J, Sheng M.","Pain Med. 2014 Jan;15(1):79-92. doi: 10.1111/pme.12233. Epub 2013 Sep 23.","Michna E","Pain Med","2014","2013/10/12","","","10.1111/pme.12233"
"24083626","Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy for patients undergoing PCI: a meta-analysis of randomized trials with adjusted indirect comparisons","Chen Y, Zhang Y, Tang Y, Huang X, Xie Y.","Curr Med Res Opin. 2014 Jan;30(1):37-49. doi: 10.1185/03007995.2013.850067. Epub 2013 Oct 18.","Chen Y","Curr Med Res Opin","2014","2013/10/03","","","10.1185/03007995.2013.850067"
"23981687","A common reference-based indirect comparison meta-analysis of intravenous valproate versus intravenous phenobarbitone for convulsive status epilepticus","Brigo F, Igwe SC, Nardone R, Tezzon F, Bongiovanni LG, Trinka E.","Epileptic Disord. 2013 Sep;15(3):314-23. doi: 10.1684/epd.2013.0601.","Brigo F","Epileptic Disord","2013","2013/08/29","","","10.1684/epd.2013.0601"
"23975660","Comparative efficacy of guanfacine extended release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder in children and adolescents: applying matching-adjusted indirect comparison methodology","Sikirica V, Findling RL, Signorovitch J, Erder MH, Dammerman R, Hodgkins P, Lu M, Xie J, Wu EQ.","CNS Drugs. 2013 Nov;27(11):943-53. doi: 10.1007/s40263-013-0102-x.","Sikirica V","CNS Drugs","2013","2013/08/27","PMC3824845","","10.1007/s40263-013-0102-x"
"23945680","Presentational approaches used in the UK for reporting evidence synthesis using indirect and mixed treatment comparisons","Tan SH, Bujkiewicz S, Sutton A, Dequen P, Cooper N.","J Health Serv Res Policy. 2013 Oct;18(4):224-32. doi: 10.1177/1355819613498379. Epub 2013 Aug 14.","Tan SH","J Health Serv Res Policy","2013","2013/08/16","","","10.1177/1355819613498379"
"23890909","Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: a meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison","Fusaro M, Cassese S, Ndrepepa G, King LA, Tada T, Ott I, Kastrati A.","Int J Cardiol. 2013 Oct 9;168(4):4002-9. doi: 10.1016/j.ijcard.2013.06.081. Epub 2013 Jul 23.","Fusaro M","Int J Cardiol","2013","2013/07/30","","","10.1016/j.ijcard.2013.06.081"
"23881267","Relative efficacy and safety of preservative-free latanoprost (T2345) for the treatment of open-angle glaucoma and ocular hypertension: an adjusted Indirect comparison meta-analysis of randomized clinical trials","Cucherat M, Stalmans I, Rouland JF.","J Glaucoma. 2014 Jan;23(1):e69-75. doi: 10.1097/IJG.0b013e3182a075e6.","Cucherat M","J Glaucoma","2014","2013/07/25","","","10.1097/IJG.0b013e3182a075e6"
"23870607","Mixed treatment comparison meta-analysis of aspirin, warfarin, and new anticoagulants for stroke prevention in patients with nonvalvular atrial fibrillation","Assiri A, Al-Majzoub O, Kanaan AO, Donovan JL, Silva M.","Clin Ther. 2013 Jul;35(7):967-984.e2. doi: 10.1016/j.clinthera.2013.05.011.","Assiri A","Clin Ther","2013","2013/07/23","","","10.1016/j.clinthera.2013.05.011"
"23843702","Interpreting discordant indirect and multiple treatment comparison meta-analyses: an evaluation of direct acting antivirals for chronic hepatitis C infection","Druyts E, Thorlund K, Humphreys S, Lion M, Cooper CL, Mills EJ.","Clin Epidemiol. 2013 Jun 20;5:173-83. doi: 10.2147/CLEP.S44273. Print 2013.","Druyts E","Clin Epidemiol","2013","2013/07/12","PMC3702222","","10.2147/CLEP.S44273"
"23801205","[Indirect comparison of different adjuvant chemotherapies for stage II-III gastric cancer after D2 gastrectomy in Asian patients]","Jiang ZM, Wei Y, Zhang YD, Zhou SW, Yang Q, Xie DR.","Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Jun;16(6):534-7.","Jiang ZM","Zhonghua Wei Chang Wai Ke Za Zhi","2013","2013/06/27","","",""
"23718547","Indirect comparison of randomised controlled trials: comparative efficacy of dexlansoprazole vs. esomeprazole in the treatment of gastro-oesophageal reflux disease","Wu MS, Tan SC, Xiong T.","Aliment Pharmacol Ther. 2013 Jul;38(2):190-201. doi: 10.1111/apt.12349. Epub 2013 May 29.","Wu MS","Aliment Pharmacol Ther","2013","2013/05/31","","","10.1111/apt.12349"
"23691937","Comparative efficacy of oral pharmaceuticals for the treatment of chronic peripheral neuropathic pain: meta-analysis and indirect treatment comparisons","Ney JP, Devine EB, Watanabe JH, Sullivan SD.","Pain Med. 2013 May;14(5):706-19. doi: 10.1111/pme.12091. Epub 2013 Apr 22.","Ney JP","Pain Med","2013","2013/05/23","","","10.1111/pme.12091"
"23618535","Lipophilic versus hydrophilic statin therapy for heart failure: a protocol for an adjusted indirect comparison meta-analysis","Bonsu KO, Kadirvelu A, Reidpath DD.","Syst Rev. 2013 Apr 23;2:22. doi: 10.1186/2046-4053-2-22.","Bonsu KO","Syst Rev","2013","2013/04/27","PMC3639793","","10.1186/2046-4053-2-22"
"23617453","Overview of methods for comparing the efficacies of drugs in the absence of head-to-head clinical trial data","Kim H, Gurrin L, Ademi Z, Liew D.","Br J Clin Pharmacol. 2014 Jan;77(1):116-21. doi: 10.1111/bcp.12150.","Kim H","Br J Clin Pharmacol","2014","2013/04/27","PMC3895352","","10.1111/bcp.12150"
"23592392","Authors' reply to Alatorre et al.: ""cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparison""","Erder MH, Xie J, Signorovitch JE, Chen KS, Hodgkins P, Lu M, Wu EQ, Sikirica V.","Appl Health Econ Health Policy. 2013 Jun;11(3):307. doi: 10.1007/s40258-013-0025-1.","Erder MH","Appl Health Econ Health Policy","2013","2013/04/18","PMC3663979","","10.1007/s40258-013-0025-1"
"23590560","Direct and indirect comparison of the efficacy and safety of adalimumab, etanercept, infliximab and golimumab in psoriatic arthritis","Fénix-Caballero S, Alegre-del Rey EJ, Castaño-Lara R, Puigventós-Latorre F, Borrero-Rubio JM, López-Vallejo JF.","J Clin Pharm Ther. 2013 Aug;38(4):286-93. doi: 10.1111/jcpt.12045. Epub 2013 Apr 17.","Fénix-Caballero S","J Clin Pharm Ther","2013","2013/04/18","","","10.1111/jcpt.12045"
"27905751","Ingenol Mebutate -- Benefit Assessment According to §35a Social Code Book V","Institute for Quality and Efficiency in Health Care.","Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2013 Apr 11. Extract of Dossier Assessment No. A13-04.","Institute for Quality and Efficiency in Health Care","Ingenol Mebutate -- Benefit Assessment According to §35a Social Code Book V","2013","2013/04/11","","",""
"23569909","Additive potential of ginger starch on antifungal potency of honey against Candida albicans","Moussa A, Noureddine D, Hammoudi SM, Saad A, Bourabeh A, Houari H.","Asian Pac J Trop Biomed. 2012 Apr;2(4):253-5. doi: 10.1016/S2221-1691(12)60018-5.","Moussa A","Asian Pac J Trop Biomed","2012","2013/04/10","PMC3609294","","10.1016/S2221-1691(12)60018-5"
"23557834","Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison","Dretzke J, Meadows A, Novielli N, Huissoon A, Fry-Smith A, Meads C.","J Allergy Clin Immunol. 2013 May;131(5):1361-6. doi: 10.1016/j.jaci.2013.02.013. Epub 2013 Apr 1.","Dretzke J","J Allergy Clin Immunol","2013","2013/04/06","","","10.1016/j.jaci.2013.02.013"
"23549384","Comparing Bayesian and frequentist approaches for multiple outcome mixed treatment comparisons","Hong H, Carlin BP, Shamliyan TA, Wyman JF, Ramakrishnan R, Sainfort F, Kane RL.","Med Decis Making. 2013 Jul;33(5):702-14. doi: 10.1177/0272989X13481110. Epub 2013 Apr 2.","Hong H","Med Decis Making","2013","2013/04/04","","","10.1177/0272989X13481110"
"23539190","Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparison","Alatorre CI, Haynes V, Faries D, Upadhyaya H, Kelsey D.","Appl Health Econ Health Policy. 2013 Jun;11(3):305. doi: 10.1007/s40258-013-0024-2.","Alatorre CI","Appl Health Econ Health Policy","2013","2013/03/30","","","10.1007/s40258-013-0024-2"
"23519234","Relative effects of two different enoxaparin regimens as comparators against newer oral anticoagulants: meta-analysis and adjusted indirect comparison","Kwok CS, Pradhan S, Yeong JK, Loke YK.","Chest. 2013 Aug;144(2):593-600. doi: 10.1378/chest.12-2634.","Kwok CS","Chest","2013","2013/03/23","","","10.1378/chest.12-2634"
"23638487","Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons","Carlin BP, Hong H, Shamliyan TA, Sainfort F, Kane RL.","Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Mar. Report No.: 12(13)-EHC103-EF.","Carlin BP","Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons","2013","2013/03/01","","",""
"23442134","Biological treatments for moderate-to-severe psoriasis: indirect comparison","Galván-Banqueri M, Marín Gil R, Santos Ramos B, Bautista Paloma FJ.","J Clin Pharm Ther. 2013 Apr;38(2):121-30. doi: 10.1111/jcpt.12044. Epub 2013 Feb 26.","Galván-Banqueri M","J Clin Pharm Ther","2013","2013/02/28","","","10.1111/jcpt.12044"
"23339434","Matching-adjusted indirect comparison of adalimumab vs etanercept and infliximab for the treatment of psoriatic arthritis","Kirson NY, Rao S, Birnbaum HG, Kantor E, Wei RS, Cifaldi M.","J Med Econ. 2013;16(4):479-89. doi: 10.3111/13696998.2013.768530. Epub 2013 Feb 7.","Kirson NY","J Med Econ","2013","2013/01/24","","","10.3111/13696998.2013.768530"
"23244817","Rank reversal in indirect comparisons","Norton EC, Miller MM, Wang JJ, Coyne K, Kleinman LC.","Value Health. 2012 Dec;15(8):1137-40. doi: 10.1016/j.jval.2012.06.001. Epub 2012 Sep 7.","Norton EC","Value Health","2012","2012/12/19","PMC3527821","NIHMS390121","10.1016/j.jval.2012.06.001"
"23239696","Measures used to treat contrast-induced nephropathy: overview of reviews","Kwok CS, Pang CL, Yeong JK, Loke YK.","Br J Radiol. 2013 Jan;86(1021):20120272. doi: 10.1259/bjr.20120272.","Kwok CS","Br J Radiol","2013","2012/12/15","PMC3615404","","10.1259/bjr.20120272"
"23196824","Bioequivalence between generic tacrolimus products marketed in Spain by adjusted indirect comparison","Herranz M, Morales-Alcelay S, Corredera-Hernández MT, de la Torre-Alvarado JM, Blázquez-Pérez A, Suárez-Gea ML, Alvarez C, García-Arieta A.","Eur J Clin Pharmacol. 2013 May;69(5):1157-62. doi: 10.1007/s00228-012-1456-6. Epub 2012 Nov 30.","Herranz M","Eur J Clin Pharmacol","2013","2012/12/01","","","10.1007/s00228-012-1456-6"
"23186991","Overall similarity and consistency assessment scores are not sufficiently accurate for predicting discrepancy between direct and indirect comparison estimates","Xiong T, Parekh-Bhurke S, Loke YK, Abdelhamid A, Sutton AJ, Eastwood AJ, Holland R, Chen YF, Walsh T, Glenny AM, Song F.","J Clin Epidemiol. 2013 Feb;66(2):184-91. doi: 10.1016/j.jclinepi.2012.06.022. Epub 2012 Nov 24.","Xiong T","J Clin Epidemiol","2013","2012/11/29","PMC3537077","","10.1016/j.jclinepi.2012.06.022"
"23177302","[Clinical evidence synthesis and network meta-analysis with indirect-treatment comparisons]","Catalá-López F, Tobías A.","Med Clin (Barc). 2013 Feb 16;140(4):182-7. doi: 10.1016/j.medcli.2012.09.013. Epub 2012 Nov 21.","Catalá-López F","Med Clin (Barc)","2013","2012/11/27","","","10.1016/j.medcli.2012.09.013"
"23167972","Impact of evergreening on patients and health insurance: a meta analysis and reimbursement cost analysis of citalopram/escitalopram antidepressants","Alkhafaji AA, Trinquart L, Baron G, Desvarieux M, Ravaud P.","BMC Med. 2012 Nov 20;10:142. doi: 10.1186/1741-7015-10-142.","Alkhafaji AA","BMC Med","2012","2012/11/22","PMC3520785","","10.1186/1741-7015-10-142"
"23163976","A framework for organizing and selecting quantitative approaches for benefit-harm assessment","Puhan MA, Singh S, Weiss CO, Varadhan R, Boyd CM.","BMC Med Res Methodol. 2012 Nov 19;12:173. doi: 10.1186/1471-2288-12-173.","Puhan MA","BMC Med Res Methodol","2012","2012/11/21","PMC3572426","","10.1186/1471-2288-12-173"
"23150473","Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials","Fox BD, Kahn SR, Langleben D, Eisenberg MJ, Shimony A.","BMJ. 2012 Nov 13;345:e7498. doi: 10.1136/bmj.e7498.","Fox BD","BMJ","2012","2012/11/15","PMC3496553","","10.1136/bmj.e7498"
"23140823","Safety of multikinase inhibitors in metastatic renal cell carcinoma and indirect treatment comparisons","Catalá-López F.","Eur J Cancer. 2013 Mar;49(4):984-5. doi: 10.1016/j.ejca.2012.10.011. Epub 2012 Nov 6.","Catalá-López F","Eur J Cancer","2013","2012/11/13","","","10.1016/j.ejca.2012.10.011"
"23129490","Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis","Rasmussen LH, Larsen TB, Graungaard T, Skjøth F, Lip GY.","BMJ. 2012 Nov 5;345:e7097. doi: 10.1136/bmj.e7097.","Rasmussen LH","BMJ","2012","2012/11/07","PMC3489505","","10.1136/bmj.e7097"
"23113551","Cost effectiveness of guanfacine extended-release versus atomoxetine for the treatment of attention-deficit/hyperactivity disorder: application of a matching-adjusted indirect comparison","Erder MH, Xie J, Signorovitch JE, Chen KS, Hodgkins P, Lu M, Wu EQ, Sikirica V.","Appl Health Econ Health Policy. 2012 Nov 1;10(6):381-95. doi: 10.1007/BF03261873.","Erder MH","Appl Health Econ Health Policy","2012","2012/11/02","","","10.1007/BF03261873"
"23092868","Mixed treatment comparison of the treatment discontinuations of biologic disease-modifying antirheumatic drugs in adults with rheumatoid arthritis","Desai RJ, Hansen RA, Rao JK, Wilkins TM, Harden EA, Yuen A, Jonas DE, Roubey R, Jonas B, Gartlehner G, Lux L, Donahue KE.","Ann Pharmacother. 2012 Nov;46(11):1491-505. doi: 10.1345/aph.1R203. Epub 2012 Oct 23.","Desai RJ","Ann Pharmacother","2012","2012/10/25","","","10.1345/aph.1R203"
"23011014","Statistical approaches to indirectly compare bioequivalence between generics: a comparison of methodologies employing artemether/lumefantrine 20/120 mg tablets as prequalified by WHO","Gwaza L, Gordon J, Welink J, Potthast H, Hansson H, Stahl M, García-Arieta A.","Eur J Clin Pharmacol. 2012 Dec;68(12):1611-8. doi: 10.1007/s00228-012-1396-1. Epub 2012 Sep 21.","Gwaza L","Eur J Clin Pharmacol","2012","2012/09/27","","","10.1007/s00228-012-1396-1"
"22999145","Matching-adjusted indirect comparisons: a new tool for timely comparative effectiveness research","Signorovitch JE, Sikirica V, Erder MH, Xie J, Lu M, Hodgkins PS, Betts KA, Wu EQ.","Value Health. 2012 Sep-Oct;15(6):940-7. doi: 10.1016/j.jval.2012.05.004.","Signorovitch JE","Value Health","2012","2012/09/25","","","10.1016/j.jval.2012.05.004"
"22987606","Combining individual patient data and aggregate data in mixed treatment comparison meta-analysis: Individual patient data may be beneficial if only for a subset of trials","Donegan S, Williamson P, D'Alessandro U, Garner P, Smith CT.","Stat Med. 2013 Mar 15;32(6):914-30. doi: 10.1002/sim.5584. Epub 2012 Sep 17.","Donegan S","Stat Med","2013","2012/09/19","","","10.1002/sim.5584"
"22970794","Simulation evaluation of statistical properties of methods for indirect and mixed treatment comparisons","Song F, Clark A, Bachmann MO, Maas J.","BMC Med Res Methodol. 2012 Sep 12;12:138. doi: 10.1186/1471-2288-12-138.","Song F","BMC Med Res Methodol","2012","2012/09/14","PMC3524036","","10.1186/1471-2288-12-138"
"22949487","Two zotarolimus-eluting stent generations: a meta-analysis of 12 randomised trials versus other limus-eluting stents and an adjusted indirect comparison","Cassese S, Ndrepepa G, King LA, Tada T, Fusaro M, Kastrati A.","Heart. 2012 Nov;98(22):1632-40. doi: 10.1136/heartjnl-2012-302519. Epub 2012 Sep 4.","Cassese S","Heart","2012","2012/09/06","","","10.1136/heartjnl-2012-302519"
"22924967","The cost effectiveness of newer epilepsy treatments: a review of the literature on partial-onset seizures","Bolin K, Forsgren L.","Pharmacoeconomics. 2012 Oct 1;30(10):903-23. doi: 10.2165/11597110-000000000-00000.","Bolin K","Pharmacoeconomics","2012","2012/08/29","","","10.2165/11597110-000000000-00000"
"22912382","Systematic review and adjusted indirect comparison meta-analysis of oral anticoagulants in atrial fibrillation","Baker WL, Phung OJ.","Circ Cardiovasc Qual Outcomes. 2012 Sep 1;5(5):711-9. doi: 10.1161/CIRCOUTCOMES.112.966572. Epub 2012 Aug 21.","Baker WL","Circ Cardiovasc Qual Outcomes","2012","2012/08/23","","","10.1161/CIRCOUTCOMES.112.966572"
"22898892","Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada. Comparative efficacy and cost-effectiveness","Kansal AR, Sharma M, Bradley-Kennedy C, Clemens A, Monz BU, Peng S, Roskell N, Sorensen SV.","Thromb Haemost. 2012 Oct;108(4):672-82. doi: 10.1160/TH12-06-0388. Epub 2012 Aug 17.","Kansal AR","Thromb Haemost","2012","2012/08/18","","","10.1160/TH12-06-0388"
"22881362","Cost-effectiveness of everolimus vs sunitinib in treating patients with advanced, progressive pancreatic neuroendocrine tumors in the United States","Casciano R, Chulikavit M, Perrin A, Liu Z, Wang X, Garrison LP.","J Med Econ. 2012;15 Suppl 1:55-64. doi: 10.3111/13696998.2012.720319. Epub 2012 Sep 3.","Casciano R","J Med Econ","2012","2012/08/14","","","10.3111/13696998.2012.720319"
"22865774","A conditional error function approach for subgroup selection in adaptive clinical trials","Friede T, Parsons N, Stallard N.","Stat Med. 2012 Dec 30;31(30):4309-20. doi: 10.1002/sim.5541. Epub 2012 Aug 3.","Friede T","Stat Med","2012","2012/08/07","","","10.1002/sim.5541"
"22832638","Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis","Freemantle N, Cooper C, Diez-Perez A, Gitlin M, Radcliffe H, Shepherd S, Roux C.","Osteoporos Int. 2013 Jan;24(1):209-17. doi: 10.1007/s00198-012-2068-9. Epub 2012 Jul 26.","Freemantle N","Osteoporos Int","2013","2012/07/27","PMC3662000","EMS53243","10.1007/s00198-012-2068-9"
"22788256","Comparative effectiveness and child health","Prosser LA.","Pharmacoeconomics. 2012 Aug 1;30(8):637-45. doi: 10.2165/11633830-000000000-00000.","Prosser LA","Pharmacoeconomics","2012","2012/07/14","","","10.2165/11633830-000000000-00000"
"22787066","Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation","Schneeweiss S, Gagne JJ, Patrick AR, Choudhry NK, Avorn J.","Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):480-6. doi: 10.1161/CIRCOUTCOMES.112.965988. Epub 2012 Jul 10.","Schneeweiss S","Circ Cardiovasc Qual Outcomes","2012","2012/07/13","PMC3471365","NIHMS394538","10.1161/CIRCOUTCOMES.112.965988"
"22786621","Assessing the consistency assumption by exploring treatment by covariate interactions in mixed treatment comparison meta-analysis: individual patient-level covariates versus aggregate trial-level covariates","Donegan S, Williamson P, D'Alessandro U, Tudur Smith C.","Stat Med. 2012 Dec 20;31(29):3840-57. doi: 10.1002/sim.5470. Epub 2012 Jul 11.","Donegan S","Stat Med","2012","2012/07/13","","","10.1002/sim.5470"
"22771555","Adjusted indirect comparison of new oral anticoagulants for stroke prevention in atrial fibrillation","Testa L, Agnifili M, Latini RA, Mattioli R, Lanotte S, De Marco F, Oreglia J, Latib A, Pizzocri S, Laudisa ML, Brambilla N, Bedogni F.","QJM. 2012 Oct;105(10):949-57. doi: 10.1093/qjmed/hcs114. Epub 2012 Jul 6.","Testa L","QJM","2012","2012/07/10","","","10.1093/qjmed/hcs114"
"22764016","Mixed treatment comparisons using aggregate and individual participant level data","Saramago P, Sutton AJ, Cooper NJ, Manca A.","Stat Med. 2012 Dec 10;31(28):3516-36. doi: 10.1002/sim.5442. Epub 2012 Jul 5.","Saramago P","Stat Med","2012","2012/07/06","","","10.1002/sim.5442"
"22701591","Evidence for female-biased dispersal in the protandrous hermaphroditic Asian Seabass, Lates calcarifer","Yue GH, Xia JH, Liu F, Lin G.","PLoS One. 2012;7(6):e37976. doi: 10.1371/journal.pone.0037976. Epub 2012 Jun 12.","Yue GH","PLoS One","2012","2012/06/16","PMC3373547","","10.1371/journal.pone.0037976"
"22700784","Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons","Gómez-Outes A, Terleira-Fernández AI, Suárez-Gea ML, Vargas-Castrillón E.","BMJ. 2012 Jun 14;344:e3675. doi: 10.1136/bmj.e3675.","Gómez-Outes A","BMJ","2012","2012/06/16","PMC3375207","","10.1136/bmj.e3675"
"22693038","Systematic review and meta-analysis of randomized trials of central nervous system directed therapy for childhood acute lymphoblastic leukemia","Richards S, Pui CH, Gayon P; Childhood Acute Lymphoblastic Leukemia Collaborative Group (CALLCG).","Pediatr Blood Cancer. 2013 Feb;60(2):185-95. doi: 10.1002/pbc.24228. Epub 2012 Jun 12.","Richards S","Pediatr Blood Cancer","2013","2012/06/14","PMC3461084","NIHMS378763","10.1002/pbc.24228"
"22657254","Clinical and cost effectiveness of bevacizumab + FOLFIRI combination versus FOLFIRI alone as first-line treatment of metastatic colorectal cancer in South Korea","Lee EK, Revil C, Ngoh CA, Lister J, Kwon JM, Park MH, Park SJ, Park YS, Shin SJ, Lee MA, Lee NS, Zang DY, Bae EJ, Kang MJ.","Clin Ther. 2012 Jun;34(6):1408-19. doi: 10.1016/j.clinthera.2012.05.001. Epub 2012 May 31.","Lee EK","Clin Ther","2012","2012/06/05","","","10.1016/j.clinthera.2012.05.001"
"22641255","A review of preference-based health-related quality of life questionnaires in spinal cord injury research","Whitehurst DG, Noonan VK, Dvorak MF, Bryan S.","Spinal Cord. 2012 Sep;50(9):646-54. doi: 10.1038/sc.2012.46. Epub 2012 May 29.","Whitehurst DG","Spinal Cord","2012","2012/05/30","","","10.1038/sc.2012.46"
"22583463","Efficacy of once-daily indacaterol relative to alternative bronchodilators in COPD: a patient-level mixed treatment comparison","Cope S, Capkun-Niggli G, Gale R, Lassen C, Owen R, Ouwens MJ, Bergman G, Jansen JP.","Value Health. 2012 May;15(3):524-33. doi: 10.1016/j.jval.2012.01.009. Epub 2012 Apr 11.","Cope S","Value Health","2012","2012/05/16","","","10.1016/j.jval.2012.01.009"
"22552988","Comparative effectiveness research using matching-adjusted indirect comparison: an application to treatment with guanfacine extended release or atomoxetine in children with attention-deficit/hyperactivity disorder and comorbid oppositional defiant disorder","Signorovitch J, Erder MH, Xie J, Sikirica V, Lu M, Hodgkins PS, Wu EQ.","Pharmacoepidemiol Drug Saf. 2012 May;21 Suppl 2:130-7. doi: 10.1002/pds.3246.","Signorovitch J","Pharmacoepidemiol Drug Saf","2012","2012/05/04","","","10.1002/pds.3246"
"22554024","Multiple treatment comparisons in a series of anti-malarial trials with an ordinal primary outcome and repeated treatment evaluations","Whegang Youdom S, Samson A, Basco LK, Thalabard JC.","Malar J. 2012 May 3;11:147. doi: 10.1186/1475-2875-11-147.","Whegang Youdom S","Malar J","2012","2012/05/05","PMC3496581","","10.1186/1475-2875-11-147"
"27790010","The role of adalimumab in rheumatic and autoimmune disorders: comparison with other biologic agents","Reimold AM.","Open Access Rheumatol. 2012 May 3;4:33-47. doi: 10.2147/OARRR.S14569. eCollection 2012.","Reimold AM","Open Access Rheumatol","2012","2012/05/03","PMC5045097","","10.2147/OARRR.S14569"
"22525304","Risk of Clostridium difficile infection with acid suppressing drugs and antibiotics: meta-analysis","Kwok CS, Arthur AK, Anibueze CI, Singh S, Cavallazzi R, Loke YK.","Am J Gastroenterol. 2012 Jul;107(7):1011-9. doi: 10.1038/ajg.2012.108. Epub 2012 Apr 24.","Kwok CS","Am J Gastroenterol","2012","2012/04/25","","","10.1038/ajg.2012.108"
"22516128","Comparative effectiveness of antibiotics for uncomplicated urinary tract infections: network meta-analysis of randomized trials","Knottnerus BJ, Grigoryan L, Geerlings SE, Moll van Charante EP, Verheij TJ, Kessels AG, ter Riet G.","Fam Pract. 2012 Dec;29(6):659-70. doi: 10.1093/fampra/cms029. Epub 2012 Apr 19.","Knottnerus BJ","Fam Pract","2012","2012/04/21","","","10.1093/fampra/cms029"
"22505698","Indirect treatment comparison of abatacept with methotrexate versus other biologic agents for active rheumatoid arthritis despite methotrexate therapy in the United kingdom","Guyot P, Taylor PC, Christensen R, Pericleous L, Drost P, Eijgelshoven I, Bergman G, Lebmeier M.","J Rheumatol. 2012 Jun;39(6):1198-206. doi: 10.3899/jrheum.111345. Epub 2012 Apr 15.","Guyot P","J Rheumatol","2012","2012/04/17","","","10.3899/jrheum.111345"
"21609655","Trabectedin for the treatment of relapsed ovarian cancer","Papaioannou D, Rafia R, Stevenson MD, Stevens JW, Evans P.","Health Technol Assess. 2011 May;15 Suppl 1:69-75. doi: 10.3310/hta15suppl1/08.","Papaioannou D","Health Technol Assess","2011","2011/05/26","","","10.3310/hta15suppl1/08"
"22462530","Annualized relapse rate of first-line treatments for multiple sclerosis: a meta-analysis, including indirect comparisons versus fingolimod","Roskell NS, Zimovetz EA, Rycroft CE, Eckert BJ, Tyas DA.","Curr Med Res Opin. 2012 May;28(5):767-80. doi: 10.1185/03007995.2012.681637. Epub 2012 Apr 24.","Roskell NS","Curr Med Res Opin","2012","2012/04/03","","","10.1185/03007995.2012.681637"
"27905717","Heterogeneity: Subgroups, Meta-Regression, Bias And Bias-Adjustment","Dias S, Sutton AJ, Welton NJ, Ades AE.","London: National Institute for Health and Care Excellence (NICE); 2012 Apr. NICE DSU Technical Support Document No. 3.","Dias S","Heterogeneity: Subgroups, Meta-Regression, Bias And Bias-Adjustment","2012","2012/04/01","","",""
"22696776","Drug Therapy for Rheumatoid Arthritis in Adults: An Update","Donahue KE, Jonas DE, Hansen RA, Roubey R, Jonas B, Lux LJ, Gartlehner G, Harden E, Wilkins T, Peravali V, Bangdiwala SI, Yuen A, Thieda P, Morgan LC, Crotty K, Desai R, Van Noord M.","Rockville (MD): Agency for Healthcare Research and Quality (US); 2012 Apr. Report No.: 12-EHC025-EF.","Donahue KE","Drug Therapy for Rheumatoid Arthritis in Adults: An Update","2012","2012/04/01","","",""
"22414178","Erlotinib and pemetrexed as maintenance therapy for advanced non-small-cell lung cancer: a systematic review and indirect comparison","Qi WX, Tang LN, He AN, Shen Z, Lin F, Yao Y.","Curr Med Res Opin. 2012 Apr;28(4):643-50. doi: 10.1185/03007995.2012.675880. Epub 2012 Mar 29.","Qi WX","Curr Med Res Opin","2012","2012/03/15","","","10.1185/03007995.2012.675880"
"22407741","Meta-analyses: what they can and cannot do","Nordmann AJ, Kasenda B, Briel M.","Swiss Med Wkly. 2012 Mar 9;142:w13518. doi: 10.4414/smw.2012.13518. eCollection 2012.","Nordmann AJ","Swiss Med Wkly","2012","2012/03/13","","","10.4414/smw.2012.13518"
"24367204","Lapatinib in patients with metastatic breast cancer following initial treatment with trastuzumab: an economic analysis from the Brazilian public health care perspective","Machado M, Einarson TR.","Breast Cancer (Dove Med Press). 2012 Nov 13;4:173-82. doi: 10.2147/BCTT.S37003. eCollection 2012.","Machado M","Breast Cancer (Dove Med Press)","2012","2013/12/25","PMC3846651","","10.2147/BCTT.S37003"
"22197769","Improvement of flow and bulk density of pharmaceutical powders using surface modification","Jallo LJ, Ghoroi C, Gurumurthy L, Patel U, Davé RN.","Int J Pharm. 2012 Feb 28;423(2):213-25. doi: 10.1016/j.ijpharm.2011.12.012. Epub 2011 Dec 17.","Jallo LJ","Int J Pharm","2012","2011/12/27","","","10.1016/j.ijpharm.2011.12.012"
"22048230","Assessing the comparative effectiveness of newly marketed medications: methodological challenges and implications for drug development","Schneeweiss S, Gagne JJ, Glynn RJ, Ruhl M, Rassen JA.","Clin Pharmacol Ther. 2011 Dec;90(6):777-90. doi: 10.1038/clpt.2011.235. Epub 2011 Nov 2.","Schneeweiss S","Clin Pharmacol Ther","2011","2011/11/04","","","10.1038/clpt.2011.235"
"21962424","Noninvasive ventilation in acute cardiogenic pulmonary edema: a meta-analysis of randomized controlled trials","Mariani J, Macchia A, Belziti C, Deabreu M, Gagliardi J, Doval H, Tognoni G, Tajer C.","J Card Fail. 2011 Oct;17(10):850-9. doi: 10.1016/j.cardfail.2011.05.010. Epub 2011 Jul 8.","Mariani J","J Card Fail","2011","2011/10/04","","","10.1016/j.cardfail.2011.05.010"
"21937141","Raltitrexed plus cisplatin is cost-effective compared with pemetrexed plus cisplatin in patients with malignant pleural mesothelioma","Woods B, Paracha N, Scott DA, Thatcher N.","Lung Cancer. 2012 Feb;75(2):261-7. doi: 10.1016/j.lungcan.2011.07.011. Epub 2011 Sep 19.","Woods B","Lung Cancer","2012","2011/09/23","","","10.1016/j.lungcan.2011.07.011"
"21935329","Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy","Mickisch GH, Schwander B, Escudier B, Bellmunt J, Maroto JP, Porta C, Walzer S, Siebert U.","Clinicoecon Outcomes Res. 2011;3:19-27. doi: 10.2147/CEOR.S16118. Epub 2011 Jan 25.","Mickisch GH","Clinicoecon Outcomes Res","2011","2011/09/22","PMC3169982","","10.2147/CEOR.S16118"
"21920996","Adverse events associated with individual statin treatments for cardiovascular disease: an indirect comparison meta-analysis","Alberton M, Wu P, Druyts E, Briel M, Mills EJ.","QJM. 2012 Feb;105(2):145-57. doi: 10.1093/qjmed/hcr158. Epub 2011 Sep 14.","Alberton M","QJM","2012","2011/09/17","","","10.1093/qjmed/hcr158"
"21856857","Structure and host recognition of serotype 13 glycopeptidolipid from Mycobacterium intracellulare","Naka T, Nakata N, Maeda S, Yamamoto R, Doe M, Mizuno S, Niki M, Kobayashi K, Ogura H, Makino M, Fujiwara N.","J Bacteriol. 2011 Oct;193(20):5766-74. doi: 10.1128/JB.05412-11. Epub 2011 Aug 19.","Naka T","J Bacteriol","2011","2011/08/23","PMC3187198","","10.1128/JB.05412-11"
"21854080","Denosumab for the prevention of osteoporotic fractures in post-menopausal women: a NICE single technology appraisal","Scotland G, Waugh N, Royle P, McNamee P, Henderson R, Hollick R.","Pharmacoeconomics. 2011 Nov;29(11):951-61. doi: 10.2165/11589310-000000000-00000.","Scotland G","Pharmacoeconomics","2011","2011/08/23","","","10.2165/11589310-000000000-00000"
"21819162","Comparative efficacy of vildagliptin and sitagliptin in Japanese patients with type 2 diabetes mellitus: a matching-adjusted indirect comparison of randomized trials","Signorovitch JE, Wu EQ, Swallow E, Kantor E, Fan L, Gruenberger JB.","Clin Drug Investig. 2011;31(9):665-74. doi: 10.2165/11592490-000000000-00000.","Signorovitch JE","Clin Drug Investig","2011","2011/08/09","","","10.2165/11592490-000000000-00000"
"21741714","Agreement between adjusted indirect comparison and simplified network meta-analyses on prasugrel and ticagrelor (Reply to Passaro et al. - Int J Cardiol 2011)","Biondi-Zoccai G, D'Ascenzo F, Abbate A, Agostoni P, Modena MG.","Int J Cardiol. 2011 Sep 1;151(2):228-9. doi: 10.1016/j.ijcard.2011.06.036. Epub 2011 Jul 8.","Biondi-Zoccai G","Int J Cardiol","2011","2011/07/12","","","10.1016/j.ijcard.2011.06.036"
"21704235","Multikinase inhibitors in metastatic renal cell carcinoma: indirect comparison meta-analysis","Leung HW, Chan AL.","Clin Ther. 2011 Jun;33(6):708-16. doi: 10.1016/j.clinthera.2011.05.003.","Leung HW","Clin Ther","2011","2011/06/28","","","10.1016/j.clinthera.2011.05.003"
"21698473","[Is it possible to compare different studies on efficacy of biologicals in patients with rheumatoid arthritis? : mixed treatment comparison as a new tool for indirect comparison of clinical studies]","Krüger K, Hellmich B, Rubbert-Roth A, Müller-Ladner U, Kielhorn A.","Z Rheumatol. 2011 Aug;70(6):517-24. doi: 10.1007/s00393-011-0827-1.","Krüger K","Z Rheumatol","2011","2011/06/24","","","10.1007/s00393-011-0827-1"
"21692768","Cross-reactivity among some metals in a murine metal allergy model","Kinbara M, Nagai Y, Takano-Yamamoto T, Sugawara S, Endo Y.","Br J Dermatol. 2011 Nov;165(5):1022-9. doi: 10.1111/j.1365-2133.2011.10468.x. Epub 2011 Sep 20.","Kinbara M","Br J Dermatol","2011","2011/06/23","","","10.1111/j.1365-2133.2011.10468.x"
"21676119","Budesonide/formoterol vs. salmeterol/fluticasone in COPD: a systematic review and adjusted indirect comparison of pneumonia in randomised controlled trials","Halpin DM, Gray J, Edwards SJ, Morais J, Singh D.","Int J Clin Pract. 2011 Jul;65(7):764-74. doi: 10.1111/j.1742-1241.2011.02685.x.","Halpin DM","Int J Clin Pract","2011","2011/06/17","","","10.1111/j.1742-1241.2011.02685.x"
"21669367","Conducting indirect-treatment-comparison and network-meta-analysis studies: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 2","Hoaglin DC, Hawkins N, Jansen JP, Scott DA, Itzler R, Cappelleri JC, Boersma C, Thompson D, Larholt KM, Diaz M, Barrett A.","Value Health. 2011 Jun;14(4):429-37. doi: 10.1016/j.jval.2011.01.011.","Hoaglin DC","Value Health","2011","2011/06/15","","","10.1016/j.jval.2011.01.011"
"21669366","Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1","Jansen JP, Fleurence R, Devine B, Itzler R, Barrett A, Hawkins N, Lee K, Boersma C, Annemans L, Cappelleri JC.","Value Health. 2011 Jun;14(4):417-28. doi: 10.1016/j.jval.2011.04.002.","Jansen JP","Value Health","2011","2011/06/15","","","10.1016/j.jval.2011.04.002"
"21977547","Drug Class Review: Neuropathic Pain: Final Update 1 Report","Selph S, Carson S, Fu R, Thakurta S, Low A, McDonagh M.","Portland (OR): Oregon Health & Science University; 2011 Jun.","Selph S","Drug Class Review: Neuropathic Pain: Final Update 1 Report","2011","2011/06/01","","",""
"21599551","An adjusted indirect comparison of everolimus and sorafenib therapy in sunitinib-refractory metastatic renal cell carcinoma patients using repeated matched samples","Di Lorenzo G, Casciano R, Malangone E, Buonerba C, Sherman S, Willet J, Wang X, Liu Z, De Placido S.","Expert Opin Pharmacother. 2011 Jul;12(10):1491-7. doi: 10.1517/14656566.2011.587119. Epub 2011 May 21.","Di Lorenzo G","Expert Opin Pharmacother","2011","2011/05/24","","","10.1517/14656566.2011.587119"
"21585706","Comparative effectiveness of bevacizumab plus cisplatin-based chemotherapy versus pemetrexed plus cisplatin treatment in East Asian non-squamous non-small cell lung cancer patients applying real-life outcomes","Chang GC, Ahn MJ, Wright E, Kim HT, Kim JH, Kang JH, Kim SW, Sherman S, Walzer S.","Asia Pac J Clin Oncol. 2011 Jun;7 Suppl 2:34-40. doi: 10.1111/j.1743-7563.2011.01400.x.","Chang GC","Asia Pac J Clin Oncol","2011","2011/05/19","","","10.1111/j.1743-7563.2011.01400.x"
"21585704","An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia","Chang JW, Thongprasert S, Wright E, Tsang K, Kim HT, Ahn MJ, Kim JH, Kang JH, Kim SW, Walzer S.","Asia Pac J Clin Oncol. 2011 Jun;7 Suppl 2:13-21. doi: 10.1111/j.1743-7563.2011.01398.x.","Chang JW","Asia Pac J Clin Oncol","2011","2011/05/19","","","10.1111/j.1743-7563.2011.01398.x"
"21594220","Network meta-analysis of randomised controlled trials: direct and indirect treatment comparisons","Buti J, Glenny AM, Worthington HV, Nieri M, Baccini M.","Eur J Oral Implantol. 2011 Spring;4(1):55-62.","Buti J","Eur J Oral Implantol","2011","2011/05/20","","",""
"21548941","Network meta-analysis of survival data with fractional polynomials","Jansen JP.","BMC Med Res Methodol. 2011 May 6;11:61. doi: 10.1186/1471-2288-11-61.","Jansen JP","BMC Med Res Methodol","2011","2011/05/10","PMC3112194","","10.1186/1471-2288-11-61"
"21524239","Comparative efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison of randomized trials","Signorovitch JE, Wu EQ, Betts KA, Parikh K, Kantor E, Guo A, Bollu VK, Williams D, Wei LJ, DeAngelo DJ.","Curr Med Res Opin. 2011 Jun;27(6):1263-71. doi: 10.1185/03007995.2011.576238. Epub 2011 Apr 28.","Signorovitch JE","Curr Med Res Opin","2011","2011/04/29","","","10.1185/03007995.2011.576238"
"21388558","Drug efficacy by direct and adjusted indirect comparison to placebo: An illustration by Mycobacterium avium complex prophylaxis in HIV","Chu J, Sloan CE, Freedberg KA, Yazdanpanah Y, Losina E.","AIDS Res Ther. 2011 Mar 10;8:14. doi: 10.1186/1742-6405-8-14.","Chu J","AIDS Res Ther","2011","2011/03/11","PMC3065397","","10.1186/1742-6405-8-14"
"21375022","[Observation on therapeutic effect of routine acupoints plus mental activity-adjusting acupoints in the treatment of post-surgical gastroparesis syndrome]","Zhang CY.","Zhen Ci Yan Jiu. 2010 Dec;35(6):458-61.","Zhang CY","Zhen Ci Yan Jiu","2010","2011/03/08","","",""
"21375020","[Effect of otopoint-needle embedment on headache and plasma 5-HT content in migraine patients]","Jia CS, Zheng LY, Shi J, Ma XS, Li XF, Li WL, Zhu HJ.","Zhen Ci Yan Jiu. 2010 Dec;35(6):448-52, 473.","Jia CS","Zhen Ci Yan Jiu","2010","2011/03/08","","",""
"21367471","Combination of direct and adjusted indirect comparisons of sirolimus- versus paclitaxel-eluting stents for ST-segment elevation myocardial infarction","Takagi H, Umemoto T.","Int J Cardiol. 2011 May 19;149(1):142-4. doi: 10.1016/j.ijcard.2011.02.011. Epub 2011 Mar 2.","Takagi H","Int J Cardiol","2011","2011/03/04","","","10.1016/j.ijcard.2011.02.011"
"21330105","Mixed treatment comparison meta-analysis of altered fractionated radiotherapy and chemotherapy in head and neck cancer","Blanchard P, Hill C, Guihenneuc-Jouyaux C, Baey C, Bourhis J, Pignon JP; MACH-NC and MARCH Collaborative Groups.","J Clin Epidemiol. 2011 Sep;64(9):985-92. doi: 10.1016/j.jclinepi.2010.10.016. Epub 2011 Feb 18.","Blanchard P","J Clin Epidemiol","2011","2011/02/19","","","10.1016/j.jclinepi.2010.10.016"
"21239748","Comparison of certolizumab pegol with other anticytokine agents for treatment of rheumatoid arthritis: a multiple-treatment Bayesian metaanalysis","Launois R, Avouac B, Berenbaum F, Blin O, Bru I, Fautrel B, Joubert JM, Sibilia J, Combe B.","J Rheumatol. 2011 May;38(5):835-45. doi: 10.3899/jrheum.100665. Epub 2011 Jan 15.","Launois R","J Rheumatol","2011","2011/01/18","","","10.3899/jrheum.100665"
"21199320","A meta-analysis of pain response in the treatment of fibromyalgia","Roskell NS, Beard SM, Zhao Y, Le TK.","Pain Pract. 2011 Nov-Dec;11(6):516-27. doi: 10.1111/j.1533-2500.2010.00441.x. Epub 2010 Dec 28.","Roskell NS","Pain Pract","2011","2011/01/05","","","10.1111/j.1533-2500.2010.00441.x"
"21198726","Dabigatran and rivaroxaban for prevention of venous thromboembolism--systematic review and adjusted indirect comparison","Loke YK, Kwok CS.","J Clin Pharm Ther. 2011 Feb;36(1):111-24. doi: 10.1111/j.1365-2710.2010.01162.x.","Loke YK","J Clin Pharm Ther","2011","2011/01/05","","","10.1111/j.1365-2710.2010.01162.x"
"21189424","Effectiveness of valganciclovir 900 mg versus 450 mg for cytomegalovirus prophylaxis in transplantation: direct and indirect treatment comparison meta-analysis","Kalil AC, Mindru C, Florescu DF.","Clin Infect Dis. 2011 Feb 1;52(3):313-21. doi: 10.1093/cid/ciq143. Epub 2010 Dec 28.","Kalil AC","Clin Infect Dis","2011","2010/12/30","","","10.1093/cid/ciq143"
"21182357","Effectiveness of biologic therapies for rheumatoid arthritis: an indirect comparisons approach","Devine EB, Alfonso-Cristancho R, Sullivan SD.","Pharmacotherapy. 2011 Jan;31(1):39-51. doi: 10.1592/phco.31.1.39.","Devine EB","Pharmacotherapy","2011","2010/12/25","","","10.1592/phco.31.1.39"
"21097801","Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysis","Salliot C, Finckh A, Katchamart W, Lu Y, Sun Y, Bombardier C, Keystone E.","Ann Rheum Dis. 2011 Feb;70(2):266-71. doi: 10.1136/ard.2010.132134. Epub 2010 Nov 19.","Salliot C","Ann Rheum Dis","2011","2010/11/25","","","10.1136/ard.2010.132134"
"21078630","Comparative efficacy and acceptability of amitriptyline, duloxetine and milnacipran in fibromyalgia syndrome: a systematic review with meta-analysis","Häuser W, Petzke F, Üçeyler N, Sommer C.","Rheumatology (Oxford). 2011 Mar;50(3):532-43. doi: 10.1093/rheumatology/keq354. Epub 2010 Nov 14.","Häuser W","Rheumatology (Oxford)","2011","2010/11/17","","","10.1093/rheumatology/keq354"
"20935294","Dental workers' pneumoconiosis complicated by Mycobacterium avium-intracellulare complex (MAIC) infection","Collins A, Burhan H, Davies P.","Occup Environ Med. 2011 Jan;68(1):82. doi: 10.1136/oem.2010.057778. Epub 2010 Oct 8.","Collins A","Occup Environ Med","2011","2010/10/12","","","10.1136/oem.2010.057778"
"20831304","No head-to-head trial? simulate the missing arms","Caro JJ, Ishak KJ.","Pharmacoeconomics. 2010;28(10):957-67. doi: 10.2165/11537420-000000000-00000.","Caro JJ","Pharmacoeconomics","2010","2010/09/14","","","10.2165/11537420-000000000-00000"
"20831302","Comparative effectiveness without head-to-head trials: a method for matching-adjusted indirect comparisons applied to psoriasis treatment with adalimumab or etanercept","Signorovitch JE, Wu EQ, Yu AP, Gerrits CM, Kantor E, Bao Y, Gupta SR, Mulani PM.","Pharmacoeconomics. 2010;28(10):935-45. doi: 10.2165/11538370-000000000-00000.","Signorovitch JE","Pharmacoeconomics","2010","2010/09/14","","","10.2165/11538370-000000000-00000"
"20831287","Perspectives on comparative effectiveness research: views from diverse constituencies","Nellesen D, Birnbaum HG, Greenberg PE.","Pharmacoeconomics. 2010;28(10):789-98. doi: 10.2165/11535790-000000000-00000.","Nellesen D","Pharmacoeconomics","2010","2010/09/14","","","10.2165/11535790-000000000-00000"
"20828843","Adjusted indirect comparison meta-analysis of prasugrel versus ticagrelor for patients with acute coronary syndromes","Biondi-Zoccai G, Lotrionte M, Agostoni P, Abbate A, Romagnoli E, Sangiorgi G, Angiolillo DJ, Valgimigli M, Testa L, Gaita F, Sheiban I.","Int J Cardiol. 2011 Aug 4;150(3):325-31. doi: 10.1016/j.ijcard.2010.08.035. Epub 2010 Sep 9.","Biondi-Zoccai G","Int J Cardiol","2011","2010/09/11","","","10.1016/j.ijcard.2010.08.035"
"20825406","Allergy-inducing nickel concentration is lowered by lipopolysaccharide at both the sensitization and elicitation steps in a murine model","Kinbara M, Sato N, Kuroishi T, Takano-Yamamoto T, Sugawara S, Endo Y.","Br J Dermatol. 2011 Feb;164(2):356-62. doi: 10.1111/j.1365-2133.2010.10016.x. Epub 2010 Nov 23.","Kinbara M","Br J Dermatol","2011","2010/09/10","","","10.1111/j.1365-2133.2010.10016.x"
"20727460","Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer","Nuijten M, Heigener DF, Bischoff HG, Chouaid C, Vergnenègre A, de Castro Carpeño J, Aultman R, Walzer S, Siebert U.","Lung Cancer. 2010 Aug;69 Suppl 1:S4-10. doi: 10.1016/S0169-5002(10)70132-X.","Nuijten M","Lung Cancer","2010","2010/08/24","","","10.1016/S0169-5002(10)70132-X"
"20713583","Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients","Middleton LJ, Champaneria R, Daniels JP, Bhattacharya S, Cooper KG, Hilken NH, O'Donovan P, Gannon M, Gray R, Khan KS; International Heavy Menstrual Bleeding Individual Patient Data Meta-analysis Collaborative Group, Abbott J, Barrington J, Bhattacharya S, Bongers MY, Brun JL, Busfield R, Sowter M, Clark TJ, Cooper J, Cooper KG, Corson SL, Dickersin K, Dwyer N, Gannon M, Hawe J, Hurskainen R, Meyer WR, O'Connor H, Pinion S, Sambrook AM, Tam WH, van Zon-Rabelink IA, Zupi E.","BMJ. 2010 Aug 16;341:c3929. doi: 10.1136/bmj.c3929.","Middleton LJ","BMJ","2010","2010/08/18","PMC2922496","","10.1136/bmj.c3929"
"20507803","Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer","Fleeman N, Bagust A, McLeod C, Greenhalgh J, Boland A, Dundar Y, Dickson R, Tudur Smith C, Davis H, Green J, Pearson M.","Health Technol Assess. 2010 May;14 Suppl 1:47-53. doi: 10.3310/hta14Suppl1/07.","Fleeman N","Health Technol Assess","2010","2010/05/29","","","10.3310/hta14Suppl1/07"
"20418173","Comparative efficacy and harms of duloxetine, milnacipran, and pregabalin in fibromyalgia syndrome","Häuser W, Petzke F, Sommer C.","J Pain. 2010 Jun;11(6):505-21. doi: 10.1016/j.jpain.2010.01.002. Epub 2010 Apr 24.","Häuser W","J Pain","2010","2010/04/27","","","10.1016/j.jpain.2010.01.002"
"20191599","Controlling ecological bias in evidence synthesis of trials reporting on collapsed and overlapping covariate categories","Govan L, Ades AE, Weir CJ, Welton NJ, Langhorne P.","Stat Med. 2010 May 30;29(12):1340-56. doi: 10.1002/sim.3869.","Govan L","Stat Med","2010","2010/03/02","","","10.1002/sim.3869"
"20149473","Clinical outcomes of radiofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocelullar carcinoma: a meta-analysis","Germani G, Pleguezuelo M, Gurusamy K, Meyer T, Isgrò G, Burroughs AK.","J Hepatol. 2010 Mar;52(3):380-8. doi: 10.1016/j.jhep.2009.12.004. Epub 2010 Jan 17.","Germani G","J Hepatol","2010","2010/02/13","","","10.1016/j.jhep.2009.12.004"
"20142203","Effect of drug-eluting stents in patients with acute ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: a meta-analysis of randomised trials and an adjusted indirect comparison","Piscione F, Piccolo R, Cassese S, Galasso G, De Rosa R, D'Andrea C, Chiariello M.","EuroIntervention. 2010 Feb;5(7):853-60. doi: 10.4244/eijv5i7a143.","Piscione F","EuroIntervention","2010","2010/02/10","","","10.4244/eijv5i7a143"
"20084004","Meta-analysis as the core of evidence-based behavioral medicine: tools and pitfalls of a statistical approach","Nestoriuc Y, Kriston L, Rief W.","Curr Opin Psychiatry. 2010 Mar;23(2):145-50. doi: 10.1097/YCO.0b013e328336666b.","Nestoriuc Y","Curr Opin Psychiatry","2010","2010/01/20","","","10.1097/YCO.0b013e328336666b"
